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1.1 Basic concept of photochemistry 
Every chemical reaction occurs only when a molecule is provided the necessary 
activation energy. A simple example is the combustions of hydrocarbons into carbon 
dioxide and water. In this reaction, the activation energy is provided in the form of heat 
or a spark. When activation energy is provided in the form of light then the reaction is 
known as photochemical reaction. Photochemistry, a sub-discipline of chemistry, is the 
study of the interactions between atoms or molecules with light. In our day-to-day life 
many important processes involve photochemistry. The foremost example is 
photosynthesis, in which most plants use the sunlight to convert carbon dioxide and water 
into glucose and release oxygen as a side product. Not only plants but human also rely on 
photochemistry for the formation of vitamin D with sunlight. Often medicine bottles are 
made with darkened glass or labeled with ‘keep away from light’, which is necessary to 
prevent the drugs from photodegradation. 
Light is another form of electromagnetic radiation, a source of energy. The Grotthuss-
Draper law states that only the light that is absorbed by a system or molecule can bring 
about a photochemical change or photochemical reaction. Materials such as dye or 
phosphorus must be able to absorb light at optical frequencies. The Stark-Einstein law 
says that every photon that is absorbed will cause a chemical or physical reaction. The 
Franck-Condon principle says that the heavy atom nuclei do not change their positions, 
this leads to an initial geometry of the excited state which is usually not the energy 
minimum. During excitation the electron spin remains unchanged. Spin inversion during 
excitation is forbidden by quantum mechanics and therefore unlikely. 
Right after the excitation several things may happen. (1) Vibronic relaxation brings the 
molecule quickly into the new energy minimum structure for the excited state. Energy is 
released into the solvent. (2) Intersystem crossing leads to triplet states by spin inversion. 
Again, the new energy minimum is reached by vibrational relaxation. (3) Emission of 
light and return to the ground state (luminescence, fluorescence, phosphorescence). (4) 
Quenching of the exited state: energy is transferred to another molecule. Usually 
diffusion controlled dynamic quenching by collision is observed. (5) Radiation less 
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deactivation. Molecule goes back to ground state by vibrational (thermal) deactivation 
(no light emission). The energy goes to the solvent/environment of molecule.  
At the molecular level there are many reasons that make photochemistry interesting. 1) 
The excited states are rich in energy. Therefore, the reactions that may occur can be 
highly endothermic in the ground state. Using the equation E = h! we can correlate light 
of a wavelength of 350 nm with an energy of 343 kJ/mol. 2) In the excited state 
antibonding orbitals are occupied. This may allow reactions that are not possible for 
electronic reasons in the ground state. 3) Photochemical reaction can include singlet and 
triplet states, while thermal reactions usually only show singlet states. In photochemical 
reaction intermediates may be formed which are not accessible at thermal conditions. But 
for all those things to happen the most important criteria are that a molecule must absorb 
the photon and there should be a proper source of light to provide the photon of particular 
energy it requires to excite.  
A molecule absorbs visible and/or ultraviolet light, which introduces energy to recognize 
or break most covalent bonds. The equation E = hc/! tells us that longer wavelength 
visible light (400-800 nm) is less energetic than light in the accessible shorter wavelength 
(200-400 nm) near ultraviolet region (Fig. 1).  
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Fig. 1:  Energy and wavelength relationship of light (self drawn). "
Consequently, ultraviolet light is most often used to effect photochemical change. It is 
also important to construct lamps and reaction vessels from glass that is transparent to the 
desired wavelength so that the light reaches to the targeted functional group without 
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being blocked by the medium, the reactor. Quartz is used for both, reactor as well as lamp 
(cut off < 170 nm) otherwise filter of pyrex (cut off < 275 nm), corex (cut off < 260 nm) 
or vycor (cut off < 220 nm) is necessary to remove unwanted wavelengths. 
Reactant molecule is elevated to excited state by directly absorbing photon from the light 
source. If the reactant molecule is not able to absorb the required photon or if the required 
light source of certain wavelength is not available then a photosensitizer is employed, 
which absorbs the photon and transfer the energy to the reactant. This process in known 
as photosensitization. In general inorganic metal complexes and organic dyes are 
employed as photosensitizers. The reverse process is called quenching when a 
photoexcited state is deactivated by a chemical compound. 
 
1.2 Historical background 
Inspired by the ability of plants to make use of solar energy, Giacomo Ciamician 
(professor of chemistry at the university of Bologna, Italy from 1889-1922) was the first 
scientist to investigate the photochemical reaction in a systematic way. He is known as 
the father of photochemistry. He clearly understood the importance of sunlight, as 
apparent by the following words: “there is another agent that has a profound effect on 
the processes of organisms and that deserves to be deeply investigated: that is light”.1a-b 
He realized that chemistry is a central science that permeates many other field of 
knowledge, and that can play an essential role in solving the four greatest problems of 
humanity: food, health, energy and environment. Specifically, his thought on the energy 
problem are very close to those discussed in present days. He strongly recommended to 
replace fossil fuels (i.e., coal) with the energy that the earth receives from the sun 
everyday. In particular, he forecasted the production of fuels by means of artificial 
photochemical reactions (artificial photosynthesis), which is still one of the most 
important goals of current research in the field of chemistry.  
Considering the secret of complex chemistry of plants resides in the use of light, he 
undertook to study in a systematic way what he called “the chemical action of light”. He 
not only published many important results, but also he enjoyed very much working with 
light. He joked about the unexpected behavior of some photochemical reactions- “ In 
ordinary….chemistry the reactions take place in some definite way, but the 
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photochemical reactions often furnish surprises…..”.1b During his researches Ciamician 
met also an experimental difficulty. In order to perform photochemical experiments, a 
suitable light source is essential. Nowadays scientists are engaged in this research field by 
using powerful halogen, mercury and tungsten lamps with light filters that allow the 
selection of almost monochromatic light beams or LEDs. In most cases, also continuous 
or pulsed laser sources are now routine equipment in photochemical laboratories. At the 
beginning of the last century, however, halogen, mercury, LED and laser light sources 
were not yet available and the light emitted by the tungsten lamps was too faint and too 
“red” to induce photochemical reactions. Since the sun was the only convenient light 
source for his photochemical experiments, the balconies of the institute where Ciamician 
worked were the most suitable place for his laboratory (Fig. 2), and he was quite happy  
 
 
 
Fig. 2: (a) Prof. Giacomo Ciamician (1857-1922), (b) Giacomo Ciamician surveys his collection of tubes 
and flasks exposed to the sun on the balcony of his institute1a (Images are taken from ref. 1a with the 
permission of Prof. M. Venturi and Prof. V. Balzani, Bologna, Italy; authors of ref 1a). 
 
about that: “Whoever saw Ciamician in his laboratory balcony, where hundreds of 
bottles and glass pipes containing various substances and mixtures were exposed to the 
sun rays, and heard him speaking of his results and projects, can say how happy he was. 
But only who worked with him can know how much work he had to do, how much 
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patience he had to have, how able he had to be, how much nose he had to have, ... to 
isolate and characterize the products of very complex reactions ...”1b 
 
1.3 Visible light an indefinitely renewable source for chemical reactions 
Fossil fuels supply energy for transportation, industrial manufacturing, heating of 
buildings, and the production of electricity. Thus consumption of fossil fuels generates 
urgent and serious problems such as global climate variation, environmental pollution 
and natural sources depletion. However, the reserves of coal, oil, and natural gas are 
limited; in fact, they are called nonrenewable energy resources, because once the supplies 
that are available are used up, they cannot be replaced. It is predicted that at the current 
rate of energy consumption, available reserves of oil and natural gas will be greatly 
decreased during the twenty-first century. Coal is more plentiful, but its use can 
contribute to environmental problems such as global warming (an increase in Earth's 
temperature over time). Because of growing energy demands in developing nations as 
well as the energy needs of industrialized societies, it will become increasingly necessary 
to turn to alternative sources of energy in the future. Conserving energy and using it more 
efficiently are additional ways of addressing the energy problem. Giacomo noticed that 
the enormous quantity of energy that the earth received from the sun, in comparison with 
the part that is being stored by the plants in the geological periods, is largely wasted. The 
exploitation of solar light first of all involved the best use of cultivable lands in order to 
afford both food and (renewable) starting materials for the chemical industry. The 
conversion of solar energy could be improved by modern agriculture to afford enough 
food for mankind. Furthermore, plants could be used as a chemical laboratory. As for 
non-cultivable land, such as that exposed to a high amount of solar energy like the Sahara 
desert (which receives daily solar energy equivalent to five times the annual production 
of coal), suitable photochemical plants could be set up for the production of simple 
compounds such as ozone or sulfur trioxide (to be used as reagents), for organic synthesis 
or for producing electrical energy by batteries based on photochemical processes. The 
Earth receives 174 petawatts (1 petawatt = 1015 watts) of incoming solar radiation at the 
upper atmosphere. Approximately 30% is reflected back to space while the rest is 
absorbed by clouds, oceans and land masses. The spectrum of solar light at the Earth's 
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surface is mostly spread across the visible and near infrared ranges with a small part in 
the near ultraviolet (Fig. 3). Therefore, the use of visible light as a promoter in synthesis 
is very appealing because of its natural vast abundance. Apart from that handling visible 
light (compare to UV light) is very easy and safe and it can be potentially applied on an 
industrial scale.  
 
Fig. 3: Solar radiation spectrum (self drawn). 
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Necessity is the mother of invention. The increasing need for more economical synthetic 
methods and sustainable processes can be seen as a key driving force for new inventions 
that inspires the creative rethinking of known concepts, which lead to the development of 
novel chemistry. The infinitely available, easily handled and environmentally friendly 
visible light makes it attractive for chemists to promote it for green chemical reactions. 
One obstacle is the requirement for specialized photoreactors to generate high intensity 
UV light or to concentrate natural sunlight.2 Thus it is particularly important to develop 
efficient method for the utilization of visible light to perform chemical reactions. 
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However, the lack of visible light absorption by many organic molecules has limited the 
potential application of photochemical reactions. One major approach to address this 
barrier and to develop new efficient processes using visible light is the use of 
photosensitizers and photocatalysts by utilizing their electron/energy transfer processes to 
sensitize organic molecules to carry out required photochemical reactions3. Photoredox 
catalysis relies on the general property of excited states to be both more easily reduced as 
well as more easily oxidized than their corresponding ground states, and so the 
photocatalyst can serve either as an electron donor or an electron acceptor to be 
regenerated in the catalytic cycle (Scheme 1). Photo-excitation of a photocatalyst (PCat) 
by an appropriate wavelength gives an excited species with higher energy electron 
(PCat*), which may be converted to a radical cation (PCat •+) by donating an electron to 
the quencher (Q). "
 
 
Scheme 1. Photoredox catalysis by oxidative and reductive pathways with the electronic state of the 
catalyst. PCat = photocatalyst, Q = quencher, D = donor, A = acceptor, GS and ES = ground state and 
excited state of photocatalyst respectively. 
 
The quencher upon 1e-reduction results in a stable anionic radical (Q •"), which undergoes 
reductive transformations. For completing the photocatalytic cycle, the cationic radical 
species of the photocatalyst (PCat.+) accepts an electron from the donor molecule (D) and 
comes back to the ground state and get ready for next cycle (oxidative quenching) . The 
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oxidative transformation occurs when the reverse process takes place, in which the 
photoexcited catalyst (PCat*) accepts an electron from the quencher and then donates the 
same to an accepter molecule (A) with return to the ground state and completion of the 
catalytic cycle (reductive quenching). Depending upon the nature of the quencher, i.e. 
donor or acceptor, it is possible to use the photocatalyst both in oxidative as well as in 
reductive pathways. 
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Scheme 2: Inorganic and organic photoredox catalysts. 
 
A number of inorganic compounds such as TiO2, CdS, Ru(bpy)3Cl2 (1), 
Ir(ppy)2(dtbbpy)PF6 (2), Re(bpy)(CO)3SCN (3), Rh{4,4’(tBu)2bpy}3 (4) are used as 
visible light photocatalysts. Besides inorganic compounds, organic compounds are also 
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used as visible light photocatalyst, a few of these are fluorescein (5), eosin Y (6), alizarin 
red S (7), flavin (8), 9,10-dicyanoanthracene (9), rose bengal (10) etc (Scheme 2).  
 
Ru(bpy)3Cl2 as photocatalyst 
Current research has focused on the use of the widely applicable and greatly studied 
organometallic ruthenium (II) polypyridine complexes (e.g., [Ru(bpy)3]2+), which are 
superior photoredox catalysts not only because of their absorbance in the visible range 
(!max = 452 nm), but also because of their unique properties in terms of chemical stability, 
excited-state lifetimes (originating from metal-to-ligand charge-transfer (MLCT)), and 
their favorable redox potentials in the excited state that can be tuned by the adjacent 
ligands.4 Moreover, Ru(bpy)3Cl2 can readily accept a photon from a variety of light 
sources to populate the *[Ru(bpy)3]2+ metal-to-ligand charge transfer (MLCT) excited 
state (Scheme 3). *[Ru(bpy)3]2+ can function as a reductant or an oxidant depending upon 
the conditions employed and the proper selection of the quencher (Scheme 3).  
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Scheme 3: Reductive and oxidative photocatalytic cycles of Ru(bpy)3Cl2. 
 
Oxidative quenching of *[Ru(bpy)3]2+ by S2O82-, Ar-NO2, or methyl viologen (MV2+) 
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provides [Ru(bpy)3]3+, a strong oxidant (+1.29 V vs. SCE = Standard Calomel Electrode, 
in CH3CN), which can easily oxidized reactant molecules to their radical cations (SM to 
SM.+) (Path A, oxidative quenching). While the interaction of *[Ru(bpy)3]2+ with 
reductive quenchers (e.g., tertiary amine (NR3), oxalate, xanthate, ascorbate) generates 
[Ru(bpy)3]+, a strong reducing agent (-1.33 V vs. SCE in CH3CN), which is able to 
transform reactants to their radical anions (SM to SM.-) (Path B, reductive quenching).5 
In spite of the excellent photoredox properties and their ease of preparation from 
commercially available precursors, tris(bipyridine) ruthenium complexes have been paid 
very little attention from synthetic organic chemists. In 1984, Cano-Yelo and Deronzier 
reported one of the first examples, representing a photocatalytic Pschorr reaction for the 
synthesis of phenanthrene and substituted phenanthrenes (Scheme 4).6 The Pschorr 
reaction involves an intramolecular arylation upon reduction of a diazonium salt by a 
reducing agent, electrochemical reduction, or simple heating.7  
 
 
Scheme 4: Photocatalytic Pschor reaction. 
As the starting material 11 was used for the photocatalytic Pschorr reaction; visible light 
irradiation of 11 in the presence of Ru(bpy)32+ in acetonitrile produced phenanthrene 
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carboxylic acid 12 in quantitative yield. The proposed mechanism of this reaction is 
outlined in Scheme 5. Excitation of [Ru(bpy)3]2+ by visible light generates *[Ru(bpy)3]2+ 
{Ru(bpy)33+/ *Ru(bpy)32+ = - 0.86 V vs. SCE} which transfers an electron to 11 (E1/2 
= " 0.1 V vs. SCE in CH3CN) to produce the aryl radical 14. Intramolecular radical 
arylation furnishes radical 15 which undergoes oxidation by [Ru(bpy)3]3+ and subsequent 
deprotonation to give 12 while regenerating the catalyst [Ru(bpy)3]2+. 
 
 
 
Scheme 5: Mechanism of Pschorr reaction. 
 
In 2006, Hasegawa and et al. reported the photocatalytic reductive opening of C#–O 
bonds of ketoepoxides to afford $-hydroxy ketones.8 They used N,N-
dimethylbenzimidazolines (Scheme 6, compound 18 or 19) as sacrificial electron and 
hydrogen atom donors. The low oxidation potentials of ADMBI 18 (+0.28 V vs. SCE) 
and HPDMBI 19 (+0.30 V vs. SCE) suggest that the reaction is occurring via reductive 
quenching of *[Ru(bpy)3]2+ to [Ru(bpy)3]+. Protonation of the ketone allows single 
electron transfer from [Ru(bpy)3]+ to the %*-orbital of the carbonyl group of 16. 
Subsequent opening of the epoxide and hydrogen atom abstraction affords the observed 
$-hydroxy ketone 17. Although only moderate yields and conversion was achieved, this 
reaction demonstrates the potential of [Ru(bpy)3]+ as a useful reducing agent. 
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Scheme 6: Ring opening of epoxide by reductive photocatalysis. 
 
Pioneering studies by Krische et al. demonstrated that bis-enones could undergo copper- 
and cobalt-mediated single electron transfer to initiate formal [2+2] cycloaddition 
reactions.9 Inspired by this work, in 2008, Yoon and co-workers applied Ru-based 
photoredox catalysis with visible light to generate the required radical anion intermediate 
from the corresponding aryl enones.10 The electron donor diisopropylethylamine 
(DIPEA) was used to generate the reductive Ru+ species. Upon irradiation with simple 
visible-light sources or sunlight, symmetrical and unsymmetrical substrates that possess 
at least one aryl enone moiety undergo efficient cyclization with high to excellent 
diastereoselectivity (Scheme 7). Aryl enones with either electron-donating or electron-
withdrawing substituents are suitable reaction partners, while a variety of #,$-unsaturated 
carbonyl compounds can serve as Michael-type acceptors; even quaternary centers can be 
formed in the case of #-substituted derivatives (Scheme 7, 25). In contrast to the 
intramolecular reaction, in which the cis (meso) isomer is formed preferentially, the 
intermolecular dimerization affords the all-trans (rac) cyclobutane moieties. LiBF4 turned 
out to be crucial for the reaction to proceed; playing a dual role; the Li salt not only 
improves the solubility of the reactants in the CH3CN, but possibly also serves as a Lewis 
acid to facilitate the single electron transfer (SET) activation of the enone. 
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Scheme 7: Visible light photocatalysed [2+2] cycloaddition of enones. 
 
The authors proposed that excitation of [Ru(bpy)3]2+ by visible light generates the 
photoexcited state *[Ru(bpy)3]2+, which is followed by single electron transfer from 
DIPEA forming [Ru(bpy)3]+, a strong reductant (-1.33 V vs. SCE). A single electron 
reduction of lithium coordinated enone 31 produces the radical 32, eventually leading to 
the cyclobutane product 21 (Scheme 8). Presumably, an intramolecular 1,4-addition of 
radical in 31 to #, $-unsaturated carbonyl moiety takes place, followed by radical 
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cyclization, furnishing the cyclobutane radical 33. Oxidation of 33 can be achieved either 
by excited *[Ru(bpy)3]2+ or by the DIPEA radical cation and produces the cyclobutane 21 
along with [Ru(bpy)3]+ or DIPEA. 
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Scheme 8: Proposed mechanism for photocatalysed [2+2] cycloaddition reaction. 
 
After successfully achieving the homodimarization of aryl enones Yoon et al. reported a 
highly diastereoselective cross intermolecular [2+2] cycloaddition of acyclic enones 
under comparable reaction conditions.11  To overcome the major undesired pathway of 
homodimerization of the aryl enone, the authors had to select more reactive Michael 
acceptors as the second reaction component (Scheme 9). A mixture of methyl vinyl 
ketone 35 and aryl enone 34 (2.5∶1), [Ru(bpy)3]2+ (5 mol%), iPr2NEt, and LiBF4 was 
subjected to visible light irradiation for 4 h and provided the cross [2+2]-cycloadduct 36 
(84%, >10∶1 dr) in a highly chemoselective fashion. Only trace amounts of homo-
coupled product derived from 34 were observed. Both electron-rich and poor substrates 
are compatible under these conditions. 
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Scheme 9: Intermolecular [2+2] cycloaddition of enones. 
 
Variation of the substituents at the $-position was possible; however the reaction was 
sensitive to steric bulk. Substitution at the $-position with primary and secondary alkyl 
groups proceeded smoothly, whereas tert-butyl substitution provided a very low yield of 
41. #, $-Unsaturated thioesters proved to be very good Michael acceptor partners to 
provide good yields of hetero-coupled product. Formation of quaternary centers also 
proceeded smoothly with reasonably good yield and diastereoselectivity (44, 57%, dr 
5∶1). On the basis of the previous results, as expected, the reaction between two alkyl 
enones did not provide any of the cycloaddition products 45. Interestingly, irradiation of 
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34 and 35 with UV light did not provide any cycloaddition products, it causes 
predominantly photochemical E/Z isomerization of the substrates (eqn 1). 
 
 
 
The important feature of Yoon’s reactions was the selective excitation of photocatalyst 
(Ru(bpy)3Cl2) and not the enones. These visible light mediated intra- and intermolecular 
cycloaddition reactions were very effective with respect to their chemoselectivity, 
diastereoselectivity and yield. The major drawback of these methods was the requirement 
of an alkene that was sufficiently electron deficient to undergo efficient one-electron 
reduction by Ru(bpy)32+, in fact, electron rich olefins (e. g. styrene) do not react under the 
reaction conditions mentioned.  
To overcome the above mentioned disadvantage, the Yoon group designed a 
complementary method for photooxidative electron transfer catalysis that could engage 
electron-rich olefins in productive [2+2]-cycloadditions.12 Utilizing the oxidative 
quenching cycle of Ru(bpy)32+ (Scheme 10) they were able to perform intramolecular 
[2+2]-cycloaddition reactions of a variety of styrene derivatives. It seemed logical that 
the photogenerated Ru(bpy)33+ complex generated upon visible light irradiation of 
Ru(bpy)32+ in the presence of methyl viologen (MV2+) should also oxidize electron-rich 
styrene, affording a radical cation that undergoes subsequent a [2+2]-cycloaddition 
reaction. Bis(styrene) 46 (Scheme 11) underwent efficient intramolecular cycloaddition 
upon irradiation in the presence of 5 mol % [Ru(bpy)3]2+ and 15 mol % MV2+, affording 
cyclobutane 47 in 89% yield with excellent diastereoselectivity. In contrast, no 
cycloaddition product was observed upon irradiation of 46 with UV light under 
conventional methods. In this study it was also reported that the above-mentioned 
reaction works very well in MeNO2 rather than in MeCN, DMF and DMSO. 
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Scheme 10: Oxidative quenching cycle. 
 
Addition of MgSO4 gave slightly higher and reproducible yields. Both electron rich and 
electron poor styrenes reacted smoothly with the photogenerated radical cation. From the 
[2+2] cycloaddition product it was very clear that at least one styrene must bear an 
electron donating substituent at the para or ortho position (47 and 48), meta substituted 
and unsubstitured styrenes were most likely not electron rich enough to undergo one-
electron oxidation to afford the key radical cation intermediate. Substituents at the #-
position of the styrene are tolerated (52), which enables access to all-carbon quaternary 
stereocenters on the cyclobutane framework. In contrast, $-substituents significantly 
retard the rate of reaction. The identity of the tether seems to be critical; both oxygen and 
nitrogen-containing tethers gave good yields (55). 
The authors also reported that the irradiation of isomeric bis(styrene) with visible light in 
the presence of Ru(bpy)32+ and MV2+ always gave the same cis diastereomer as the major 
cycloaddition product. Compounds 57 and 58, (E,Z)-bis(styrenes) isomeric to the (E,E)-
substrate 46 (Scheme 12) were irradiated separately under the above standard conditions. 
In all cases, the major product observed was the same cis diasteromer being obtained 
from the cycloaddition of 46, indicating that the stereochemical integrity of the olefins is 
lost in the course of the reaction. 
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Scheme 11: Photooxidative [2+2] cycloaddition. 
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For better understanding they monitored the cycloaddition of 57 by GC. During the 
course of the reaction, 57 underwent isomerization to 46 at a rate competitive with that of 
cycloaddition. 
 
 
Scheme 12: Stereoconvergent [2+2] cycloaddition. 
 
As the reaction proceeds, the ratio of cis-57 to the isomeric trans cycloadduct increases 
from 1:1 at 30 min to 5:1 upon completion of the reaction. This allows the conclusion 
that the [2+2]-cycloaddition step is itself stereospecific, as predicted from previous 
theoretical and experimental studies of radical cation cyclobutanations,13 but that the rate 
of the cycloaddition is relatively slow compared to the rate of olefin isomerization.  
Merging photoredox catalysis with organocatalysis, Macmillan et al. reported14 the 
asymmetric #-alkylation of aldehydes. The combination of Ru-mediated photoredox 
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catalysis with a SOMO-type aminocatalysis (SOMO: singly occupied molecular orbital) 
provided a catalytic recycling system for the photocatalyst where both its oxidation and 
reduction steps were productive. 
 
 
 
Scheme 13: The combination of photoredox catalysis and organocatalysis. 
 
Not only does the cooperative interaction of the two catalytic cycles (photoredox and 
organocatalytic) yield #-alkylated aldehydes with high enantioselectivities in a 
previously elusive reaction, but also a sacrificial electron donor was not needed. In fact, 
the alkyl radicals, which were photocatalytically derived from the corresponding 
activated halides, were directly trapped by the electron-rich enamine species (Scheme 
13). The resulting #-amino radical was in turn oxidized by the photoexcited 
*[Ru(bpy)3]2+ providing the reductive Ru+ species for the dehalogenation. The #-
alkylation method proceeded under mild conditions and also required only a standard 
energy-saving light bulb as a light source. The chiral imidazolidinone catalyst allows for 
the effective enantiofacial differentiation for the radical attack of the enamine, but will 
not react with the sterically more hindered #-substituted products, and potential product 
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racemization by enamine formation was avoided. Broad ranges of #-alkylation products 
were accessible from aliphatic aldehydes in good to excellent yields with high 
enantioselectivities (Scheme 14). 
 
 
 
Scheme 14: Asymmetric #-alkylation of aldehyde. 
 
In a very recent extension of this merger of enamine and organometallic photoredox 
catalysis, MacMillan and coworkers have reported a visible-light-mediated, conceptually 
new approach to enantioselective #-benzylation of aldehydes.15 Irradiation of the 
catalytic system promoted the reductive generation of electrophilic benzyl radicals and 
their subsequent addition to the electron-rich enamine, which was formed by a 
cooperative aminocatalytic cycle. Good results were obtained by using the Ir-based 
complex fac-Ir(ppy)3+ (ppy = 2-phenylpyridine) in catalytic amount. The asymmetric 
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formation of the pharmaceutically important #-benzyl compounds proceeds at room 
temperature in high yields and enantioselectivity. A broad range of electron-deficient aryl 
and heteroaryl methylene bromides are well tolerated for this benzylation reaction 
(Scheme 15). 
 
 
 
Scheme 15: Asymmetric #-benzylation of aldehyde. 
 
MacMillan’s approach not only demonstrates the power of photoredox chemistry, but 
also illustrates the great possibilities that appear from the combination of different 
concepts. 
Photoredox-mediated reductive dehalogenation was first reported by Fukuzumi for #-
haloacetophenones and it has been further developed by Stephenson and co-workers into 
a synthetically useful transformation.16 Halogens #-to a carbonyl, electron withdrawing 
or aryl group could be selectively reduced under these conditions. Conceptually, this 
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reaction also proceeds via reductive quenching of photoexcited *[Ru(bpy)3]2+ to 
[Ru(bpy)3]+ and subsequent electron transfer to C–X bond #-to an electron-withdrawing 
group, followed by hydrogen abstraction. For this transformation, the authors have 
described two set of reaction conditions in DMF (Scheme 16): A. Ru(bpy)3Cl2 (1.0 
mol%), iPr2NEt (10 equiv.) and HCO2H (10 equiv.); or B. Ru(bpy)3Cl2 (1.0 mol%), 
iPr2NEt (2.0 equiv.) and Hantzsch ester (1.1 equiv.). 
 
 
 
Scheme 16: Reductive dehalogenation using photoredox catalysis. 
 
Both conditions provided reductive dehalogenation in excellent yields and could be 
chosen based on the specific substrate. In particular, condition B was utilized for less 
activated halogen substrates for which the SN2 substitution of the formate ion was 
competitive with the reductive dehalogenation when using conditions A. 
Isotopic labeling experiments revealed that iPr2NEt was the major source of the hydrogen 
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atom which quenches the alkyl radical. Based on these observations, they proposed the 
mechanism shown in Scheme 17. Reductive quenching of visible light excited 
*[Ru(bpy)3]2+ to Ru(bpy)3+ by iPr2NEt·HCO2H and subsequent electron transfer to cleave 
the C–X bond #-to an electron withdrawing group generates the alkyl radical. Reduction 
of this radical could be achieved via two pathways: (a) hydrogen abstraction from formic 
acid (Ha, minor); or (b) hydrogen abstraction from iPr2NEt (Hb, major). 
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Scheme 17: Plausible mechanism for the reductive dehalogenation. 
 
Although the reductive dehalogenation using photoredox catalysis at this stage is only 
limited to activated halogen compounds, it should be possible to be extended to the 
reduction of unactivated halogen substrates by modifying redox potentials of the 
photocatalysts. Furthermore, photocatalytic generation of a radical by the reduction of a 
C–X bond has great potential as an alternative for C–C bond forming reactions via the 
chemistry of alkyl free-radicals. 
Another conceptual attempt was made by Stephenson and co-workers was that the 
iminium ion generated under photoredox conditions could be intercepted with an 
appropriate nucleophile.17 Preliminary studies indicated that simple nucleophiles such as 
CH3OH could trap the iminium ion generated from N-aryltetrahydroisoquinolines 89 in 
the presence of Ir(ppy)2(dtbbpy)PF6 (1 mol%) under visible light irradiation. Simply 
switching the solvent from CH3OH to CH3NO2 provided the aza-Henry products in 
excellent yields for a variety of substrates (Scheme 18). Although the reaction is much 
slower, N-phenylpyrrolidine was also a competent substrate in this reaction (99, 27% 
yield, 40% conversion after 72 h). 
Both light and a photocatalyst were found to be necessary for the efficient conversion to 
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the aza-Henry products, while the exclusion of oxygen from the reaction resulted in a 
diminished rate. On the basis of luminescence quenching experiments, the following 
mechanism was proposed (Scheme 19), the radical cation of the amine 100 was formed 
upon visible light excitation of the Ir3+ catalyst and reductive quenching.  
 
 
 
Scheme 18: Oxidative aza-Henry reactions using photoredox catalyis. 
While the mechanism for catalyst turnover was not clear at this time, the authors 
proposed that adventitious oxygen likely played a critical role in the reaction. The 
corresponding radical anion may abstract a hydrogen atom from the trialkylammonium 
radical cation to form the desired iminium ion. Nucleophilic attack of nitromethane onto 
the iminium provides the observed product 103. 
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Scheme 19: Proposed mechanism of the aza-Henry reaction. 
 
The dual reactivity (oxidative and reductive quenching) of the photoexcited state of 
catalysts such as [Ru(bpy)3]2+ or Ir3+ and their applications in organic synthesis discussed 
here provide an introduction to photoredox catalysis as it has been utilized in organic 
synthesis. Recent reports by MacMillan, Yoon and Stephenson showed the utility of 
reductive as well as oxidative quenching of *[Ru(bpy)3]2+ or *Ir3+ and its application to 
various synthetic transformations. Yoon’s formal [2+2]-cycloadditions of enones 
represent ‘visible light’ as a reagent for chemical reactions. MacMillan’s photoredox 
organocatalysis demonstrates the control of facial selectivity in radical mediated 
asymmetric alkylations. Finally, Stephenson’s work on photoredox catalysis provides a 
tin-free, environmental friendly method to access free radical intermediates for reductive 
dehalogenation. These recent developments in photoredox catalysis provide early 
attempts into the broad potential of these methods to mediate a variety of useful chemical 
transformations. 
 
 
Organic Dyes as Photocatalyst 
Organic dyes, which are more environments friendly, cheaper and easier to prepare, 
present a practical alternative to inorganic photocatalysts. In fact, several industrial pilot 
studies have been conducted with organic dyes as photocatalyst.18 Organic dyes as 
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photocatalysts can also be used in conjunction with ultraviolet light from 419 nm 
Rayonet lamps. However, the high cost and toxicity of the ruthenium and iridium salts as 
well as their limited availability in the future are the practical imitation to these metal-
based methods. Therefore, the use of organic dyes as photocatalyst in combination with 
visible light is one of special interest to study.  
Recently, Choon-Hong et al. reported19 the use of Rose Bengal (10), an organic dye, as a 
visible light photocatalyst to investigate novel #-oxyamination reactions between 1,3-
dicarbonyl compounds and a free radical (TEMPO). Compounds that are difficult to 
obtain such as quaternary fluorinated compounds were synthesized using this method. 
This visible light photocatalytic reaction was also performed in water. Rose Bengal (RB), 
which has a strong absorption band in the range of 500–600 nm, was efficient in 
catalyzing the #-oxyamination reaction between $-ketoester 104 and TEMPO 105 to give 
the product 106 (Scheme 20). There is a great effect of solvent on the reactivity of this 
reaction where the optimized condition showed that acetonitrile was the best solvent for 
the photocatalysis reaction. Although [Ru(bpy)3]2+ gave very low conversion to the 
product but using Rose Bengal, very good conversion and yield were obtained. Electron 
deficient aromatic compounds showed faster reaction rate than electron rich aromatic 
compounds, while alkyl ketone ester did not give any products. Using the same 
methodology a variety of #-fluoro #-hydroxy acid derivatives were synthesized with 
high yield.  
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Scheme 20: Visible light mediated #-oxyamination reaction. 
 
As Rose Bengal is well known as a sensitizer for singlet oxygen production, control 
experiments were conducted in a glove box to verify the role of oxygen. It was clearly 
shown that oxygen was not essential for the visible light driven #-oxyamination reaction. 
Based on that result, they proposed a mechanism for the #-oxyamination reactions 
(Scheme 21).  
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Scheme 21: Proposed mechanism for #-oxyamination reaction. 
 
Photoexcitation by visible light, Rose Bengal (RB) accepts a photon from the visible light 
to form RB*. As a reductant, it transfers an electron to the substrate 104 via a single 
electron transfer process (SET). Rose Bengal was recycled via another SET process from 
the electron rich intermediate 117. The radical 118 was coupled with free radical TEMPO 
to give the product 106. Thus, this method was applied to the synthesis of a variety of #-
hydroxy acid derivatives with excellent yields and also to the synthesis of quaternary #-
fluorinated #-hydroxy acid derivatives. 
Zeitler et al. reported20 a versatile metal-free, purely organic photoredox catalysis by 
utilizing green light, the most abundant part of solar energy. They demonstrated the 
successful application of simple, inexpensive organic dyes as effective photocatalysts for 
the cooperative organocatalytic asymmetric intermolecular #-alkylation of aldehydes. 
They observed that classic organic dyes show striking similarities to the widely employed 
organometallic ruthenium- and iridium-containing photosensitizers. To achieve this 
desired transformation they investigated the conditions reported by Stephenson and co-
workers for the photocatalytic dehalogenation of activated benzylic halides in the 
presence of [Ru(bpy)3]2+. Upon irradiation with green light from high-power LEDs with 
an emission of ! = 530 nm, they found that among the dyes, eosin Y was the best organic 
photocatalyst for their subsequent studies and using the same they performed 
dehalogenations of a varieties of aromatic halogen compounds (Table 1). Electron-
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withdrawing substituents (Table 1, entry 2), polar functional groups such as esters were 
well tolerated in that conditions and exclusive chemoselectivity for #-activated substrates 
over aryl halides was observed for the defunctionalization (Table 1, entries 3 and 4). In 
all cases the obtained yields of the isolated products were equal or better than those for 
the reported transition-metal-catalyzed counterpart proving the effectiveness of their 
operationally simple, inexpensive conditions. 
Next they applied the organic dyes as photoredox catalysts in the asymmetric 
organocatalytic C"C bond formations developed by MacMillan et al. The 
transformations (Scheme 22) were found to be both high-yielding and enantioselective 
when a combination of eosin Y (6) and MacMillan’s imidazolidinone catalyst were 
applied.  
Table 1: Photocatalytic reductive dehalogenation using eosin Y 
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Even though the organic-dye-sensitized conditions required longer reaction times, but it 
did not give any product racemization. Performing the reaction under direct sunlight led 
to faster conversion with a slight lowering in enantioselectivity, most probably because of 
the increased reaction temperature. 
From a mechanistic point of view they proposed that eosin Y acts as a photoredox 
catalyst after its excitation with visible light and population of its more stable triplet state 
finally enabling single-electron transfer (Scheme 23). 
 
 
Scheme 22: Organocatalytic enantioselective #-alkylation using eosin Y as photocatalyst. 
 
Similar to the chemistry of *Ru2+ both reductive and oxidative quenching are known for 
excited eosin Y 3EY*. As all the results were comparable to those of MacMillan et al. 
they presume that eosin Y acts as a reductant relying on the sacrificial oxidation of a 
catalytic amount of the enamine as the initial electron reservoir to furnish the electron-
deficient alkyl radical by means of SET with an alkyl halide. Addition of this radical to 
the electron-rich olefin of the enamine that is simultaneously generated within the 
organocatalytic cycle merges both activation pathways. In the catalytic cycle the 
subsequent oxidation of the amino radical to the iminium species provides the electron 
for the reductive quenching of the dye’s excited state 3EY*. 
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Scheme 23: Proposed mechanism with organic dye. 
 
 
Conclusion: 
The dual reactivity of the photoexcited state of catalysts such as [Ru(bpy)3]2+ and their 
applications in organic synthesis discussed above, provide an introduction to photoredox 
catalysis as it has been utilized in organic synthesis. Recent efforts by Yoon, MacMillan 
and Stephenson demonstrate the utility of reductive quenching of *[Ru(bpy)3]2+ and its 
application to various synthetic transformations. Stephenson’s work on photoredox 
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catalysis provides a tin-free, environmental friendly method to access free radical 
intermediates for reductive dehalogenation and the mild generation of reactive iminium 
intermediates via C–H activation. On the other hand recent efforts by Tan and Zeitler 
demonstrate the use of organic dyes as photocatalyst, an alternative of metal free 
phtocatalysis using visible light makes the organic synthesis more economic and 
environmentally benign catalyst. Above all, use of visible light in organic synthesis 
makes photoredox catalysis as an attractive and ‘green’ alternative for chemical 
synthesis. These recent developments in photoredox catalysis provide an early glimpse 
into the broad potential of these methods to mediate a variety of useful chemical 
transformations. 
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2. Aim of the work 
 
2.1 Development and application of new catalytic system for organic transformation 
in presence of visible light 
The aim of this work was to develop new chemical transformations going through radical 
intermediates, which are liberated by photoredox catalysis in the presence of visible light. 
MacMillan and Stephenson have focused on the use of photoredox catalyst Ru(bpy)3Cl2 
to promote enantioselective alkylations of aldehydes1# or reductive dehalogenations,2 
respectively, starting from acyl bromides or tertiary benzyl halides. In all of these cases, 
photoexcited *Ru2+ receives an electron from a sacrificial electron donor such as a 
tertiary amine, which in turn transfers that electron to a substrate. Applying those 
conditions to a variety of primary acyl bromides, we noticed however their undesired 
direct reaction with the tertiary amine by a nucleophilic substitution, thus greatly 
reducing the yield of the desired radical processes. In the search for an alternative 
photocatalytic system we came across the combination of 1,5-dimethoxynaphthalene 
(DMN) as a primary and ascorbic acid as a sacrificial electron donor,3 being applied by 
Pandey et al.4 for the cyclization of aldehydes and ketones onto tethered#!,"$unsaturated 
esters. We studied here that these reagents in combination with Ru(bpy)3Cl2 form an 
excellent photocatalytic system allowing the visible light mediated reductive 
debromination of vicinal dibromides as well as# !$halocarbonyl compounds in high 
yields.5 ##
2.2 Photocatalytic oxygenation of cyclic enamines and enol ethers 
Last few decades, increasing attention has been drawn to "-and #-amino acids and their 
derivaties as an important constituents of natural products and as valuable intermediates 
for the preparation of peptidomimetics6 and "-and #-lactums.7 Abundant methods are 
known for the synthesis of !-amino acids,8 there are considerably fewer routes to the "-
and higher amino acid analogs.9 Reiser et al. reported10 a general approach to both "-and 
#-amino esters and amino aldehydes by ozonolysis of 2,3-dihydropyrrols and 1,2,3,4-
tetrahydropyridines. However, alternative of ozonolysis for this process is highly 
!"#$%&$'(")$*%+,$#
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desirable due to huge energy demand of the process, toxicity of ozone and safety risk. We 
developed an alternative method for oxidative ring opening of cyclic enamines and enol 
ethers by using singlet oxygen, generated by photocatalyst Ru(bpy)3Cl2 in the presence of 
visible light, to the corresponding acyclic amino aldehyde derivatives. This method is 
also applicable for oxidative ring opening of cyclic enol ethers to their formyl protected 
aldol and homoaldol products. 
 #
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3. Visible Light mediated reductive dehalogenation of !-halo ketones 
 
3.1 Reduction of Carbon–Halogen bond 
Taking into account the general resistance to degradation of organic halogenated 
materials, many efficient methods and techniques have been developed to properly treat 
this type of compounds.1 Inactivation by oxidative methods and incineration2 generally 
causes the production of some harmful chemicals. Reductive methods can be considered 
as an alternative to oxidation by incineration. Among them, electrochemical,3 
photochemical,4 ultrasonic,5 microbial,6 and radiolytic and thermal7 reductive methods 
have been reported. 
In this regard, chemical methods have been by far the most studied ones.8 The chemical 
reduction of organic halides involving the replacement of halogen by hydrogen is the so 
called hydrogenolysis of the carbon-halogen bond or hydrodehalogenation reaction. The 
great importance of this reaction draws attention from all chemists, and organic chemists 
in particular, due to its importance for organic synthesis. The large variety of reducing 
systems developed to date practically guarantees the existence of a specific reagent for a 
given substrate, to successfully carry out this type of transformation. Therefore, the 
method of choice will depend mainly on the characteristics of the substrate i.e., the nature 
of the carbon-halogen bond involved, hybridization at the halogen-bearing carbon, 
substituent effects, and the presence of other halogens or functional groups. 
The most important chemical methods8 to accomplish the hydrodehalogenation of 
organic halides are catalytic hydrogenation,9a reduction with metals or low-valent metal 
compounds,9b reduction with metal hydrides,9c-d and reduction with some strong 
nucleophilic neutral or anionic species.9e A few metal- or low-valent metal compound-
mediated processes are discussed below.  
 
3.2 Metal mediated dehalogenation 
Both alkali and alkaline-earth metals in the zero valent state are well-known reducing 
agents of the carbon-halogen bond. One of the simplest ways to achieve the halogen- 
hydrogen interchange in an organic halide is using lithium as an electron source followed 
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by the addition of a proton source. In the past few years, Yus et al. have developed a 
methodology based on the use of lithium powder and a catalytic amount of an arene 
(naphthalene) or 4,4’-di-tert-butylbiphenyl (DTBB), which has been applied to the 
generation of very reactive organolithium intermediates under very mild reaction 
conditions, either from halogenated or nonhalogenated materials.10 Thus, the lithiation 
reaction under these conditions (alternatively stoichiometric lithium naphthalenide was 
used in some cases) applied to a series of alkyl, aryl, vinyl, and benzyl chlorides or to an 
alkyl bromide, followed by the addition of water or deuterium oxide, led to the 
corresponding reduced products (Table 2).11 
 
Table 2: Reduction of organic halides with Li-naphthalene. 
starting material condition product yield(%)ref
Cl R
OO Li, C10H8, -78 °C (D)H R
OO 80-9011a,b
OH
ClPh
i) nBuLi, -78 °C
ii) Li, C10H8
OH
HPh
8911c
Cl i) Li, C10H8 , -78 °C
ii) R1COR2 R1
R2
OH
63-9611d
Cl R
OO
R = H, Me
n
R = H, Et, Ph
n = 2, 3
(D)H R
OO
n
73-9211fLi, C10H8 (4-8 %), 
-78 °C
R
NHCOPh
Cl
R = Et, Ph
i) nBuLi, -78 °C
ii) Li, C10H8 R
NHCOPh
H(D) 84-9111g,h
Cl H
 
 
Organotin hydrides are certainly the most frequently used organotin compounds in the 
laboratory, which have proved to be capable and versatile reagents for both radical 
generation and kinetically controlled radical trapping.12 By far, the most used tin hydride 
is tri-n-butyltin hydride (TBTH), with applications in many fields of synthesis including 
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the replacement of halogen by hydrogen. The system TBTH-AIBN is the most utilized 
for radical-promoted hydrodehalogenation of organic halides. For instance, in the early 
1990s Lin et al. applied it to the efficient dechlorination of 2’- chloro-3’-O-
imidazolycarbonyl and 2’-chloro-3’-O- acetyl nucleosides to give the corresponding 2’- 
deoxynucleosides in 97 % and 96 % yield, respectively.13 
anti-!-Bromo "-hydroxy esters 133, which were synthesized by Corey et al., are useful 
precursors of acetate aldols 134, obtained in good yields by debromination with TBTH-
AIBN in benzene or toluene under refluxing condition. In general, shorter reaction times 
and better yields were observed with toluene in comparison to benzene (Scheme 25).14 
 
R
O
OtBu
Br
OH nBu3SnH, AIBN PhH or PhMe
 reflux, 
30 min to 15 h
 74 - 96 %
R
O
OtBu
OH
133 134
R = Ph, Cy, (E)-PhCH=CH, PhCH2CH2  
Scheme 25: Dehalogenation of anti-!-bromo-"-hydroxy esters. 
 
There are wide varieties of tin hydrides known in literature, which show good 
performance for the dehalogenation of bromides, iodides, and !-halocarbonyl 
compounds. However, the necessity to employ stoichiometric amounts of these strongly 
reducing agents might cause problems of selectivity and functional group compatibility. 
Moreover, the toxicity of the widely used organotin compounds makes the development 
of more sustainable alternatives desirable. 
 
!"3 Visible light promoted dehalogenation 
To overcome the disadvantage of using reagents that are toxic, hazardous and difficult to 
purify (cf. nBu3SnH/AIBN) for dehalogenations, Stephenson et al. reported15 a 
conceptually new methodology for the tin-free reductive dehalogenation reaction 
promoted by visible light in the presence of a catalytic amount of photocatalyst, 
Ru(bpy)3Cl2. They showed dehalogenation of a variety of compounds by utilizing the 
reductive quenching property of photoexcited *Ru(bpy)32+ to Ru(bpy)3+ and subsequent 
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electron transfer to carbon-halogen bond !-to an electron-withdrawing group, followed 
by proton abstraction. The visible light mediated reductive cleavage of !-activated 
carbon–halogen bonds proceeds under mild conditions by a radical mechanism and 
tolerates a number of different hydrogen sources. When a tenfold excess of iPr2NEt was 
used, the tertiary amine plays a dual role, sacrificially donating an electron to form the Ru 
reductant and allowing hydrogen- atom transfer from the amine radical cation.16 
However, if the amine-based formation of a radical is less feasible, formic acid can serve 
as a hydrogen source, as was shown by isotope labeling experiments. Alternatively, 
Hantzsch ester derivatives can act as highly efficient hydrogen sources, providing high 
yields of products in comparable reaction times (Scheme 5). Here Hantzsch esters offer 
the advantage to avoid competitive SN2-type side reactions of the formate ion. 
 
N Boc
N Boc
Br
H
Br
N Boc
N Boc
Br
H
H
A.  Ru(bpy)3Cl2
14W fluorescen bulb
iPr2NEt/HCO2H 
DMF,  90 %
81 82
or
B.  Ru(bpy)3Cl2
14W fluorescen bulb
iPr2NEt/ Hantschz ester  
DMF,  95 %
N Boc
N Boc
Br
H
+ Br
Ru+
Ru2+
*Ru2+
h!
iPr2NEt
iPr2NEt
  H
 
Scheme 26: Tin-free photoredox catalytic reductive dehalogenation. 
 
3.4 Development of Ru(bpy)3Cl2-Dimethoxynaphthalene-Ascorbic acid combination 
for dehalogenation 
Recently, our group has focused on the use of renewable and sustainable materials for 
organic transformation. Realizing the practical advantage of visible light as an “infinitely 
available” promoter for chemical transformation and inspired by the work of MacMillan17 
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and Stephenson,15 we focused our research to develop new chemical transformations 
going through radical intermediates. We wanted to utilize alkyl and vinyl bromides as 
radical precursors being liberated by photoredox catalysis in the presence of visible light. 
The idea was to trap an alkyl radical, which was generated by photoredox catalysis in the 
presence of visible light, by an alkene. Since the 2-bromoacetophenone (121) generates 
an alkyl radical very smoothly with Ru(bpy)32+ in the presence of visible light (as 
reported by MacMillan17), we used the same to trap the alkyl radical with 1-octene or 
with allyl benzene. Applying identical conditions reported by MacMillan17 and 
Stephenson15, we observed a negligible amount of addition product 136 (Scheme 27).  
 
entry alkene product isolated yield (%)
1 C5H11 7
2 Ph 10
Br
O
2 eqv. 1 eqv.
R +
R
Br
Ph
O
A. Ru(bpy)3Cl2 (0.5 mol%)
     2,6-lutidine (2 equiv.) 
     455 nm, DMF, rt, 24-48 h
 or
B. Ru(bpy)3Cl2 (0.5 mol%)
     DIPEA (2 equiv.), 455 nm
     DMF, rt, 24-48 h
O
Ph
Br
Ph
O
Ph
Br
C5H11
3
O
I
O
No cyclized product -----
121
halide
121
121
.....
135 136
135a 136a
135b 136b
135c  
Scheme 27: Addition of alkyl halide to alkene mediated by visible light. 
 
In both cases only one regioisomeric product was obtained (entry 1 and 2, Scheme 27). 
Surprisingly, we noticed that there was no starting material (alkyl halide 121, used in 1 
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equiv.) remaining at the end of the reaction. Low yield of the product and at the same 
time total consumption of starting material prompted us to investigate the mass balance 
of the reaction. In further investigation we observed that tertiary amine (DIPEA or 2,6-
lutidine), which was used as sacrificial electron donor, underwent nucleophilic 
substitution reaction with the halide and resulted in the formation of undesired quaternary 
ammonium salt of the corresponding amine (Scheme 28), thus greatly reducing the yield 
of the desired radical process. We performed the reaction with several tertiary amines that 
are relatively less nucleophilic and more sterically hindered around the nitrogen centre to 
prevent nuclophilic attack to the halide. Nevertheless, in all cases we ended up with the 
undesired quaternary salt. Therefore, it was necessary to find a sacrificial electron donor 
that had more or less no nucleophilicity under the above reaction conditions. 
 
Ph
O
Br
+ NR3
Ph
O
NR3Br
O
N
Br
O
N
O
I
O
N
Br
121 137 138
138a 138b 138c  
Scheme 28: Formation of ammonium salt. 
 
In search of an alternative photocatalytic system we came across the combination of 1,5-
dimethoxynaphthalene (DMN) as a primary and ascorbic acid as secondary and 
sacrificial electron donor, as applied by Pandey et al.18 for the cyclization of aldehydes 
and ketones onto the tethered !, "-unsaturated ester by employing 9,10-
dicyanoanthracene (DCA) as a visible light harvesting electron acceptor (Scheme 29). 
We applied this sacrificial electron donor combination (DMN and ascorbic acid) with 
Ru(bpy)32+ for our reaction conditions in the presence of visible light. The reactions 
(Scheme 27) were again performed with this new photocatalytic system using DMF alone 
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and DMF : iPrOH : H2O = 88 : 10 : 2 mixture (as reported by Pandey et al.18) as solvent. 
In both cases, reactions were not clean and gave unidentified mixture of products. 
Subsequently, we performed the reactions in isopropanol-water mixture (10:1), 
nevertheless, the desired addition product was observed only in very low yield as 
compared to the previous case.  
 
CO2Et
O OH
CO2Et
O O+
(92:8)
PET
22h
77 %
PET
20h
86 %
OH CO2Et
O
O
+
(82:18)
O
OH CO2Et
O
O
+
(79 : 21)
PET
20h
89%
COOEt
O
COOEt
OH
RDCA (25 mol%)
DMN (20 mol %)
ascorbic acid (2.5 equiv.)
DMF: iPrOH: H2O = 88:10:2
405 nm
R
CO2Et
2
O
CO2Et
2
139 140
139a 140a 140A
139b 140b 140B
139c 140c 140C  
Scheme 29: Cyclization of aldehyde and ketones to their tethered !, "-unsaturated ester 
                    reported by Pandey et al.18 (PET = Photoinduced Electron Transfer). 
 
In addition to the desired product, one major side product was formed which was found 
to be the reduced product originating from the alkyl halide (Scheme 30). With this result, 
we came to the conclusion that in the reaction medium the alkyl radical was generated by 
the new photocatalytic system and it abstracted a proton more rapidly from a solvent 
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molecule or from ascorbic acid than trapping by the alkene which was present in the 
reaction mixture. We verified that reaction pathway in the absence of alkene to check 
whether it gave complete conversion to the reduced product. Indeed, 121 was completely 
converted to acetophenone within a few hours with good yield (Scheme 30). At the time 
of our study, there had only been one report from Stephenson group,15 for the 
dehalogenation of an alkyl halide using visible light in which they used tertiary amine as 
electron donor. With this result in hand, we decided to apply our photocatalytic 
combination (Ru(bpy)32+, DMN and ascorbic acid) to reductive dehalogenation of alkyl 
halides. 
 
Br
O
2 eqv. 1 eqv.
R +
R
Br
Ph
O
   Ru(bpy)3Cl2 (0.5 mol%)
   DMN (1 equiv.)
   ascorbic acid (2 equiv.)
121
DMF:iPrOH:H2O = 88:10:2
455 nm LED,  rt, 12 h
unidentified mixture 
of products
Br
O
2 eqv. 1 eqv.
R +
   Ru(bpy)3Cl2 (0.5 mol%)
   DMN (1 equiv.)
   ascorbic acid (2 equiv.)
121
iPrOH:H2O = 10:1
 455 nm LED,  rt, 12 h
+
O
R = -C5H11, 10%
R = -Ph, 14% major
Br
O
1 eqv.
   Ru(bpy)3Cl2 (0.5 mol%)
   DMN (1 equiv.)
   ascorbic acid (2 equiv.)
121
iPrOH:H2O = 10:1
 455 nm LED,  rt, 6 h
O
70%
135
135 136 141
141  
 
Scheme 30: Reaction with new photocatalytic system leads to dehlogenated product. 
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3.5 Dehalogenation of aromatic and cyclic aliphatic !-halo carbonyl compounds 
The new catalytic system, which we developed, was applied for the dehalogentaion of 
aromatic and cyclic aliphatic !-halo carbonyl compounds.  
 
Ru(bpy)3Cl2 (2 mol%)
DMN (50 mol%)
ascorbic acid (2 equiv)
MeOH:H2O (10:1)
blue LED
O O
142 143
R RX H
 
Scheme 31: Photocatalytic reductive dehalogenation of !-halocarbonyl compounds. 
 
Irradiation of !-halo carbonyl compound 142 by blue LED (455 ± 10 nm) with 
Ru(bpy)3Cl2 in the presence of DMN and ascorbic acid smoothly gave rise to 
corresponding dehalogenated compound 143 (Scheme 31). Reaction conditions for the 
dehalogenation were optimized using 2-bromo-1-(4-methoxyphenyl)ethanone 142a 
(Table 3, entry1) as model substrate.  
 
Table 3: Photocatalyzed reductive dehalogenation of !-haloketonesa. 
entry substrate time (h)
isolated
yieldb  (%)product
1 5
5 89
93
2
24 72
12 84
3
4
O
X
MeO
O
MeO
O
Br
Br
O
Br
O
Br
O2N
O
O2N
O
Br
O
142a X=Br
142b X=Cl
40 90c
15 81
143a
142c 143c
142d 143d
142e 143e
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8 7518
O
Ph
X
 142j X= Br
 142k X= Cl
143j
O
Ph 24 63
Br
Br 142l
9
NRd 48
entry substrate time (h)
isolated
yieldb  (%)product
aReaction conditions: organohalide (1.0 equiv), Ru(bpy)3Cl2 (2 mol%), DMN (50 mol%), ascorbic acid (2 
equiv), MeOH/H2O = 10:1, blue LED. bIsolated yield after purification by chromatography on SiO2, c10
mol% DMN was employed, dNR = no reaction.
24
24
54
71
5
6
O
Br
MeO
O
MeO
O
X
O
142f 143f
142g X= Br
142h X=Cl
143g
36 82
7
O
Br
O
24 50
142i 143i
 
 
Optimization of reaction conditions revealed that a methanol-water mixture (10:1) was 
the best choice of solvent for the process, employing 2 mol% of ruthenium catalyst and 
50 mol% of DMN. The reaction proceeded well in acetonitrile or only methanol, 
although with considerably longer reaction times (24 h instead of 5 h for full conversion), 
while DMF resulted in an unclean reaction with the formation of a number of 
unidentified side products. A control experiment excluding Ru(bpy)3Cl2 gave a very 
negligible amount of 143a whereas decreasing the amount of DMN (10 mol%) required 
40 h to complete the reaction. For this process we also observed that a carbonyl group 
next to halogen was necessary for successful dehalogentaion, which was confirmed when 
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142l was subjected to the same conditions for dehalogenation. Even after 48 h the starting 
material was intact (Table 3, entry 9). Both primary and secondary !-bromocarbonyl 
compounds can be reduced in high yield (Table 3, entries 1-8) under the reaction 
conditions. This protocol was also amenable to the corresponding !-chlorocarbonyl 
compounds. However, longer reaction times were necessary to achieve good conversion 
(Table 3, entries 1, 6 and 8). Good functional group tolerance, notably for those that 
could in principle also undergo reduction such as aromatic nitro or bromo moieties (Table 
3, entries 2, 3) was observed.  
 
 
 
3.6 Selective mono-debromination of ! ,!-dibromo compounds 
The selective debromination of !-bromoketones is a useful transformation in organic 
synthesis and remains a challenging problem because of the presence of more than one 
reducible groups. The problem becomes more complicated in !,!-dibromoketones 
particularly when selective debromination of one bromo group is required. Although a 
number of methods have been reported for the debromination of !-bromocarbonyl 
compounds using a variety of reagents, only one procedure is known19 for 
monodebromination of gem-!,!-dibromoketones. This provoked us to find a suitable 
method for this challenging transformation. 
In this regard, the protocol, which we developed for the reduction of acyl halides, was 
applied for selective debromination of !, !-dibromo to their corresponding monobromo 
ketones. By proper control of reaction time, the selective photocatalytic reduction of !, 
!-dibromoketones to either monobromo ketones or to the doubly debrominated parent 
ketones became possible (Scheme 32). The reaction conditions were the same as for 
debromination of !-halocarbonyl compounds except that for selective 
monodebromination the reaction was stopped (confirmed by TLC) when the doubly 
debrominated product just started to form (Table 4).  
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Ru(bpy)3Cl2 (2 mol%)
DMN (50 mol%)
ascorbic acid (2 equiv)
MeOH:H2O (10:1)
blue LED
shorter time
O O
144 145
R R
O
146
R Br
Br
H
Br
H
H
Ru(bpy)3Cl2 (2 mol%)
DMN (50 mol%)
ascorbic acid (2 equiv)
MeOH:H2O (10:1)
blue LED
longer time
 
Scheme 32: Selective monodebromination of !, !-dibromocarbonyl compounds. 
 
A good functional group tolerance, such as aromatic bromo (that could in principle 
undergo reduction) was observed (Table 4, entry 1, 2). But selective monodechlorination 
did not work well with this protocol. 
 
Table 4: Photocatalysed selective debromination of dibromo compoundsa. 
Entry Substrate Time (h)
Isolated
yieldb  (%)Product
9 71
0.5 88c
2 70c
0.5 54c
1
2
3
4
O
Br
MeO
O
Br
Br
O
Br
O
Br
O
Br
Br Br
O
Br
Br Br
O
Br
MeO Br
O
Br
Br
144a 146
144a 145a
144b 145b
144c 145c
aReaction conditions: organohalide (1.0 equiv), Ru(bpy)3Cl2 (2 mol%), DMN (50 mol%),
ascorbic acid (2 equiv), MeOH/H2O = 10:1, blue LED. bIsolated yield after purification by 
chromatography on SiO2, cThe reaction was stopped (TLC monitoring) when 2-fold
debrominated product just started to form.  
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3.7 Proposed mechanism 
Mechanistically, we proposed that the dehalogenation involves the activation of the 
substrate to form a radical intermediate by transferring one electron from Ru(I) (Scheme 
33) following literature precedent. It is well established that Ru(II) readily accepts a 
photon from a variety of light sources (here from blue LED) to populate the activated 
*Ru(II) metal-to-ligand charge transfer excited state. DMN acting as the primary donor, 
transfers an electron to initiate the catalytic cycle by generating a Ru(I) complex. As 
Ru(I) is a potent reductant, it is able to transfer a single electron to the !-halocarbonyl 
substrate, thus furnishing a radical anion that rapidly eliminates a halide. The resulting !-
acyl radical then can be further reduced by the photocatalyst to give an enolate that 
ultimately undergoes protonation to give the dehalogenated product.    
 
DMN
DMNHA
1/2A +1/2 H+ +1/2 HA Ru2+(bpy)3
h!
HA- = Ascorbate ion
Ru+(bpy)3
R R1
O
Br/Cl
R R1
O
Br/Cl
R R1
O
R R1
O
H
HA
R R1
O
protonation
-Br/Cl
 
Scheme 33: Mechanistic proposal for photocatalytic dehalogenation. 
 
 
Conclusion: 
In conclusion, we have developed a conceptually new photocatalytic system with visible 
light to drive sequential electron transfer processes for reductive dehalogenation of 
monobromides or chlorides to their dehalogenated counterparts and gem-dibromides to 
monobromides selectively. As a key structural feature, a carbonyl group positioned ,-./, to one halogen atom is required for the success of this transformation.  
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4. Debromination of vic-dibromides to alkene by visible light 
 
4.1 Protection-deprotection of olefins by bromination-debromination  
To expand the scope of our work, we wanted to apply our photocatalytic combination to 
more competitive substrates. We planned to dehalogenate the halogen which is !-to the 
carbonyl in the presence of halogen "-to the carbonyl, e.g., compound 147 contains two 
bromine atoms: one is !-to the carbonyl and the other is "-to the carbonyl. We wanted to 
selectively dehalogenate the !-bromine (Scheme 34), as our photocatalytic combination 
works only when there is a carbonyl next to the halogen. For this purpose we irradiated 
vicinal dibromocarbonyl compounds 147 by a blue LED (455 ± 10 nm) with Ru(bpy)3Cl2 
in the presence of DMN and ascorbic acid. Although from the irradiation we expected !-
dehalogenated product 149, in reality we obtained !, "-unsaturated carbonyl compound 
148 in good yields. We utilize this methodology for the deprotection of bromine to get 
olefins. 
 
R
O
Y
Br
Br
R
O
Y
Br
R
O
Y
H
expected obtained
147 148
Ru(bpy)3Cl2 (2 mol%)
DMN (50 mol%)
ascorbic acid (2 equiv)
MeOH:H2O (10:1)
blue LED
!"
Y = OEt, Ph, oxazolidinone, furan
R = aryl, alkyl
149
 
Scheme 34: Photocatalyzed reductive debromination of vicinal dibromides. 
 
 
Bromination-debromination sequences are widely used in organic synthesis for the 
protection-deprotection of olefins. Although functionalization of olefins by simple 
bromination generally proceeds smoothly and stereospecifically in high yields, reversing 
the process to the parent olefin via a debromination step is more challenging. There are a 
number of reagents known for this transformation,20 however, the necessity to employ 
stoichiometric amounts of strongly reducing agents might cause problems of selectivity 
and functional group compatibility. Moreover, the toxicity of some reagents such as the 
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widely used organotin compounds makes the development of environmentally friendly 
catalytic alternatives desirable. However, our visible light mediated mild photocatalytic 
combination gave reductive debromination of vicinal dibromides to !, "-unsaturated 
compounds in high yields. 
 
 
4.2 Debromination of vic-dibromide leading to disubstituted alkene 
A representative range of disubstitued vic-dibromides 147 underwent debromination by 
this procedure to provide the corresponding alkenes 148 (Table 5), with quantum yields 
ranging between 0.01 and 0.02. The same optimized reaction conditions as mentioned 
before were employed. Reducing the amount of DMN was possible (from 50 mol% to 25 
mol%) but resulted in slower conversion of the substrate (cf entries 1 and 2). However, 
DMN could be recovered at the end of the reaction and reused, making the employment 
of higher amounts more practical but nevertheless economically acceptable. A carbonyl 
substituent, e.g., a ketone, ester, lactone or oxazolidinone, adjacent to the bromide was 
required for the debromination to take place (entries 1-9), e.g., no reaction took place 
with 1,2-dibromo-1,2-diphenylethane (entry 10). Moreover, alkyl substituted dibromides 
reacted sluggishly in most cases (Table 5, entries 8,9). Only (E)-configurated 
disubstituted alkenes were obtained from acyclic precursors in all cases, even when a 
43:57 mixture of erythro and threo vic-dibromide 147c (Table 5, entry 3) was subjected 
to the above conditions. The cyclic dibromide 147d also underwent debromination 
smoothly (Table 5, entry 4), giving rise to the (Z)-configurated alkene 148d 
predetermined by the ring size of the cycle.  
Using 147a (Table 5, entry 1) as a representative substrate, a series of control 
experiments were performed. Exclusion of any one of the reaction components 
((Ru(bpy)3Cl2), DMN or ascorbic acid) yielded only a negligible amount of the product, 
even after 48 h. 
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entry substrate time (h)
isolated
yield (%)product
OBr
Br
O
8 92
O
OEt
Br
Br
O
OEt 8 88
1
2
O
OEt
Br
Br
O
OEt3d 12 73
147a 148a
147b 148b
147c 148b
36 83c
36 74c
O Br
Br
O
8 75
O
O
Br
Br
O
O
24 26e
5
6
10
O
N O
OBr
Br
O
N O
O
5 897
Br
Br
24 NRf-----
8
OBr
Br
O
36 28e
C7H15
Br
Br
O
OEt C7H15
O
OEt 24 26
e9
147e 148e
147f 148f
147g 148g
147h 148h
147i 148i
147j
O O
Br
Br
O O
5 924
147d 148d
Table 5: Reductive debromination of vic dibromocarbonyl compounds leading to disubstituted alkene.
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4.3 Trisubstituted alkene by reductive debromination of vic-dibromo compounds 
Dibromocarbonyl compounds leading to trisubstituted alkenes after dehalogenation were 
also employed utilizing the same photocatalytic combination. In all the cases yields were 
good but the E/Z-selectivity in debrominations of compounds that gave rise to 
trisubstituted alkenes (Scheme 35, Table 6) seemed to be governed by the relative 
stability  
R
O
Y R
O
Y
Ru(bpy)3Cl2 (2 mol%)
DMN (50 mol%)
ascorbic acid (2 equiv)
MeOH:H2O (10:1)
blue LED
R1 Br
Br R2
R1
R2
150 151  
Scheme 35: Photocatalytic vicinal debromination leads to trisubstituted alkene. 
 
of the products, allowing in some cases the conversion of stereomixtures of dibromides to 
one geometrically pure alkene (Table 6, entry 1 and 3), but might also lead to E/Z-
mixtures of alkenes despite starting from diastereomerically pure dibromide (Table 6, 
entry 5). Moreover, alkyl-substituted dibromides reacted sluggishly which leads to lower 
conversion to product (Table 6, entries 2 and 3). 
 
Table 6: Reductive debromination of vicinal dibromides leading to trisubstituted alkenea. 
Entry Substrate Time (h)
Isolated
yieldb (%)Product
1
2
3
12 70
24 65c
24 27c
150a: erythro:threo=67:33
150b: erythro:threo=80:20
151a: E:Z=95:5
151b: E:Z=84:16
Ph
Br O
OEt
Br Ph
O
OEt
PhH2CH2C
Br O
OEt
Br
PhH2CH2C
O
OEt
150c: erythro:threo=52:48 151c: E:Z=95:5
O
OEt
Br
Br
O
OEt
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4
150d: erythro:threo=100:0 151d: E:Z=100:0
24 75c
5 24 65
c
150e: erythro:threo=100:0 151e: E:Z=75:25
Ph
OBr
Br
Ph
O
Ph
O
OEt
Br
Br
Ph
O
OEt
Entry Substrate Time (h)
Isolated
yieldb (%)Product
aReaction conditions: organohalide (1.0 equiv), Ru(bpy)3Cl2 (2 mol%), DMN (50 mol%),  ascorbic acid  (2 equiv), 
MeOH/H2O  = 10:1, blue LED. bIsolated yield after purification by chromatography on SiO2, 
c4 mol% of Ru(bpy)3Cl2 was employed  
 
 
4.4 Photocatalysed debromination leads to alkyne 
The synthesis of an alkyne from the corresponding vic-dibromoalkene was also achieved 
successfully utilizing the same reaction conditions as previously applied for the 
debromination of the vic-dibromoalkanes (Scheme 36). Thus, treatment of (E)-ethyl 2,3-
dibromo-3-phenylacrylate 152 in the previously reported reaction condition gave ethyl 3-
phenylpropiolate 153 in good yield. 
 
Ru(bpy)3Cl2 (2 mol%)
DMN (50 mol%)
ascorbic acid (2 equiv)
MeOH:H2O (10:1)
blue LED
Br
Br
CO2Et Ph CO2Et
5h, 72%
152 153  
Scheme 36: Photocatalytic reductive debromination of a vic-dibromoalkene. 
 
 
 
4.5 Mechanistic explanation 
We propose a similar mechanism that was already put forward for the dehalogenation of 
!-halocarbonyl compounds. The excited *Ru(II) accepts an electron from the primary 
electron donor DMN to generate a Ru(I) complex. As Ru(I) is potent reductant, it 
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transfers a single electron to the vic-dibromide substrate which furnishes a radical anion 
and rapidly eliminates a bromide. The resulting !-acyl radical again accepts an electron 
from the photocatalyst and gives an enolate, which eliminates the other bromide and 
leads to the !, "-unsaturated carbonyl compound (Scheme 37). We also observed that 
E2-type anti-elimination does not occurs for the disubstituted vic-dibromides (Table 5, 
entry 3, even when we started with a mixture of erythro and threo dibromides, we ended 
up with only E-isomer in the product). For trisubstituted substrate the elimination also 
proceed by the same type of mechanism where a stable radical or anion intermediate 
breaks down to the alkenes according to their thermodynamic stability (Table 6, entry 5, 
although we started with diastereomerically pure dibromides but we ended up with E/Z 
mixture of products). 
 
DMN
DMNHA
Ru2+(bpy)3
h!
HA- = Ascorbate ion
Ru+(bpy)3
Y R1
O
Br
Y R1
O
Br
Y R1
O
Y R1
O
HA
Y R1
O
elimination
Br
Br
BrBr
 
Scheme 37: Mechanistic proposal for debromination of vic-dibromides. 
 
 
Conclusion 
In conclusion, we have developed a conceptually new photocatalytic system with visible 
light to drive sequential electron transfer processes for reductive debromination of vicinal 
dibromides to (E)-alkenes and alkynes, gem-dibromides to monobromides, and 
monobromides or chlorides to their dehalogenated counterparts. As a key structural 
feature, an !-carbonyl group to one halogen atom is required for the success of the 
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transformation. The photosystem is also highlighted by its chemoselectivity, resulting in 
reduced products in high yields under mild reaction conditions. 
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5. Efficient Photocatalytic oxygenation of cyclic enamines and enol ethers 
 
5.1 Singlet Oxygen (1O2) 
Molecular oxygen is one of the most important substances on the earth. Oxygen 
comprises 21% of the atmosphere, 89 % of seawater by weight, and at least 47 % of the 
Earth’s crust. Almost all living organisms utilize oxygen for energy generation and 
respiration. In the 1840s Michael Faraday discovered that oxygen is attracted to a 
magnet. Almost a century later, in 1925, Robert Mulliken explained why oxygen is 
magnetic using quantum theory. His analysis showed that molecular oxygen has two 
unpaired electrons in its lowest energy state, which is known as triplet ground state of 
oxygen. Singlet oxygen (1O2) is a higher energy state molecular oxygen species. Singlet 
oxygen (1O2) was first observed in 1924 and then defined as a more reactive form of 
oxygen. The main method of production of 1O2 is by photosensitization reactions. In 
1931, Kautsky (from Heidelberg University, Germany) first proposed that 1O2 might be a 
reaction intermediate in dye-sensitized photo-oxygenation.1 Following this suggestion, 
many studies have showed that 1O2 is an important and versatile reagent for oxidation 
reactions including cycloaddition reactions to produce endoperoxides and ene reactions to 
provide allylic hydroperoxides. It has been also demonstrated that 1O2 can react with 
many kinds of biological molecules such as DNA, proteins and lipids.2 Since oxygen is 
ubiquitous and efficiently quenches electronically excited states, 1O2 is likely to be 
formed following irradiation in numerous ways and involved in various chemical and 
biological processes as well as in several disease processes. Therefore, better 
understanding of its chemical and physical nature is important and interesting area of 
study till date. 
 
 
5.2 Electronic structures and the lifetime of singlet oxygen 
Molecular orbital theory can explain the electronic structure of molecular oxygen. The 
lowest electronic state of oxygen is a triplet ground state (3!g-) with two unpaired 
electrons distributed in the highest occupied orbitals. Rearrangement of the electron spins 
within these two degenerate orbitals result in two possible singlet excited states (Table 7). 
The 1"g state has an energy only 23 kcal above that of the ground state; both electrons are 
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paired in a single orbital, leaving the other vacant. This state might be expected to 
undergo two-electron reactions. The higher energy singlet state (1!g+) comes from the 
spin pairing electrons in different orbitals and might be expected to undergo one-electron 
free-radical reactions. In both forms of 1O2, the spin restriction is removed so that the 
oxidizing ability is greatly increased. The 1!g+ state has a much shorter lifetime than 1"g 
state because 1!g+ is more reactive than the 1"g form. It decays to 1"g state before chemical 
reactions can occur. The different energy states of two excited states of molecular oxygen 
are summarized in Table 7 and the molecular orbital picture is shown in fig 4. 
 
Table 7: Different energy state of molecular oxygen. 
State of the oxygen molecule Occupancy of highest orbitals Energy above ground state 
Second excited state (1!g+)                      37 kcal/mol 
First excited state (1"g)                23 kcal/mol 
Ground state (3!g-)                        
 
 
!" !"
! !
!" !"
! !
!" !"
! !
1. 3#g- (Ground State)
2. 1#g+ Second excited state 1$g3. First excited state
 
 
Fig. 4. Molecular orbital of singlet oxygen. 
 
 
5.3 Generation of singlet oxygen 
Both physical and chemical methods can generate singlet oxygen. One of the most 
important methods is photosensitization. Photosensitization refers to light-activated 
process that requires the presence of a light-absorbing substance, the photosensitizer, that 
initiate a physical, chemical, or biological process in a non-absorbing substrate. The 
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photosensitizer absorbs light from suitable light source and populates the singlet excited 
state which converts to metastable triplet state via Inter System Crossing (ISC). The 
pathway in which the photosensitizer triplet state reacts first with a substrate other than 
molecular oxygen is termed Type I. In the alternative Type II pathway, the photosensitizer 
triplet state reacts first with molecular oxygen and generates 1O2, which reacts with 
substrate and leads to the product formation (Fig. 5), while the photosensitizer returns to 
the ground state. The commonly used photosensitizers are rose bengal 10, eosin, 
methylene blue, tetraphenylporphyrin and its derivatives, C60 etc.  
 
Sen
1Sen*
3Sen*
+ 3O2
Singlet oxygen (1O2)
ISC
GS
ES
E
h!
Substrate
Product  
Fig. 5. Type II pathway to produce 1O2 (GS = Ground State, ES = Excited State, Sen = Sensitizer, ISC = 
Inter System Crossing). 
 
There are several chemical methods which can generate 1O2. One of the biologically 
significant reactions is hydrogen peroxide and hypochlorite ion reaction, because OCl- 
can be formed by the enzyme myeloperoxidase during phagocytosis according to OCl- + 
H2O2 # 1O2 + Cl- + H2O. Other chemical methods include the thermolysis of 
endoperoxides of some aromatic hydrocarbons and some organic ozonides. 
 
5.4 Quenching of singlet oxygen 
Quenching of singlet oxygen involves the deactivation of the excited state of molecule. 
Deactivation can be accomplished by either physical or chemical quenching. Physical 
quenching leads only to the deactivation of singlet oxygen to its ground state with no 
oxygen consumption or product formation. In chemical quenching, by contrast, singlet 
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oxygen reacts with quencher R to produce RO2. Two major mechanisms of 1O2 quenching 
are known, namely energy transfer and charge transfer quenching. Energy transfer 
quenching is the reverse of reaction by which singlet oxygen is formed. It involves 
formation of triplet quencher and ground state oxygen (1O2 + Q # 3O2 + *Q). Charge 
transfer quenching involves the interaction between the electron-deficient 1O2 molecule 
and electron donors (substrate molecules) to form a charge transfer complex, which leads 
to different chemical reactions. 
 
 
5.5 Reactions of singlet oxygen 
The most important reactions of singlet oxygen involve its reactions with carbon-carbon 
double bonds, which are present in many biological molecules, such as carotene, 
chlorophyll, and unsaturated fatty acids.  
(a) Alder-ene reaction (Schenck reaction) 
In this reaction, oxygen adds stereospecifically to the alkyl substituted olefins to form 
allylic hydroperoxides with migration of the double bond. The resulting allylic 
hydroperoxides can be easily converted into $, %-unsaturated carbonyl compounds and 
allyl alcohols.3,4 A variety of mechanisms have been proposed to explain the products 
observed in this reaction. The cis-alkene is more reactive than trans isomer. A few ene 
reactions are shown below (Scheme 38). 
 
OOH
OOH OH
1O2
1O2 PPh3
154 155
156 157 158  
Scheme 38: Singlet oxygen mediated ene reactions. 
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(b) [4+2] Cycloaddition reaction 
Singlet oxygen can react as a good dienophile with dienes such as cis dienes or aromatic 
hydrocarbons to yield endoperoxides, which can be reduced by thiourea to give 
corresponding diols. This reaction is similar to the well-known Diels-Alder reaction.3 The 
initially formed endoperoxides may undergo fragmentation back to reactants or rearrange 
to products through the homolytic fission of the oxygen-oxygen bond. The concerted 
character of this addition reaction has been indicated based on experimental observations. 
Few examples are shown below (Scheme 39). 
O
O
OH
OH
O
O
OH
OH
O
O
1O2
1O2
1O2
thiourea
thiourea
159 160 161
164163162
165 166  
 
Scheme 39: [4+2] reaction with singlet oxygen as dinophile 
 
(c) Reaction with electron rich system 
Singlet oxygen can also react with electron rich systems, in which carbon-carbon double 
bonds have adjacent electron donating atoms (oxygen, nitrogen, sulfur). In these 
reactions, an oxetane type adduct is formed. When these dioxetanes are unstable they 
decompose to give carbonyl compounds (Scheme 40). Decomposition of dioxetane is 
sometimes accompanied by chemiluminiscence. 
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Scheme 40: Reaction of singlet oxygen with electron rich system. 
 
 
5.6 Ru(bpy)3Cl2 complex as sensitizer for singlet oxygen generation 
Visible-light sensitization is an attractive means to initiate organic reactions5 because of 
the lack of absorbance of visible light by organic compounds. This means that the side 
reactions often associated with the use of high-energy UV light are minimized. 
Photocatalysts such as Ru(bpy)3Cl2 (bpy = 2,2’-bipyridine) offer a means to selectively 
functionalize organic molecules; however, their use in initiating chemical reactions 
relevant to organic chemistry is very limited.6 Tuning the excited state property of the 
photocatalyst, it is possible to design organic transformations by transferring electron or 
energy from the higher energy state catalyst to the substrate molecules (Scheme 41). 
Electron transfer from excited photocatalyst to substrate molecules occurs by oxidative 
and reductive quenching pathways, which have been discussed broadly in the previous 
part of this thesis. Organic reactions mediated by energy transfer from excited 
photocatalyst are discussed in this part.  
The excited photocatalyst, usually in the triplet state, reacts with triplet oxygen to give 
singlet oxygen. Singlet oxygen is a highly reactive species that has shown to be 
efficiently photosensitized by a large number of compounds, most of which have been 
organic compounds.7,8 Sometimes inorganic complexes are more effective in this purpose 
rather than organic compounds. One of the best example is Ru(bpy)3Cl2.9,10 The complex 
ion tris(2,2’-bipyridine) ruthenium(II) [Ru(bpy)3]2+ is known to be a good singlet oxygen 
photo-sensitizer due to both its relatively strong absorption in the visible region of the 
spectrum and long lived triplet metal to ligand charge transfer state 3MLCT, making its 
excited state susceptible to quench by oxygen in normal organic solvents.11-16 
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Scheme 41: Photocatalysis by electron transfer and energy transfer pathways. Q = quencher, D = donor, A 
= acceptor, S = substrate molecule.  
 
 
 
5.7 Oxygenation of cyclic enamines and enol ethers 
Singlet molecular oxygen production by photocatalyst Ru(bpy)3Cl2, had been studied 
widely, but the application of 1O2, produced particularly by this catalyst in the presence of 
visible light, has not been truly studied for organic transformations. In accord with our 
interest to develop new chemical transformations going through radical intermediates, we 
wanted to utilize cyclic enamines as radical precursors being liberated by photoredox 
catalysis. In the course of the reaction, we observed oxidative cleavage of enamine 
double bond to the corresponding carbonyl derivatives in the presence of molecular 
oxygen and catalytic amount of photocatalyst Ru(bpy)3Cl2 promoted by visible light. 
Enamins are known to be excellent substrates for dye-sensitized photooxygentaion; the 
C-C double bond is cleaved to give a ketone or aldehyde and an amide17 (Scheme 42). 
With this literature evidence, we planned to oxygenate cyclic enamines to obtain 
synthetically useful amino acid derivatives.  
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Scheme 42: Photooxygenation of enamines.17 
 
Our preliminary studies focused on the oxidative cleavage of enamine double bond of 
172a. Initial success was obtained upon subjecting 172a to irradiation by a blue LED 
lamp (& = 455 ± 10 nm) with Ru(bpy)3Cl2 (2 mol%) in open air using CH3CN as solvent 
for 24 h. These conditions provided 56 % isolated yield of the product 173a, with 
remaining unidentified side products. Subsequent optimization revealed that the presence 
of oxygen accelerate the oxidation by reduction of reaction time with diminish side 
products. In addition, lowering of catalyst loading (0.5 mol %) was possible for the 
oxidation with prolonging the reaction time (Table 8). 
 
Table 8: Optimization of the oxidative cleavage of enamine double bond of 172a 
N H
H
CO2Me
Boc OHC
Boc(OHC)N
CO2Me
Ru(bpy)3Cl2
blue LED
O2, CH3CN
172a 173a
entry conditions yield(%)a
1 open air, Ru(bpy)3Cl2 (5 mol%), 24 h 56
2 open air, Ru(bpy)3Cl2 (2 mol%), 24 h 52
3 O2 bubble, Ru(bpy)3Cl2 (2 mol%), 30 min 72
4 O2 bubble, Ru(bpy)3Cl2 (0.5 mol%), 6 h 65
aIsolated yield after purification  by chromatography on SiO2  
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Using 172a as representative substrate, different solvents were also evaluated in this 
oxidation reaction (Table 9). The screening of solvents revealed that CH3CN was the best 
choice of solvent for this reaction. The reaction proceeds smoothly within 30 min without 
significant formation of side products. Chloroform was also a good alternative for the 
reaction, whereas due to the longer reaction time we preferred CH3CN. In other solvents 
such as MeOH, DMF gave the desire product with considerably longer reaction time and 
more unidentified spots in TLC.  
 
Table 9: Screening of different solvents in the photooxidation reaction 
entry solvent yield(%)a
1 42
2 70
3 48
4 72
aIsolated yield after purification  by chromatography on SiO2
DMF
CHCl3
MeOH
CH3CN
Time (h)
2.0
3.0
4.0
0.5
 
The scope of this process was illustrated by the examples detailed in Table 10. Utilizing 
our optimized conditions, we were able to successfully oxidize different types of cyclic 
enamines in the presence of other functional groups such as carboxylic acid (entry 2), 
free hydroxyl (entry 3) and nitro (entry 7). Many cyclopropyl substituted amino acids, 
especially cyclopropanecarboxylic acid, display important biological properties; 
consequently their syntheses have been widely studied.18 The strategy described here 
provided the diastereoselective access to 2-aminocyclopropanecarboxylic acid derivatives 
173a-c from readily available starting materials 172a-c. Different types of N-formyl 
aldehydes obtained in good yields from cyclic enamines (entry 4 and 6) whereas in 
similar fashion N-formyl ketone 173e was obtained from substituted enamine in excellent 
yield (entry 5, 7 and 8). A ring expansion product 173h! was observed in case of 
compound 172h along with the desired product. Furthermore, these reactions were 
highlighted with their excellent yield in almost all the cases with shorter reaction time. 
The reactions were also independent of the protection group present at the nitrogen atom. 
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Table 10: Oxidative cleavage of cyclic enaminesa 
entry substrate product time (h) yieldb
1
N H
H
CO2Me
Boc OHC
Boc(OHC)N
CO2Me
2
N H
H
CO2H
Boc
3
N H
H
CH2OH
Boc
OHC
Boc(OHC)N
CO2H
OHC
Boc(OHC)N
CH2OH
5 N
Boc
O N(CHO)Boc
6 N
Boc
H
O
N(CHO)Boc
7
N
O2N
N
O
O2N
172a 173a
172b 173b
172c 173c
172e 173e
172f 173f
172g 173g
0.5
N
O
N
O
O
3.5 94
3.0 72
4.0 93
1.0 89
72
1.0
8
N
5.0 35  + 26
172h 173h 173h'
+
85
O
4 N
Boc O N(CHO)Boc
H
172d 173d
2.5 81
aReaction conditions: cyclic enamine (1.0 equiv.), Ru(bpy)3Cl2 (2 mol %), O2, CH3CN, blue LED. bIsolated yield after 
purification  by chromatography on SiO2  
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Throughout our investigations, we conducted a series of control experiments using 172a 
as a representative substrate. Exclusion of any of the reaction components, including 
visible light, Ru(bpy)3Cl2 did not afford any oxidized product 173a even after 24 h. The 
necessity of singlet oxygen was also examined by adding NaN3 in the reaction mixture 
during the oxidation of 172a by above conditions. The azide ion is a strong physical 
quencher of singlet molecular oxygen and is frequently employed to show involvement of 
1O2 in oxidation processes.19 To prove the crucial role of singlet oxygen in this reaction, 
172a was subjected to irradiation in CH3CN-D2O mixture (4:1, D2O was employed to 
dissolve sodium azide. Singlet oxygen has also longer life time in D2O compared to H2O) 
by a blue LED with Ru(bpy)3Cl2 in the presence of one equivalent of sodium azide. There 
was no formation of 173a even after 12 h, while in the absence of NaN3 in the same 
solvent condition gave the desire aldehyde 173a in 30 min (Scheme 43). Singlet oxygen, 
generated by the sensitization of the catalyst, was immediately quenched by azide ion 
present in the reaction mixture and therefore, no product formation was observed. This 
directly indicated the necessity of singlet oxygen in the above oxidation process. 
 
N H
H
CO2Me
BocOHC
Boc(OHC)N
CO2Me
Ru(bpy)3Cl2
blue LED
172a173a
NaN3, O2
CH3CN:D2O (4:1)
12 h
Ru(bpy)3Cl2
blue LED
O2
CH3CN:D2O (4:1)
30 min., 72 %
No product
formation
 
Scheme 43: Quenching of singlet oxygen by azide ion. 
 
To further support the generation of singlet oxygen in our reaction conditions, we 
performed literature reported [4+2]-cycloaddition of singlet oxygen with cyclodienes20-21 
in our reaction conditions. Treatment of cyclodienes 162 and 165 with blue LED in the 
presence of catalytic amount of Ru(bpy)3Cl2 gave endoperoxides 163 and 166 in good 
yields, which were isolated in room temperature. This directly indicates the generation of 
singlet oxygen in our reaction conditions. 
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Table 11: Visible light promoted [4+2] cycloaddition of singlet oxygen catalyzed by Ru(bpy)3Cl2 
O
O
R1
R2
R1
R2
Ru(bpy)3Cl2 (1 mol%)
blue LED
O2, CH3CN
entry substrate time (h) yielda (%)
1 R1 = R2 = H
2
162
R1 = Me,   R2 = iPr
165
product
O
O
O
O
163
166
1.0
1.0
62
65
aIsolated yield after purification  by chromatography on SiO2  
 
Accordingly, we proposed a mechanism wherein the photoexcited *Ru(II) undergoes 
energy transfer leading to singlet oxygen production. The enamines add to singlet oxygen 
in [2+2]-cycloaddition fashion and produce unstable 1,2 dioxetanes intermediates 175, 
which decomposed quantitatively into the corresponding carbonyl fragments and 
resulting the desired products (Scheme 44).  
N
nR
N
n
O
O
R n
Ru2+
*Ru2+ 3O2
1O2
h!
(OHC)N
R
O
n = 0, 1
R = H, Me
174
175 176
 
 
Scheme 44: Proposed mechanism of photooxidation of enamines. 
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Last few years, increasing attention has been drawn to %-and '-aminoacids and their 
derivatives as important constituents of natural products and as valuable intermediates, 
e.g., for the preparation of peptidomimetics,22 and %- and '-lactums.23 However, while 
abundant methods are known for the synthesis of $-amino acids,24 there are considerably 
fewer routes to %- and higher amino acid analogs.25 Moreover, the corresponding amino 
aldehydes are often more difficult to obtain because of their tendency to undergo 
subsequent condensation reactions. One general approach to %- and '-amino esters and 
amino aldehydes by ozonolysis of 2,3-dihydropyrroles and 1,2,3,4-tetrahydropyridines 
which was reported by Reiser et al.,26 whereas the use of hazardous ozone in the 
laboratory is the practical disadvantage of that method. In this context our visible light 
mediated operationally simple and mild reaction conditions provided amino aldehydes or 
ketones. The products obtained are fully protected at nitrogen, allowing further 
derivatization of the aldehyde or the ketone group. This is especially advantageous for the 
cyclopropyl amino acid derivatives, which seem to be extremely prone to ring opening in 
the unprotected stage.27 The N-Boc group can be selectively removed by treatment with 
mild acid and provides the free amino group. The oxidative cleavage of cyclic enamine 
by this method leading to products, e.g., 173a-c, which preserved the relative and 
absolute stereochemistry of the starting material. 
We expected that the protected amino aldehyde or ketone products generated in this 
method will be further derivatized for the generation of new intermediates. To highlight 
this possibility, we have applied our photo oxidative products to the synthesis of the 
precursor of useful reactions. As illustrated above, exposure of compound 172a and 
tosyl-hydrazine to our oxidative protocol directly afforded 177 in 86% isolated yield in 
one pot (Scheme 45). The presence of tosyl-hydrazine did not affect the oxidation of the 
enamine in the same reaction mixture. Oxidation of 172a by the above method first 
generated compound 173a, which subsequently underwent hydrazone formation and 
resulting compound 177. In the similar fashion compound 172f yielded acyclic hydrazone 
178. These hydrazones can be used as precursors of Bamford-Stevens and Shapiro 
reactions, which furnish substituted alkenes at the end. 
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N H
H
CO2Me
Boc
OHC
Boc(OHC)N
CO2Me
172a 173a
Boc(OHC)N
CO2Me
177
N
TsHN Ru(bpy)3Cl2 (2 mol%),
 TsNHNH2 (1.2 equiv.)
O2, CH3CN
blue LED, 3 h
86 % (dr = 78:22)
N
Boc
H
O
N(CHO)Boc
172f 173f
N
N(CHO)Boc
TsHN
 Ru(bpy)3Cl2 (2 mol%),
 TsNHNH2 (1.2 equiv.)
O2, CH3CN
blue LED, 6 h
178
90 % (dr = 93:7)  
Scheme 45: One pot synthesis of hydrazones from cyclic enamines. 
 
To further expand upon this methodology, we wanted to examine the possibility of two 
consecutive reactions in one pot using photo oxidation reactions. Irradiation of 172a with 
Ru(bpy)3Cl2 in the presence of oxygen and Wittig salt 179, we expected N-formyl alkene 
180 as an end product. After 30 min irradiation by blue LED, we observed complete 
conversion of 172a to the corresponding amino aldehyde 173a, but no amino alkene 180 
was observed. The stirring was continued for additional 5 h in absence of light, but the 
product 180 was not formed. In another set of reaction, 172a was exposed 30 min to light 
from blue LED in the presence of Ru(bpy)3Cl2 and oxygen for complete conversion to 
173a and then Wittig salt 179 was added to the reaction mixture and stirring was 
continued for another 1 h in absence of light. This reaction conditions resulted amino 
alkene 180 as diastereomeric mixture (trans:cis = 96:4) in 67 % yield (Scheme 46). With 
this observation we concluded the decomposition of Wittig salt in the presence of light or 
oxygen and therefore no olefination product was formed. Thus, by sequential addition of 
Wittig salt to the photo oxidation product of 172a, we were able to isolate the amino 
alkene 180 in good yield. Similar sequential addition of Wittig salt 179 to the oxidation 
product of 172f afforded 181 in good yield.  
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N H
H
CO2Me
Boc
OHC
Boc(OHC)N
CO2Me
172a 173a
Boc(OHC)N
CO2Me
180
 1. Ru(bpy)3Cl2 (2 mol%)
O2, CH3CN
blue LED, 30 min
67 % (E: Z = 94:6)
N
Boc
H
O
N(CHO)Boc
172f 173f
N(CHO)Boc
MeO2C
 1. Ru(bpy)3Cl2 (2 mol%)
O2, CH3CN
blue LED, 3.5 h
181
73 % (E: Z = 90:10)
MeO2C
N H
H
CO2Me
Boc
OHC
Boc(OHC)N
CO2Me
172a 173a
Boc(OHC)N
CO2Me
180
 Ru(bpy)3Cl2 (2 mol%)
 179 (1.2 equiv.)
O2, CH3CN
blue LED, 3 h
MeO2C
not observed
O
OMe
179
2. 179 (1.2 equiv.)
1 h, no light, rt
2. 179 (1.2 equiv.)
3 h, no light, rt
Ph3P
 
Scheme 46: Synthesis of alkene starting from cyclic enamine via photo oxidation reaction. 
 
The scope of the above photo-oxygenation mediated by visible light was further explored 
with substituted cyclic enol ethers. We envisioned substituted cyclic enol ethers as direct 
precursor to aldol and homoaldol products. Therefore, the oxidative ring opening of these 
cyclic enol ethers should lead to access of aldol and homoaldol products (Scheme 47).  
 
OR1
R2
R3
R4 R1
OHCO
R2
R3
n COR4n
oxidative ring 
opening
182 183  
Scheme 47: Oxidative ring opening leads to aldol (n = 0) and homoaldol (n = 1) products. 
 
One of the well-known methods for this type of oxidative ring opening is ozonolysis,28 
but alternatives to ozonolysis are highly recommended due to huge energy demand of the 
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process, toxicity of ozone, and safety risks. By applying our mild reaction conditions, we 
were able to cleave cyclic enol ethers to their formyloxy aldehydes. Treatment of 3,4-
dihydro-2H-pyran 182a under identical photo-oxygenation reaction conditions resulted in 
homoaldol product 183a in 68 % yield. Following the same protocol 183b was obtained 
from the substituted pyran 182b.  
 
Table 12: Oxidative ring opening of cyclic enol ethers leading to homoaldol productsa 
entry substrate time (h) yieldb (%)
1
2
product
O OHCO
CHO
OAr
Ar = -C6H4-p-OMe
OHCO
CHOAr
68
60
182a 183a
3.0
3.5
182b 183b
aReaction conditions: enol ether(1.0 equiv.), Ru(bpy)3Cl2 (1 mol %), O2, CH3CN, blue LED. bIsolated yield 
after purification by chromatography on SiO2  
 
The strategy described here to prepare formyl-protected homoaldol compounds should be 
useful because of mild reaction conditions under which the products were obtained. The 
cleavage of cyclic enol ethers afforded free aldehyde functionality, which can be further 
derivatized to useful intermediates. Nevertheless, the formyl group can selectively be 
removed by using secondary amines. Further substrate scope of this type of enol ethers is 
currently under study. 
 
 
5.8 Conclusion:  
In conclusion, we have developed a photocatalytic method with visible light to drive 
sequential energy transfer processes for oxidative ring opening of cyclic enamines and 
enol ethers to their amino aldehyde and formyloxy aldehyde respectively. This 
methodology represents a potential means for accessing a variety of %- and higher amino 
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acid analogs staring from cyclic enamines. The method also leads to synthetically useful 
homoaldol products starting from cyclic enol ethers, which are difficult to obtain by other 
means. The protocol is highlighted by its chemoselectivity affording the oxidized 
compounds in high yields and mild reaction conditions. The reactions are operationally 
very simple and can eliminate the use of hazardous, toxic ozone for the oxidative ring 
opening of cyclic enamines and enol ethers.  
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6. Introduction 
 
 
6.1 Importance of natural product synthesis 
Natural products (NPs) play a dominant role in the discovery of leads for the 
development of drugs. Natural products are bioactive secondary metabolites those are 
isolated from all kingdoms of life and have proven to be a powerful source of disease 
modulating drugs throughout the history of medicinal chemistry and pharmaceutical drug 
development.1 For many centuries medical treatment were entirely of natural origin and 
composed of herbs, animal products, and inorganic materials. Those effective treatments 
were subsequently recorded and documented leading to the early herbals. The knowledge 
of drugs grew from these records to provide a scientific description of natural materials 
used in medicine2 which is known as pharmacognosy. With the improvement of the 
chemical tools and techniques, the active constituents were isolated from plants, 
structurally characterized, and in due course many were synthesized in the laboratory. 
Few cases more active or better-tolerated drugs were produced by chemical modifications 
or by synthesis of analogues of the active principles. In a recent review, Newman, Cragg 
and Snader analyzed the number of NP-derived drugs present in the total drug launches 
from 1981 to 2002 and found that NPs were a significant source of these new drugs, 
especially in the oncological and antihypertensive therapeutic areas.3 In addition to 
providing many new drug leads, NPs and NP-derived drugs were well represented in the 
top 35 worldwide selling ethical drugs in 2000, 2001 and 2002.4 A few natural products 
derived medicinal compounds are shown in Fig 6., which have been used as drugs for 
different diseases.  
There are various motives for natural product synthesis. Perhaps one wants to improve 
the knowledge of chemical reactivity and further exploit chemical properties of the 
molecule. One may also check for the correctness of the structure. If the compound has 
medical importance, one may hope that the synthetic compound will be less expensive or 
more easily accessible than the natural product. It can also be desirable to modify some 
details of the molecular structure. An antibiotic substance of medical importance is often 
first isolated from a microorganism, perhaps in amounts of few milligrams or a gram. 
There ought to be exist a number of related compounds with similar effects; they may be 
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more or less potent, some may have undesirable secondary effects. If it is possible to 
synthesize the compounds in laboratory, it will be possible to modify the details of the 
structure and to find the most effective remedies. Nature produces molecules having lot 
of complexity there by proves that nature is the uncontested master of science and fine 
arts, whereas chemists try to synthesize those molecules in the laboratory and want to be 
superior than nature, sometimes. 
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H OCOCH3
AcO OH
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N
O
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O
OCH3
O O
O
OH
O
O
OH
HO
Dexanabinol
Anti-inflammatory
(+)-Calanolide A
Anti-HIVFumagillinAnti-fungal
Quinine
Antimalarial
Taxol
Antitumor agent
Galanthamine
Anti-alzheimer
184 185 186
187 188 189  
 
Fig. 6: Medicinally important natural products. 
 
 
6.2 Total synthesis and drug discovery are synergistic and complementary  
Total synthesis of natural products attracted chemists from beginning of twentieth 
century, whereas its greatest contribution to the drug discovery and development was 
realized in the later years.5 The evolution of drug discovery and development process 
closely relates with that of total synthesis. The two disciplines must be considered in 
unity, for they are very synergistic and complementary. Academic research focuses on 
organic and natural product synthesis, which provides highly relevant basic knowledge 
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and training to researchers wishing to pursue the science of drug discovery and 
development process. Application of this knowledge to the pharmaceutical industry leads 
to the discovery of new drugs and benefits the society. Medicinal and combinatorial 
chemists have so many tools at their disposal today in their quests for huge number of 
novel and diverse small molecules. This is primarily the result of the contributions of 
total synthesis and of organic synthesis as a whole. Advancement in molecular biology 
facilitates drug discovery today by allowing the elucidation of the human genome and 
proteome, with the progress in total synthesis, which enables the construction of the 
molecules needed to bind and modulate the function of disease-associated biological 
targets. A handful of past and current “miracle drugs” from plants can easily illustrate the 
importance of total synthesis of natural products in drug discovery, from Quinine to 
Taxol, from Aspirin to the birth control pill. The development of powerful and highly 
selective methodologies those have control of reactions in chemo-, regio-, stereo-, and 
enantio-selectivity extended the frontiers of total synthesis to near the feasible limit. 
 
 
6.3 !-Butyrolactone based natural products: Guaianolides 
The synthesis of natural products possessing bioactivity is a fascinating subject which has 
excited the synthetic organic chemists world ever since. Of all the well known natural 
products, about 10% carry a !- butyrolactone moiety either as a characteristic structural 
element or even as a central unit. The utility of these structural subunits is enhanced by 
the ease of construction and functionalization of this lactone ring system. Sesquiterpenes 
and diterpenes, having a wide variety of both well-known and rare carbon skeletons, are 
the most common gorgonian and soft coral metabolites.6 Guaianolides, consisting of 
tricyclic 5,7,5-ring system, represent one of the largest subgroup of naturally occurring 
sesquiterpene lactones exhibiting significant biological activity.7,8 As the name itself 
indicates, the core structure of the guaianolides is derived from Guaiane, a natural 
product with a cis-fused 5,7-bicyclic hydroazulene ring system 190 (Fig. 7). The 
guaianolide skeleton along with the 5,7-bicyclic hydroazulene ring system often contains 
a third ring, a !-lactone, fused to the seven membered ring. Guaianolides exist in two 
forms namely, guaian-6,12-olides and guaian-8,12-olides 191 and 192 respectively (Fig. 
7). 
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Fig. 7: Skeleton of Guaianolides. 
 
These two classes differ in their site of annulation relative to the !-butyrolactone motif 
and can simply be termed as angular and linear guaianolides respectively. 
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Fig. 8: Structurally diverse guaianolides. 
 
The !-butyrolactone ring is trans-annulated in approximately 85% of all known 
guaianolides, while in few guaianolides, the hydroazulene core is also cis-fused in the 
5,7,5-tricyclic carbon skeleton.9 Along with the structural diversity, guaianolides exhibit a 
broad range of biological activity and stimulate the development of research in their total 
synthesis. Some guaianolides have been reported to possess high antitumor, 
antihistosomal, anthelminthic, contraceptive, root-growth stimulatory and germination 
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inhibitory activities.10 The representative members shown above (Fig. 8) exemplify the 
structural diversity found within this class of compounds. (+)-Arglabin (194), another 
prominent member of guaianolides, was isolated from Artemisia glabella11 and shows 
promising antitumor activity and cytotoxicity against different tumor cell lines (Human 
tumor cell lines IC50= 0.9-5.0 "g/ml)12 and the first total synthesis of (+)-Arglabin was 
recently reported from our group.13  
 
 
6.4 Sandresolide A, !-butyrolactone based diterpene 
Sesquiterpenes and diterpenes having a wide variety of well-known and rare carbon 
skeletons are the most common gorgonian and soft coral metabolites. Among Carribbean 
gorgonians, members of the genus Pseudopterogorgia are profilic in nature, with 15 
known species, of which about six species have been chemically investigated. It was 
from the same Pseudopterogorgia elisabethae that the pseudopterosins, a family of anti-
inflammatory amphilectane-based diterpene glycosides, were first reported in 1986 and 
since that time several related compounds such as the seco-pseudopterosine, the 
elisabethins, the elisabatins pseudopteroxazile and seco-pseudopterazole have been 
described. Sandresolide A (199),14 (Fig. 9) a nor-diterpene lactone was isolated from 
Pseudopterogorgia elisabethae collected near San Andres Island, possessing powerful 
anti-inflammatory activity. Pharmacological studies of Sandrasolide A (199) have shown 
that it is a chemically novel anti-inflammatory and analgesic agent, but shows acute 
toxicity in the range of 300 mg/kg in mice. Moreover, it appears that the mechanism of 
action is distinct from that of the cyclooxygenase inhibiting anti-inflammatory agents, 
making this compound especially fascinating from a biological point of view. One of the 
interesting features is that it has a different skeleton compared to linear and angular 
guaianolides, whilst it can be synthesized starting from the same building block !-butyro-
lactone. 
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Fig.9: Chemical structure of Sandresolide A. 
 
 
6.5 Conclusion 
The chemistry of natural products attracts chemists because it’s fascinating nature and its 
useful discipline in organic chemistry. More or less complicated and useful substances 
are constantly discovered and investigated. For the determination of the structure, the 
architecture of the molecule, we have today very powerful tools. The chemists of the 
twentieth century would have been greatly amazed if they had heard of the methods now 
at hand. However, one cannot say that the work is easier; the steadily improving methods 
make it possible to deal with more and more difficult problems and the ability of nature 
to build up complicated substances has, as it seems, no limits. 
The search for new synthetic ways towards the diterpenes and sesquiterpenes did not only 
result in new total synthesis of complex and biologically active natural products, but also 
contributed to the development of a wide range of new and modern chemistry. The 
diverse bioactivity of diterpenes and sesquiterpenes makes them attractive synthetic 
targets since the availability of these compounds from natural sources is very limited. As 
there are more and more members of the diterpenes and sesquiterpenes family 
discovered, full evaluation of their biological activity and their synthesis is still of current 
interest.!
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7. Aim of the work 
 
 
7.1 Development of 5-6-7 new ring system starting from simple aromatic compounds 
!$Butyrolactones are very common structural units found in about 10% of all naturally 
occurring organic compounds. They occur in a wide variety of structural patterns such as 
mono-, di- and trisubstituted monocyclic forms. They are also present as part of more 
complex structures, e.g., in bicyclic and tricyclic ring systems. A broad range of 
biological activities like strong antibiotic, antihelminthic, antifungal, antitumor, antiviral, 
anti-inflamatory and cytostatic properties etc. are exhibited by this class of compounds. 
Consequently, they have been recognized as interesting lead structures for developing 
new drugs. #
Most of the substituted !-butyrolactones are found only as single enantiomer and the 
physiological activities are often dependent on the enantiomeric purity and absolute 
configuration of the butyrolactones. Reiser et al. have developed15 a methodology to 
make enantiomerically pure !-butyrolactone moiety starting from inexpensive furoic ester 
in few steps (Scheme 48). The application of this methodology was successfully shown in 
the total synthesis of several guaianolides (e.g., total synthesis of (+)-Arglabin13) that 
consists of 5-7-5 fused angular or linear ring systems (Fig. 10, a). 
 
OMeO2C OO
CHO
H
H
OO
CHO
H
H
or
four steps
200 201 202  
Scheme 48: Synthesis of !-butyrolactone by Reiser et al. 
 
Utilizing the !-butyrolactone moiety as central basic unit, we wanted to build a different 
type of fused ring system, which was not reported previously by Reiser and co-workers. 
With this interest, we found that Sandresolide A, a diterpene that contains a novel 5-6-7 
fused ring system, different from other guaianolides (Fig. 10, b).  
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Fig. 10: Different natural products skeleton having !-lactone moiety  
 
The tricyclic 5-6-7 fused ring system was planned to synthesize utilizing the same 
methodology applied for the synthesis of guaianolides. Not only by its structural appeal 
but Sandresolide A also has good biological activity (such as anti-inflammatory agent) 
and its total synthesis was also not reported so far. All these factors prompted us to aim 
for the total synthesis of Sandrasolide A, which was chosen as one of my PhD research 
topic. #
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8. Progress towards the total synthesis of Sandresolide A 
 
 
8.1 Retrosynthetic Strategy 
The general retrosynthetic strategy shown below (Scheme 49) gives the outline to achieve 
the target molecule Sandersolide A (199). Retrosynthesis of the natural product 199 
suggested that it could be obtained from the precursor 201 via Grignard reaction followed 
by a combination of ring closing metathesis (RCM) and radical cyclization, subsequent 
functionalization of the tricyclic ring. The precursor 201 can be readily obtained from 
inexpensive furoic ester 200 by a synthetic route that has been established by Reiser et al. 
involving an enantioselective cyclopropanation of 200 followed by a 
retroaldol/lactonization sequence.15 
 
 
Scheme 49: Retrosynthetic approach towards the total synthesis of Sandresolide A.  
 
 
8.2 Synthesis of Cyclopropylcarbaldehyde 207 
Cyclopropanes are an important class of compounds because of their occurrence in 
numerous natural products, drugs and also because of their value as synthetic building 
blocks in organic synthesis. Highly functionalized 1,2,3-trisubstituted 
!"#$%&'(')*+)!,#-.&'*/(-&)0)#
!"#$%&'(#)*+#,*-.'.#/01223## !$#
cyclopropylcarbaldehyde 207 was synthesized in enantiomerically pure form in a two 
step sequence starting from methyl-2-furoate (200) (Scheme 50).16-18 Thus upon a Cu(I)- 
mediated asymmetric, regio and diastereoselective cyclopropanation of methyl-2-furoate 
(200) using ethyl diazoacetate in the presence of chiral ligand (R,R)-iPr-Box (+)-208 
resulted in cyclopropanated adduct (+)-206 with high enantioselectivity of 85-90 % ee, 
which was improved to >99 % ee upon recrystallization. The ozonolysis of the unreacted 
double bond under standard conditions followed by reductive workup afforded 
enantiomerically pure cyclopropylcarbaldehyde (+)-207 in good yield. The whole 
sequence can be scaled up to 50-100 g with out significant drop in enantiomeric excess of 
products. 
 
 
 
Scheme 50: Conditions: a) (i) ethyl diazoacetate (2.67 eq.), Cu(OTf)2 (0.66 mol%), (R,R)-iPr-box (+)-208 
(0.84 mol %), PhNHNH2 (0.70 mol %), CH2Cl2, 0 °C, 40 %, 85-90 % ee; (ii) recrystallization (pentane) 
>99 % ee, 32 %. b) (i) O3, CH2Cl2, –78 °C(ii) dimethylsulfide (4 eq.), 22 h, –78 °C to rt, 90 %. 
 
The stereochemical outcome and high enantioselectivities of the cyclopropanated product 
during asymmetric cyclopropanation depends on the stereochemistry of the 
bis(oxazoline)-ligand (BOX) 208 used in the reaction (Fig. 11).  
 
 
Fig. 11: Two enantiomers of BOX-ligand 
!"#$%&'(')*+)!,#-.&'*/(-&)0)
!"#$%&'(#)*+#,*-.'.#/01223# !%#
The use of other enantiomer of BOX ligand, i.e. (-)-208 in the above sequence gives rise 
to the synthesis of (-)-207. Thus with the choice of appropriate chiral ligand, the synthesis 
of either of the enantiomers of cyclopropylcarbaldehyde 207 can be achieved. Both 
enantiomers of the chiral BOX-ligand 208 were prepared from D or L- valinol 209 
derived from the corresponding amino acids by sodium borohydride reduction and iodine 
(Scheme 51). The regio, diastereo, and high enantio-selectivities observed during the 
cyclopropanation step can be explained by applying the models suggested by Pfaltz19 and 
Andersson20 for the asymmetric 
 
 
 
Scheme 51: Synthesis of chiral BOX-ligand. Conditions: a) valinol (2.0 eq.), NEt3 (2.5 eq.), CH2Cl2, 0 °C- 
rt, 70 min, 81 %; b) DMAP (10 mol %), NEt3 (4.0 eq.), TsCl (2.0 eq.), CH2Cl2, rt, 27 h, 85 %. 
 
cyclopropanation of alkenes. The reactive complex 212 involved in the reaction can be 
accessed by reacting partner 200 in two ways (Fig. 12). Out of the two possible 
approaches, an approach from the right side is more favored, since an attack from left 
side shows strong repulsive interaction between 200 and iPr group of the ligand (+)-208. 
In the subsequent cyclopropanation, the less substituted and presumably more electron 
rich double bond of 200 is attacked. 
 
 
Fig. 12: Model for asymmetric cyclopropanation showing the observed selectivity (reprinted from ref. 21) 
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8.3 Synthesis of trans-4, 5-disubstituted !-butyrolactone 
Having synthesized the key intermediate cyclopropylcarbaldehyde (+)-207 the next step 
was addition of allylsilane to cyclopropylcarbaldehyde (+)-207. The stereocontrol 
addition on a cyclopropyl-substituted carbonyl compound such as 207 can be explained 
by analyzing the conformational preferences and applying the Felkin-Anh-model22 in 
combination with the Curtin-Hammett-principle.23 Thus, Borontrifluoride mediated 
addition of allylsilane to cyclopropylcarbaldehyde (+)-207 proceeded with excellent 
double stereocontrol, in which the attack of the allylsilane takes place in accordance with 
Felkin-Anh paradigm (Scheme 52). The stereochemical outcome of this reaction can be 
demonstrated by the proposed transition state 213. In this case, the nucleophile attacks 
the s-cis-conformation of the carbonyl group in anti-orientation leading to the 
experimentally observed anti-Felkin-Anh-product 214. 
 
 
Scheme 52. Conditions: a) BF3!OEt2 (1.1 eq.), CH2Cl2, -78 °C, 16 h, 80 % (crude). 
 
Without purification, the adduct 214 was directly subjected to base which results in the 
saponification of the labile oxalic ester group. As a result, the now unmasked donor-
acceptor cyclopropane24 undergoes a cascade of ring opening (retroaldol) and 
lactonization to afford 201 as single stereoisomer (Scheme 53). 
 
  
Scheme 53. Retroaldol-lactonization. Conditions: a) Ba(OH)2!8H2O (0.55 eq.), MeOH, rt, 2 h, 50 % (over 
two steps). 
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9. Construction of 5-6 bicyclic fused ring 
We envisioned that for the total synthesis of Sandresolide A 199, we needed to first 
construct the tricyclic core 217 (Fig. 13), which on functionalization should give the 
required target molecule. Keeping this in mind our first target was to build up the 
tricyclic core 217. We visualized that, starting from !-lactone 201, there are two 
alternative ways to make the tricyclic core 217 (Fig. 13). 
 
 
Fig. 13: Different strategies for making tricyclic core. 
 
It should be possible to make first 5-6 fused bicyclic ring 215, followed by the 
construction of seven membered ring to end up with 217. On the other hand, it should 
also be feasible to construct first 5-7 fused bicyclic ring 216, followed by the construction 
of sixmembered ring to get tricyclic core 217 (Fig. 13). Although the later strategy is well 
known from our group i.e., the construction of 5-7 fused ring via RCM for the synthesis 
of guaianolides, we envisioned that the first strategy involving construction of 5-6 fused 
ring system 215 from !-lactone 201 would be a challenging task. Also this would lead to 
the development of a new methodology for the construction of 5-6-7 fused system 
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starting from !-lactone 201. Therefore, we proceeded for the construction of 5-6 fused 
system 215. 
 
 
9.1 Radical Cyclization Approach 
Over the past few decades, radical cyclization has emerged as a powerful carbon-carbon 
bond-forming reaction that is widely used in organic synthesis. It has been utilized to a 
greater extent for the synthesis of complex organic molecules and natural products, 
especially the formation of polycyclic ring via cascade radical cyclization25 is very 
interesting, atom economic and economically favorable process in organic synthesis. The 
radical cyclization approach was successfully utilized in the total synthesis of guainolides 
(+)-Cladantholide, (-)Estafiatin as shown below (Scheme 54).  
 
 
Scheme 54: Radical cascade reactions for total synthesis of natural products. 
 
Having such literature precedence, we wanted to apply radical cyclization approach to 
construct the six membered ring fused with !-butyrolactone. Thus it was envisioned to 
perform a radical cyclization, installation of a butene side arm in 201 was necessary to 
yield 222 as shown in Fig. 14.  
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Fig. 14: Retrosynthesis for making 5-6 fused ring. 
 
To investigate the practical feasibility of such radical cyclization, we did a model study 
by installing a one carbon less allyl side arm in 201 (Scheme 55) by Lewis acid mediated 
allyl TMS addition followed by the silyl protection of the free hydroxyl group in 223 to 
yield 224. 
 
 
Scheme 55: Allylation and protection of !-butyrolactone. Conditions: a) BF3.OEt2, allyl TMS, -78 °C, 24 h, 
82 %. b) (i) Et3N, TESCl, rt, 24 h (ii) separation, 75 %  
 
Having the model substrate compound 224 in hand, we proceed for the radical cyclization 
which is described below.  
 
 
9.1.1 High-Valent Transition Metal-Promoted Radical Cyclization Approach 
It is well reported in literature that ketones, esters, and aldehydes are very easily oxidized 
by high-valent transition metals, such as Mn (III), Fe (III), Co (II), and Cu (II) acetate, to 
give "-oxoalkyl radicals that can add to olefins to form a variety of interesting products. 
For example substituted "-tetralones 227 have been synthesized by Mn (III)- promoted 
addition of aromatic methyl ketone 225 to various olefins 226 (Scheme 56).26 It is also 
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known that Mn (III) – Cu (II) combination also works great for this type of radical 
reactions.26-28 
 
 
Scheme 56: Transition metal mediated radical cyclization. 
 
Having this literature evidence, we treated compound 224, with two equivalent of Mn 
(III) acetate in acetic acid at 94 °C (Scheme 57). Upon monitoring the reaction, there was 
no expected 5-exo-trig product formation even after 24 h. The same reaction when 
performed with identical reaction conditions employing a Mn (III) – Cu (II) acetate 
combination (Mn / Cu = 2:1 equiv.) instead of Mn (III) alone there was no expected 6-
endo-trig product formation observed, only starting material was recovered. 
 
224 228
OO H
229
OSiEt3
224
Mn (III) acetate
CH3COOH, 
94 °C, 24 h
Mn (III)-Cu (II) 
acetate (2:1)
CH3COOH, 
94 °C, 24 h
or
5-exo-trig 6-endo-trig
OO H
H
OSiEt3
OO H
H
OSiEt3
OO H
H
OSiEt3
 
Scheme 57: Approach towards cyclization using transition metal. 
 
With this observation, it was thought that the "-position of lactone carbonyl was not so 
activated to be oxidized by the metal. To make this position easily oxidizable, we 
introduced an electron withdrawing ester group that can be easily removed by 
decarbalkoxylation29 and then performed metal promoted radical cyclization (Scheme 
58). Interestingly with this approach we obtained only 5-exo-trig cyclized product 228a 
in good yield. There was no 6-endo-trig cyclized product (similar to 229) obtained 
although both are possible according to Baldwin’s rule. 
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Scheme 58: Radical cyclization leads to 5-exo-trig product. 
  
After getting the success of doing cyclization in the model substrate we were confident 
enough to make the desire cyclized product 215. For this purpose we introduced a 
homoallyl side chain and subsequent protection of the hydroxyl group gave compound 
232 (Scheme 59). Introduction of an ester group "-to the lactone carbonyl afforded 
compound 233, which was subjected to cyclization using the standard conditions applied 
during the case of model study. Interestingly, in the cyclization conditions, we obtained 
desired product 234 in combination with its regioisomer 235 as non-separable mixture in 
1:1 ratio but in very low yield (Scheme 59). By applying different reaction conditions, we 
were not able to improve the yield significantly, as well as, the separation problems 
associated with 234 and 235 led us to think alternative way for cyclization. 
 
235
1) LDA (1.2 eqv.),
    THF
2) ClCO2Et,
    -78 °C, 6 h
          65 %
Mn (III)-Cu(II) (2:1)
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OO
CHOH
H
201 231
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OO
H
H
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232
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H
H
OH
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OO H
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HEtO2C
OSiEt3
OO H
HEtO2C
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+
233
OO H
OSiEt3
EtO2C H
(1 : 1)
 
Scheme 59: Construction of six membered ring via radical cyclization. 
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9.1.2 Oxidative Radical Cyclization Approach 
Our next approach for cyclization was oxidative radical cyclization, which involves very 
interesting chemistry. An oxidative radical cyclization is a single electron transfer (SET) 
oxidation of ester enolates, which can undergo cyclization with olefins intramolecularly 
to generate an intermediate, which further can produce a variety of compounds depending 
upon the use of trapping reagent (Scheme 60). The anionic precursor 238 is simply 
generated by deprotonation of 236. 
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Scheme 60: Variation in oxidative radical cyclization 
 
In contrast, traditional Bu3SnH-mediated radical chain reaction require precursor 237 that 
often originate from functionalization of 236 or 238. Slow reaction rate of 239 to 240, 
which may not propagate chain reactions, especially at low temperatures and are not of 
particular concern in processes starting from 238. Finally, in contrast to radical chain 
reactions, removal of ultimate radical 240 can be achieved either by trapping with 
external reagents Y to form 241 or by further SET oxidation to produce a carbenium ion 
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242, which may react with nucleophiles to give 243. Opportunities for the synthesis of 
diversely functionalized products are hence much broader than those offered by tin 
hydride reactions.  
Impressed by this chemistry, we treated the lithium enolate of compound 233 for radical 
6-exo cyclization. We thought that SET oxidation of 233-enolate should give an "-
carbonyl radical and that will undergo cyclization. But in reality, treatment of compound 
233 with strong base like LDA, and ferrocinium hexafluoro complex 244 (as SET 
oxidant, reported by Jahn et al.30), did not bring any successful transformation (Scheme 
61).  
233
OO H
OSiEt3
EtO2C H
OO H
OSiEt3
EtO2C H
OO H
234
H
OSiEt3LDA,  THF
- 78 °C
244
Fe PF6
244
EtO2C
 
Scheme 61: oxidative radical cyclization approach. 
 
Changing the reaction conditions such as altering base from LDA to LHMDS, SET 
oxidant from ferrocinium complex to Cu (II)-2-ethylhexanoate31 and varying temperature 
did not show any reactivity; all the time starting material was recovered. Based on these 
observations we concluded that the radical "-to the carbonyl group is not generating in 
substrate 233 by this method. With this conclusion we thought of doing the cyclization 
with conventional AIBN/Bu3SnH method. 
 
 
9.1.3 Conventional AIBN/Bu3SnH Approach for Cyclization 
Getting almost negative results by applying the above two modern methods, we decided 
to proceed for the cyclization with conventional AIBN/Bu3SnH. Starting from 
halogenated compounds, AIBN/Bu3SnH mediated cyclization is very well known and 
quite old but effective chemistry as shown before in Scheme 54 (page- 89). For this 
intention we started from compound 232. Bromination of compound 232 (Scheme 62) 
with NBS selectively gave "-bromo carbonyl compound 245 (neither allylic bromination 
nor double bond bromination was observed, which is not ruled out theoretically possible 
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because of two allylic side chains are present in compound 232). Treatment of compound 
245 with AIBN/Bu3SnH in benzene as solvent at refluxing condition unfortunately did 
not give the cyclized product 234, rather gave the dehalogenated product 232 (Scheme 
62). 
 
1) LDA (1.2 eqv.),
  THF, Me3SiCl,
-78 °C
2). 1.1 eqv. NBS,
      4 h, 87 %OO
H
H
OSiEt3
232 245
OO H
OSiEt3
Br H
OO
H
H
OSiEt3
232
AIBN/Bu3SnH
C6H6, reflux,
 3 h, 89 %
H
dr = 80:20  
Scheme 62: AIBN/Bu3SnH approach for cyclization 
 
Failure in the methods forced us to find the problem for cyclization in molecular level. 
We realized that, for making six membered ring by radical cyclization, it is necessary for 
the double bond to be in the close proximity of the radical center. From all these 
observations, we came into conclusion that probably the large size protecting group –
OSiEt3, oriented in such a way that it was hindering the double bond to come closer to the 
radical center generated by the above applied methods (Fig. 15). Therefore, we thought 
that it is necessary to replace the bulky protecting group with a small protecting or better 
to say linear protecting group. Therefore, we changed bulky protecting group to a linear 
protecting group –MOM and carried out the same AIBN/Bu3SnH reaction (Scheme 63). 
But, unfortunately in this case also we observed dehalogenated product 246. 
 
 
 
Fig. 15: Bulkiness may be the cause of non-cyclization. 
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Scheme 63: Approach for cyclization using different protecting group. 
 
Taking the above observations into consideration, we concluded that, -MOM was also not 
a suitable protecting group to facile the cyclization. Therefore, we decided to remove the 
protecting group completely. So the future perspective for the radical cyclization was to 
deprotect the protecting group and obtain 250 (Scheme 64). Now PCC oxidation of 250 
should give the oxidized product 251, which should undergo cyclization by 
AIBN/Bu3SnH method to produce 252. Further allylation and followed by RCM should 
give the tricyclic core 254, which on functionalization should give the target molecule 
199. These approaches are currently under investigation. 
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Scheme 64: Future plans towards the synthesis Sandresolid A. 
 
 
9.2 Conclusion:  
Anybody can draw a picture, but pictures painted by famous painters such as van Gogh, 
Monet, and Picasso are praised as “art”. At the present time, anyone may be able to 
synthesize natural products, even those having complicated structure by advanced 
organic chemistry. Hence, “art” is much more essential to be introduced into the organic 
synthesis. That is the significance of the total synthesis and development of bioactive 
compounds. For the total synthesis of Sandresolide A, we took the risk to apply 
completely new and sophisticated approaches to develop new chemistry, new 
methodologies. Although the chemistry in paper does not work well all the time in flask, 
but it is sometimes necessary to go beyond the known route to develop new chemistry, 
new methodology irrespective of risk of failure. Albeit our new approaches got failed, we 
were daring enough to take the risk and wanted to develop new chemistry. But, our new 
approach should lead to the total synthesis of Sandresolide A, as there is no royal road to 
success in total synthesis and development of useful bioactive compounds, steady efforts 
are the only way to achieve that goal. 
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Summary 
 
Photocatalysis with visible light is undoubtedly one of the emerging strategies to meet the 
increasing demand for more sustainable processes. This thesis describes the use of visible 
light as a promoter for organic transformations. Most of the organic molecules are unable 
to absorb light in the visible region. Keeping this in mind, we utilized Ru(bpy)3Cl2 
complex as photosensitizer. We developed ‘‘Ru(bpy)3Cl2, 1,5-dimethoxynaphthalene-
ascorbic acid’’, a new photocatalytic combination for reduction of carbon-halogen bonds. 
This conceptually new photocatalytic system with visible light is very efficient to drive 
sequential electron transfer processes for reductive debromination of vicinal dibromo 
carbonyl compounds to (E)-alkenes and alkynes, gem-dibromides to monobromides, and 
monobromides or chlorides to their dehalogenated counterparts (Scheme 65). As a key 
structural feature, a carbonyl group positioned !-to one halogen atom is required for the 
success of the transformation. The photosystem is also highlighted by its 
chemoselectivity, resulting in reduced products in high yields under mild reaction 
conditions. 
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Scheme 65: Reductive dehalogenation of vicinal dibromo and !-halo carbonyl compounds. 
!"##$%&'
()'*$+,-'./0'1/23,3'456778! "#$!
Singlet oxygen (1O2) is a higher energy state molecular oxygen. It is quite well known as 
a reaction intermediate for cycloaddition reactions to produce endoperoxides and ene 
reactions to provide allylic hydroperoxides. This highly reactive singlet oxygen has 
shown to be efficiently photosensitized by a large number of compounds, most of which 
have been organic compounds. We utilized Ru(bpy)3Cl2 complex as a singlet oxygen 
generator in presence of visible light and performed oxidative cleavage of cyclic 
enamines and enol ethers. "-And #-aminoacids and their derivatives are very important 
constituents of natural products and as a valuable intermediates for the preparation of 
peptidomimetics. Applying our methodology we successfully performed oxidative ring 
opening of cyclic enamines, which lead to "-and higher amino acid analogs (Scheme 66). 
The oxidative cleavage of enamines by this method leads to products, which preserved 
the relative and absolute stereochemistry of starting material. This methodology can also 
be utilized as an alternative of hazardous ozone to perform this type of oxidative 
cleavage.  
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Scheme 66: Oxidative cleavage of cyclic enamines. 
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This thesis also describes the studies towards the synthesis of natural product 
Sandresolide A (199), a nor-diterpene lactone. Every natural product type isolated from 
the seemingly limitless chemical diversity in nature provides a unique set of research 
opportunities deriving from its distinctive three-dimensional architecture and biological 
properties. Diterpene and sesquiterpene lactones exhibit a broad range of biological 
activity along with the structural diversity and stimulate the development of research in 
their total synthesis. The essence of total synthesis lies in how readily available starting 
materials can be converted to complex molecular architectures through controlled, 
efficient and logically orchestrated carbon-carbon and carbon-heteroatom bond 
connectivities. 
With our synthetic approach we showed how simple aromatic starting materials could be 
converted to chiral building blocks such as anti-disubstituted #-butyro-lactones that are 
key structural motifs of guaianolides and can also be utilized as central basic unit to build 
different types of ring system other than guauanolides. 
Starting from furoic ester 200 we tried to synthesize the natural product Sandresolide A 
where trans-4,5-disubstituted #-butyro lactone (201) served as a central building block of 
the molecule (Scheme 67). !
OR
O R
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R = CO2Me > 99 % ee
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H
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OO
217
Sandresolide A
OO HO
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Scheme 67: Studied towards the synthesis of Sandresolide A. 
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11. Experimental part 
 
11.1 General information 
 
1H NMR-Spectra were recorded on Bruker Avance 300, Bruker Avance 400, Bruker 
Avance 600, Varian Inova 600, Bruker DRX-400 with a H/C/P/F QNP gradient probe 
and Bruker Avance 500 with a dual carbon/proton CPDUL cryoprobe. The chemical shift 
! is given in [ppm], calibration was set on chloroform-d1 (7.26 ppm) or tetramethylsilane 
(0.00 ppm) as internal standard. The spectra were evaluated in 1st order and the coupling 
constants are given in Hertz [Hz]. The following abbreviations for the spin multiplicity 
were used: s = singlet, d = doublet, t = triplet, q = quartet, qt = quintet, m = multiplet, dt = 
doublet of a triplet, dd = double doublet, ddd = doublet of a double doublet, sept = septet. 
The used deuterated solvents are given separately.  
13C NMR-Spectra were recorded on Bruker Avance 300, Bruker Avance 400, Bruker 
Avance 600, Varian Inova, Bruker DRX-400 with a H/C/P/F QNP gradient probe and 
Bruker Avance 500 with a dual carbon/proton CPDUL cryoprobe. The chemical shift ! is 
given in [ppm], calibration was set on chloroform-d1 (77.16 ppm), or tetramethylsilane 
(0.00 ppm) as internal standard. The multiplicity of the signals were detected by DEPT 
135 and 90 (DEPT = distortionless enhancement by polarization transfer) 
Masspectrometry was performed on Varian MAT 311A, Finnigan MAT 95, 
Thermoquest Finnigan TSQ 7000, Nermag quadrupoles, VG ZAB high-resolution 
double-focusing and VG Autospec-Q tandem hybrid with EBEqQ configuration. The 
percentage set in brackets gives the peak intensity related to the basic peak (I = 100%). 
High resolution mass spectrometry (HRMS): The molecular formula was proven by the 
calculated precise mass. 
Elemental analysis was prepared by the micro analytic section of the University of 
Regensburg using a Vario EL III or Mikro-Rapid CHN (Heraeus). 
Thin layer chromatography (TLC) was prepared on TLC-aluminium sheets (Merck, 
silica gel 60 F254, 0.2 mm). Detection in UV-light l = 254 nm, staining with I2, Mostain, 
molybdatophosphoric-acid (5% in ethanol), KMnO4 solution or vanillin-sulfuric acid. 
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Column chromatography was performed in glass columns (G2 or G3). As a stationary 
phase silica gel Merck-Geduran 60 (0.063-0.200 mm) or flash silica gel Merck 60 (0.040-
0.063 mm) was used. 
Solvents: Abs. solvents were prepared according to usual lab procedures or taken from 
the MB-SPS solvent purification system. Ethylacetate, hexanes (40-60 °C) and 
dichloromethane were purified by distillation before use. Further solvents and reagents 
were of p.a. quality. 
Reactions with oxygen- and moisture sensitive reactants were performed in oven dried 
and in vacuo heated reaction flasks under a pre-dried inert gas (nitrogen or argon) 
atmosphere. For cooling to temperatures < -40 °C a cryostat Haake EK 90 or dry ice/iso-
propanol mixture was used. 
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11.2 Dehalogenation of vicinal dibromo, !-halo and ! ,!-dibromo 
carbonyl compounds 
 
General Procedure for the preparation of !-bromo/! ,!'-dibromo carbonyl 
compounds: 
General Procedure A1 (GP-A): 
To a stirred solution of the corresponding ketone (1 mmol) in CHCl3 (3.0 mL) was added 
dropwise  2.0 mL (4.0 mL for dibromination) of bromine solution (0.55 M in chloroform) 
at 0 °C and after complete addition the reaction mixture brought into room temperature. 
The stirring was continued at room temperature for another 1h and then gently heated at 
65 °C. Completion of the reaction was determined by checking TLC. After completion of 
the reaction, reaction mixture brought to room temperature and a saturated solution of 
Na2S2O3 was added to quench the unreacted bromine and stirring continued for another 
30 min.  The reaction mixture was extracted with CHCl3 (2 x 5.0 mL) and the combined 
organic layers washed with brine. The organic layer was dried over anhydrous Na2SO4 
and concentrated in vacuo. Depending upon the substrate the desire compound was 
obtained by crystallization (EA/PE) or by column chromatography. 
 
General Procedure B2 (GP-B): 
Ketone (1 mmol) N-halosuccinimide (NBS/ NCS, 1 mmol) were triturated together with 
p-toluenesulfonic acid (PTSA, 0.1 mmol) in a porcelain mortar for 20 min. The reaction 
mixture was then heated to 80 °C for 2 h, turning into a dense paste. Water was then 
added (5.0 mL) followed by extraction with diethyl ether (20.0 mL). The organic phase 
was washed with water (10.0 mL), dried over Na2SO4 and solvent evaporated under 
reduced pressure. Depending upon the substrate the desire compound was obtained by 
crystallization (EA/PE) or by column chromatography. 
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2-Bromo-1-(4-methoxyphenyl)ethanone (142a) (GP-A)3 
According to the general procedure (GP-A), 1-(4-methoxyphenyl) 
ethanone (0.16 g, 1.01 mmol) and 2.05 mL of bromine solution 
(0.55 M in chloroform) afforded 142a (0.17 g, 0.75 mmol, 75 %) 
as crystalline solid after crystallization from EA/PE. Rf (EtOAc/hexane 1:9): 0.24. 
1H NMR (300 MHz, CDCl3), ! = 3.91 (s, 3H), 4.45 (s, 3H), 6.95 (d, J = 9.05 Hz, 2H), 
7.97 (d, J = 8.78 Hz, 2H). 
 13C NMR (75 MHz, CDCl3), ! = 30.7, 55.6, 114.1, 126.9, 131.4, 164.1, 189.9. 
 
2-Chloro-1-(4-methoxyphenyl)ethanone (142b) (GP-B)4 
According to the general procedure (GP-B), 1-(4-methoxyphenyl) 
ethanone (0.52 g, 3.46 mmol) and NCS (0.44 g, 3.33 mmol) 
afforded 142b (0.45 g, 2.49 mmol, 75 %) as crystalline solid after 
crystallization from EA/PE. Rf (EtOAc/hexane 1:9): 0.30. 
 1H NMR (300 MHz, CDCl3), ! = 3.89 (s, 3H), 4.66 (s, 2H), 6.95 (d, J = 9.05 Hz, 2H), 
7.93 (d, J = 9.05 Hz, 2H). 
13C NMR (75 MHz, CDCl3), ! = 45.7, 55.6, 114.1, 127.2, 130.9, 164.1, 189.6. 
 
2-Bromo-1(4-bromophenyl)ethanone (142c) (GP-A)5 
According to the general procedure (GP-A), 1-(4-bromophenyl) 
ethanone (0.48 g, 2.41 mmol) and 5.10 mL of bromine solution 
(0.55 M in chloroform) afforded 142c (0.57 g, 2.06 mmol, 82 %) as 
crystalline solid after crystallization from EA/PE. Rf (EtOAc/hexane 1:9): 0.47. 
1H NMR (300 MHz, CDCl3), ! = 4.4 (s, 2H), 7.65 (d, J = 8.78 Hz, 2H), 7.85 (d, J = 8.5 
Hz, 2H). 
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 13C NMR (75 MHz, CDCl3), !: 30.3, 129.3, 130.4, 132.2, 133.3, 190.4. 
2-Bromo-1-(naphthalen-2-yl)ethanone (142e) (GP-A)6 
According to the general procedure (GP-A), 1-(naphthalen-2-yl)-
ethanone (1.01 g, 5.94 mmol) and 11.80 mL of bromine solution 
(0.55 M in chloroform) afforded 142e (1.03 g, 4.17 mmol, 71 %) as 
crystalline solid after column purification on silica gel. Rf (EtOAc/hexane 1:9): 0.43. 
1H NMR (300 MHz, CDCl3), ! = 4.59 (s, 2H), 7.53-7.69 (m, 2H), 7.84-8.08 (m, 4H), 
8.52 (s, 1H). 
13C NMR (75 MHz, CDCl3), ! = 30.9, 124.2, 127.1, 127.9, 128.8, 129.0, 129.7, 131.0, 
131.3, 135.9, 191.3. 
 
2-Bromo-1-(4-methoxyphenyl)propan-1-one (142f) (GP-A)7 
According to the general procedure (GP-A), 1-(4-
methoxyphenyl)-propan-1-one (0.59 g, 3.59 mmol) and 7.30 mL 
of bromine solution (0.55 M in chloroform) afforded 142f (0.64 g, 
2.67 mmol, 73 %) as white solid after column purification on silica gel. Rf 
(EtOAc/hexane 1:9): 0.42. 
1H NMR (300 MHz, CDCl3), ! = 1.89 (d, J = 6.8 Hz, 3H); 3.88 (s, 3H); 5.27 (q, J = 6.8 
Hz, 1H); 6.96 (dd, 2.4, 8.8 Hz, 2H); 8.02 (dd, J = 2.4, 8.8 Hz, 2H). 
13C NMR (75 MHz, CDCl3), ! = 20.2, 41.4, 55.5, 113.9, 126.8, 131.3, 163.9, 192.0. 
 
2-Bromo-3,4-dihydronaphthalen-1(2H)-one (142g) (GP-B)8 
According to the general procedure (GP-B), 3,4-dihydronaphthalene-
1(2H)-one (0.49 g, 3.35 mmol) and NBS (0.61 g, 3.44 mmol) afforded 
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142g (0.44 g, 1.95 mmol, 57 %) as gummy oil after column purification on silica gel. Rf  
(EtOAc/hexane 1:9): 0.39. 
1H NMR (300 MHz, CDCl3), ! = 2.35-2.58 (m, 2H), 2.83- 2.95 (m, 1H), 3.22-3.49 (m, 
1H), 4.71 (t, J = 4.39 Hz, 1H), 7.21-7.37 (m, 2H), 7.45-7.55 (m, 1H), 8.11 (dd, J = 1.37, 
7.95 Hz, 1H). 
13C NMR (75 MHz, CDCl3), ! = 26.1, 31.9, 50.6, 127.1, 128.6, 128.8, 129.9, 134.2, 
143.0, 190.5. 
 
2-Chloro-3,4-dihydronaphthalen-1(2H)-one (142h) (GP-B)9 
According to the general procedure (GP-B), 3,4-dihydronaphthalene-
1(2H)-one (0.98 g, 6.71 mmol) and NCS (0.91 g, 6.84 mmol) afforded 
142h (0.79 g, 4.45 mmol, 65 %) as yellowish oil after column 
purification on silica gel. Rf  (EtOAc/hexane 1:9): 0.41. 
1H NMR (300 MHz, CDCl3), ! = 2.36-2.67 (m, 2H), 2.90- 3.06 (m, 1H), 3.18-3.33 (m, 
1H), 4.57-4.67 (m, 1H), 7.22-7.38 (m, 2H), 7.45-7.58 (m, 1H), 8.08 (d, J = 7.95 Hz, 1H).  
13C NMR (75 MHz, CDCl3), ! = 26.3, 32.4, 59.8, 127.1, 128.5, 128.7, 130.4, 134.1, 
143.1, 190.8. 
MS (EI, 70 eV): m/z = 90.1 (37.22), 118.0 (100), 145.1 (11.00), 180.5 (39.40) [M+]. 
 
2-Bromocyclohexanone (142i) (GP-B)10 
According to the general procedure (GP-B), cyclohexanone (1.99 g, 20.31 
mmol) and NBS (3.63 g, 20.41 mmol) afforded 142i (2.34 g, 13.26 mmol, 65 
%) as brown oil after column purification on silica gel. Rf (EtOAc/hexane 
1:9): 0.66. 
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1H NMR (300 MHz, CDCl3), ! = 1.61-2.11 (m, 4H), 2.12-2.41 (m, 3H), 2.90-3.33 (m, 
1H), 4.39-4.49 (m, 1H). 
13C NMR (75 MHz, CDCl3), ! = 22.1, 27.6, 36.7, 37.9, 53.4, 203.5. 
MS (EI, 70 eV): m/z = 97.1(100), 132.0(15.49), 176.0(29.52) [M+]. 
 
2-Bromo, 4-phenylcyclohexanone (142j) (GP-B)10 
According to the general procedure (GP-B), 4-phenylcyclohexanone (0.51 g, 
2.93 mmol) and NBS (0.51 g, 2.87 mmol) upon refluxation in CCl4 (12 h) 
afforded 142j (0.54 g, 2.15 mmol, 75 %) as white crystalline solid (mp 112-
116 oC; lit. 115-116 oC) after column purification on silica gel. Rf  
(EtOAc/hexane 1:9): 0.47. 
1H NMR (300 MHz, CDCl3), ! = 1.85-2.05 (m, 1H), 2.17-2.30 (m, 1H), 2.35-2.50 (m, 
3H), 3.25-3.41 (m, 1H), 3.45-3.60 (m, 1H), 4.40-4.47 (m, 1H), 7.20-7.40 (m, 5H).  
13C NMR (75 MHz, CDCl3), ! = 33.6, 35.6, 37.2, 41.9, 50.8, 126.9, 128.8, 143.3, 203.9.  
MS (EI, 70 eV): m/z =117.1 (100), 173.1 (32.79), 252.0 (68.19) [M+]. 
 
2-Chloro, 4-phenylcyclohexanone (142k) (GP-B) 
According to the general procedure (GP-B), 4-phenylcyclohexanone (0.49 g, 
2.81 mmol) and NCS (0.38 g, 2.87 mmol) upon refluxation in CCl4 (12 h) 
afforded 142k (0.20 g, 1.02 mmol, 35 %) as white crystalline solid after 
column purification on silica gel. Rf (EtOAc/hexane 1:9): 0.46. 
1H NMR (300 MHz, CDCl3), ! = 1.85-2.07 (m, 1H), 2.13-2.51 (m, 4H), 3.09-3.28 (m, 
1H), 3.42-3.62 (m, 1H), 4.29-4.34 (m, 1H), 7.20-7.39 (m, 5H). 
13C NMR (75 MHz, CDCl3), ! = 33.7, 35.9, 36.6, 40.5, 59.9, 126.9, 128.8, 143.2, 204.3. 
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MS (EI, 70 eV): m/z =104.1(100), 153.1(43.06), 208.1(49.82) [M+]. 
HRMS (EI, 70 eV): Calcd for C12H13ClO [M]+: 208.0655, found: 208.0658. 
2,2-Dibromo-1-(4-bromophenyl)ethanone (144a) (GP-A)11 
According to the general procedure (GP-A), 1-(4-bromophenyl)-
ethanone (0.52 g, 2.61 mmol) 9.20 mL of bromine solution (0.55 M 
in chloroform) afforded 144a (0.76 g, 2.11 mmol, 84 %) as 
crystalline solid after column purification on silica gel. Rf 
(EtOAc/hexane 1:9): 0.62. 
1H NMR (300 MHz, CDCl3), ! = 6.6 (s, 1H), 7.65 (d, J = 8.78 Hz, 2H), 7.98 (d, J = 8.50 
Hz, 2H). 
13C NMR (75 MHz, CDCl3), ! = 39.2, 129.5, 129.9, 131.2, 132.3, 185.1. 
2,2-Dibromo-1-(4-methoxyphenyl)ethanone (144b) (GP-A)12 
According to the general procedure (GP-A), 1-(4-
methoxyphenyl)-ethanone (0.42 g, 2.80 mmol) and 10.20 mL of 
bromine solution (0.55 M in chloroform) afforded 144b (0.62 g, 
2.01 mmol, 72 %) as crystalline solid after column purification on 
silica gel. Rf  (EtOAc/hexane 1:9): 0.30. 
1H NMR (300 MHz, CDCl3), ! = 3.90 (s, 3H), 6.66 (s, 1H), 6.97 (d, J = 8.78 Hz, 2H), 
8.08 (d, J = 9.05 Hz, 2H). 
13C NMR (75 MHz, CDCl3), ! = 39.8, 55.6, 114.2, 123.3, 132.2, 164.5. 
2,2-Dibromo-3,4-dihydronaphthalen-1(2H)-one (144c) (GP-B)11 
According to the general procedure (GP-B), 3, 4-dihydronaphthalene-
1(2H)-one (0.48 g, 3.28 mmol) and NBS (1.21 g, 6.84 mmol) afforded 
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144c (0.47 g, 1.54 mmol, 45 %) as colorless gummy oil after column purification on 
silica gel. Rf (EtOAc/hexane 1:9): 0.48. 
1H NMR (300 MHz, CDCl3), ! = 2.95-3.18 (m, 4H), 7.20-7.43 (m, 2H), 7.46-7.60 (m, 
1H), 8.11- 8.24 (m, 1H). 
13C NMR (75 MHz, CDCl3), ! = 29.3, 45.8, 67.3, 127.3, 127.6, 128.6, 129.4, 130.1, 
134.4, 142.1, 184.2. 
 
General procedure for preparation of vicinal dibromides:13 
To a solution or suspension of the corresponding chalcone (1.53 mmol) in 8.0 mL of 
CHCl3 was added dropwise 3.0 mL of bromine solution (0.56 M in chloroform) at 0 °C. 
The mixture was stirred at room temperature until the reaction was completed (monitored 
by TLC). After completion of the reaction a saturated solution of Na2S2O3 was added to 
quench the unreacted bromine and stirring continued for another 30 min.  The reaction 
mixture was extracted with CHCl3 (2x 8.0 mL) and the combined organic layers were 
washed with brine. The organic layer was dried over anhydrous Na2SO4 and concentrated 
in vacuo. Depending upon the substrate the desired compound was obtained by 
crystallization (EA/PE) or by column chromatography. 
 
(2S, 3R)-2, 3-dibromo-1,3-diphenylpropan-1-one (147a)14 
According to the general procedure, (E)-1,3-diphenylprop-2-en-1-
one (0.32 g, 1.53 mmol) and 3.10 mL of bromine solution (0.56 
M in chloroform) afforded 147a (0.46 g, 1.12 mmol, 82%) as 
white solid after column purification on silica gel. Rf (EtOAc/hexane 1:9): 0.46 
1H NMR (300 MHz, CDCl3): ! = 5.65 (d, J = 11.4 Hz, 1H), 5.83 (d, J = 11.4 Hz, 1H), 
7.34-7.49 (m, 3H), 7.51-7.61 (m, 4H), 7.63-7.71 (m, 1H), 8.10 (d, J = 8.4 Hz, 2H). 
 13C NMR (75 MHz, CDCl3): ! = 46.8, 49.8, 128.4, 128.9, 128.9, 129.0, 129.3, 134.2, 
134.4, 138.2, 191.2. 
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(2S, 3R)-ethyl 2,3-dibromo-3-phenylpropanoate (147b)15 
According to the general procedure, ethyl cinnamate (1.99 g, 11.31 
mmol) and 22.30 mL of bromine solution (0.56 M in chloroform) 
afforded 147b (3.35 g, 9.97 mmol, 88%) as white crystalline solid 
after crystallization from EA/PE mixture. Rf (EtOAc/hexane 1:9): 0.59 
1H NMR (300 MHz, CDCl3): ! = 1.38 (t, J = 7.13 Hz, 3H), 4.36 (q, J = 7.13 Hz, 2H), 
4.83 (d, J = 11.8 Hz, 1H), 5.35 (d, J = 11.8 Hz, 1H), 7.30-7.65 (m, 5H). 
13C NMR (75 MHz, CDCl3): ! = 13.9, 47.0, 50.7, 62.7, 128.1, 128.9, 129.4, 137.7, 167.8. 
MS (EI, 70 eV): m/z = 77.1 (42.09), 103.1 (100), 183.0 (29.65), 225 (59.95), 335.8 (2.26) 
[M+]. 
3,4-Dibromochroman-2-one (147d)16     
According to the general procedure, 2H-chromen-2-one (0.51 g, 3.49 
mmol) and 6.70 mL of bromine solution (0.56 M in chloroform) 
afforded 147d (0.96 g, 3.15 mmol, 92 %) as light yellow solid after 
crystallization from EA/PE mixture. Rf  (EtOAc/hexane 1:9): 0.33. 
1H NMR (300 MHz, CDCl3): ! = 4.96 (d, J = 2.74 Hz, 1H), 5.35 (d, J = 2.74 Hz, 1H), 
7.14-7.29 (m, 2H), 7.36- 7.52 (m, 2H). 
13C NMR (75 MHz, CDCl3): ! = 39.3, 43.7, 117.7, 119.9, 125.6, 128.7, 131.6, 150.4, 
160.7. 
MS (EI, 70 eV): m/z = 118.0 (100), 146.0 (76.33), 225.0 (35.64), 303.8 (6.25) [M+].  
(R)-2-bromo-2-((S)-bromo(phenyl)methyl)-3,4-dihydronaphthalen-1(2H)-one (147e) 
17 
According to the general procedure, (E)-2-benzylidene-3,4-
dihydro naphthalen-1(2H)-one (0.39 g, 1.66 mmol) and 3.40 mL 
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of bromine solution (0.56 M in chloroform) afforded 147e (0.52 g, 1.33 mmol, 78 %) as 
light pink solid (mp 152-154 °C; lit. 153-154 °C) after column purification on silica gel. 
Rf (EtOAc/hexane 1:9): 0.48. 
1H NMR (300 MHz, CDCl3): ! = 2.42-2.52 (m, 1H), 2.93-3.27 (m, 3H), 6.2 (s, 1H), 7.25-
7.65 (m, 8H), 8.25 (d, J = 7.68 Hz, 1H). 
13C NMR (75MHz, CDCl3): ! = 26.2, 30.7, 55.4, 68.8, 127.3, 127.8, 128.7, 128.9, 129.4, 
129.8, 131.1, 134.3, 136.2, 142.5, 188.6. 
MS (EI, 70 eV): m/z = 233.1 (100), 313.0 (4.16), 393.9 (0.15) [M+]. 
 
(2S,3R)-2,3-dibromo-1-(furan-2-yl)-3-phenylpropan-1-one (147f)18 !
According to the general procedure, (E)-1-(furan-2-yl)-3-
phenylprop-2-en-1-one (0.81 g, 4.09 mmol) and 8.05 mL of 
bromine solution (0.56 M in chloroform) afforded 147f (1.21 g, 
3.35 mmol, 82 %) as light yellow solid after column purification on silica gel. Rf  
(EtOAc/hexane 1:9): 0.34. 
1H NMR (300 MHz, CDCl3): ! = 5.57 (d, J = 11.80 Hz, 1H), 5.74 (d, J = 11.80 Hz, 1H), 
6.64- 6.72 (m, 1H), 7.35-7.60 (m, 6H), 7.70-7.79 (m, 1H). 
13C NMR (75MHz, CDCl3): ! = 47.1, 49.1, 113.3, 119.8, 128.3, 128.9, 129.3, 138.1, 
147.6, 150.3, 180.1. 
MS (EI, 70 eV): m/z = 95.0 (100), 197.1 (86.18), 277.0 (9.71), 357.9 (0.15) [M+]. 
(S)-3-((2S, 3R)-2,3-dibromo-3-phenylpropanoyl)-4-isopropyloxazolidin-2-one 
(147g)19 
According to the general procedure, (S)-3-cinnamoyl-4-
isopropyloxazolidin-2-one (1.19 g, 4.63 mmol) and 9.10 mL of 
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bromine solution (0.56 M in chloroform) afforded 147g (1.72 g, 4.07 mmol, 88 %) as 
light yellow solid after column purification on silica gel. Rf  (EtOAc/hexane 1:9): 0.27. 
1H NMR (300 MHz, CDCl3): ! = 0.88-1.02 (m, 6H), 2.40-2.60 (m, 1H), 4.20-4.47 (m, 
2H), 4.50-4.65 (m, 1H), 5.51 (d, J = 11.52 Hz, 1H), 6.58 (d, J = 11.52 Hz, 1H), 7.26-7.60 
(m, 5H). 
13C NMR (75 MHz, CDCl3): ! = 14.8, 17.8, 28.0, 43.4, 50.2, 58.6, 63.5, 128.4, 128.9, 
129.4, 137.5, 153.2, 167.2. 
MS (EI, 70 eV): m/z = 260.2 (35.79), 277.1 (100), 279.2 (75.78), 437.0 (6.60) [MNH4+]. 
 
(2R,3S)-2,3-dibromo-3-cyclohexyl-1-phenylpropan-1-one (147h) 
According to the general procedure, (E)-3-cyclohexyl-1-
phenylprop-2-en-1-one (0.54 g, 2.52 mmol) and 4.90 mL of 
bromine solution (0.56 M in chloroform) afforded 147h (0.83 g, 
2.22 mmol, 88 %) as white solid after column purification on silica gel. Rf  
(EtOAc/hexane 1:9): 0.63. 
1H NMR (300 MHz, CDCl3): ! = 1.11-1.95 (m, 10H), 2.00-2. 22 (m, 1H), 4.72 (dd, J = 
2.19, 11.25 Hz, 1H), 5.52 (d, J = 11.25 Hz, 1H), 7.46-7.55 (m, 2H), 7.59-7.66 (m, 1H), 
7.95-8.08(m, 2H). 
13C NMR (75MHz, CDCl3): ! = 25.5, 26.0, 26.07, 26.13, 32.0, 39.6, 45.4, 59.1, 128.8, 
128.9, 133.9, 134.6, 191.3. 
MS (EI, 70 eV): m/z = 105.0 (100), 213.1 (1.99), 292.1 [M-HBr]. 
Elemental Analysis: Anal. Calcd for C15H18Br2O: C, 48.16; H, 4.85. Found: C, 48.59; H, 
4.94. 
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Ethyl 2,3-dibromodecanoate (147i) 
According to the general procedure, (E)-ethyl dec-2-enoate (0.78 g, 
4.02 mmol) and 7.90 mL of bromine solution (0.56 M in 
chloroform) afforded 147i (1.18 g, 3.31 mmol, 82 %) as gummy oil 
after column purification on silica gel. Rf (EtOAc/hexane 1:9): 0.70. 
1H NMR (300 MHz, CDCl3): ! = 0.89 (t, J = 6.72 Hz, 3H), 1.21-1.67 (m, 13H), 1.74-1.88 
(m, 1H), 2.15-2.30 (m, 1H), 4.28 (q, J = 7.13 Hz, 2H), 4.36-4.40 (m, 2H).  
13C NMR (75MHz, CDCl3): ! = 13.8, 14.1, 22.6, 26.2, 28.7, 29.0, 31.7, 35.1, 48.1, 52.9, 
62.3, 167.9. 
MS (EI, 70 eV): m/z = 216.3 (100), 233.3 (11.01), 374.0 (41.02) [MNH4+]. 
HRMS (EI, 70 eV): Calcd for C12H22Br2O2 [M+H]+: 357.0065, found: 357.0029. 
 
(1R,2S)-1,2-dibromo-1,2-diphenylethane (147j)14 
According to the general procedure, (E)-1,2-diphenylethene (2.11 g, 
11.72 mmol) and 21.80 mL of bromine solution (0.56 M in 
chloroform) afforded 147j (3.62 g, 10.66 mmol, 96 %) as white 
solid after column purification on silica gel. Rf (EtOAc/hexane 1:9): 0.69. 
1H NMR (300 MHz, CDCl3): ! = 5.52 (s, 2H), 7.12-7.32 (m, 10H). 
13C NMR (75 MHz, CDCl3): ! = 59.1, 128.2, 128.6, 137.8. 
 
Ethyl 2,3-dibromo-3-phenylbutanoate (erythro:threo = 67:33) (150a) 
According to the the general procedure, (E)-ethyl 3-phenylbut-2-enoate 
(1.01 g, 5.31 mmol) and 10.40 mL of bromine solution (0.56 M in 
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chloroform) afforded 150a (1.25 g, 3.57 mmol, 68 %) as colorless oil after column 
purification on silica gel. Rf (EtOAc/hexane 1:9): 0.60.  
1H NMR (erythro compound) (300 MHz, CDCl3): ! = 1.37 (t, J = 7.13 Hz, 3H), 2.55 (s, 
3H), 4.30-4.37 (m, 2H), 5.08 (s, 1H), 7.30-7.40 (m, 3H), 7.57-7.67 (m, 2H).  
13C NMR (75MHz, CDCl3): ! = 13.8, 25.4, 54.0, 62.3, 65.7, 126.6, 128.4, 142.5, 167.5.   
1H NMR (threo compound) (300 MHz, CDCl3): ! = 0.90 (t, J = 7.13 Hz, 3H), 2.55 (s, 
3H), 3.86 (q, J = 7.04 Hz, 2H), 5.11 (s, 1H), 7.30-7.40 (m, 3H), 7.57-7.67 (m, 2H).  
13C NMR (75MHz, CDCl3): ! = 13.5, 27.8, 57.8, 61.8, 68.9, 127.1, 128.9, 140.5, 166.5. 
MS (EI, 70 eV): m/z = 191.2 (41.45), 208.2 (100), 286.1 (2.85) [M-HBr], 368.0 (10.02) 
[MNH4+]. 
HRMS (EI, 70 eV): Calcd for C12H14Br2O2 [M-H]+: 346.9283, found: 346.9284 
 
Ethyl 2,3-dibromo-3-methyl-5-phenylpentanoate (erythro:threo = 80:20) (150b)! 
According to the the general procedure, ethyl 3-methyl-5-
phenylpent-2-enoate (0.49 g, 2.24 mmol) and 4.50 mL of 
bromine solution (0.56 M in chloroform) afforded 150b (0.67 g, 
1.78 mmol, 78 %) as colorless oil after column purification on silica gel. Rf  
(EtOAc/hexane 1:9): 0.66. 
1H NMR (erythro compound) (300 MHz, CDCl3): ! = 1.35 (t, J = 7.13 Hz, 3H), 2.10 (s, 
3H), 2.20-2.30 (m, 2H), 2.80-2.90 (m, 2H), 4.24-4.32 (m, 2H), 4.70 (s, 1H), 7.17-7.36 
(m, 5H).  
13C NMR (75MHz, CDCl3): ! = 13.9, 26.7, 31.7, 46.0, 51.9, 62.2, 66.8, 126.2, 128.5, 
140.6, 167.5. 
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1H NMR (threo compound) (300 MHz, CDCl3): ! = 1.32 (t, J = 7.13 Hz, 3H), 2.00 (s, 
3H), 2.20-2.30 (m, 2H), 2.80-2.90 (m, 2H), 4.24-4.32 (m, 2H), 4.74 (s, 1H), 7.17-7.36 
(m, 5H).  
13C NMR (75MHz, CDCl3): ! = 13.9, 29.8, 32.5, 41.3, 55.5, 62.2, 67.6, 126.2, 128.5, 
141.0, 167.4.  
MS (EI, 70 eV): m/z = 91.1 (100), 131.1 (28.72), 217.2 (15.40), 299.1 (5.21), 376.0 
(1.20) [M+]. 
HRMS (EI, 70 eV): Calcd for C14H18Br2O2, [M+]: 375.9674, found: 375.9667. 
 
(2S,3R)-ethyl 2,3-dibromo-3-cyclohexyl-2-methylpropanoate (erythro:threo= 52:48)  
(150c) 
According to the general procedure, (E)-ethyl 3-cyclohexyl-2-
methylacrylate (0.74 g, 3.77 mmol) and 7.40 mL of bromine 
solution (0.56 M in chloroform) afforded 150c (1.02 g, 2.80 mmol, 
75 %) as colorless oil after column purification on silica gel. Rf  (EtOAc/hexane 1:9): 
0.81. 
1H NMR (erythro compound) (300 MHz, CDCl3): ! = 1.32 (t, J = 7.13 Hz, 3H), 1.00-2.20 
(m, 11H), 1.99 (s, 3H), 4.20-4.32 (m, 2H), 4.54 (d, J = 3.63 Hz, 1H). 
13C NMR (75MHz, CDCl3): ! = 13.8, 23.6, 25.8, 26.1, 31.9, 33.7, 39.4, 42.8, 62.5, 64.9, 
68.9, 169.2. 
1H NMR (threo compound) (300 MHz, CDCl3): ! = 1.32 (t, J = 7.13 Hz, 3H), 1.00-2.20 
(m, 11H), 2.02 (s, 3H), 4.20-4.32 (m, 2H), 4.59 (d, J = 1.64 Hz, 1H). 
13C NMR (75MHz, CDCl3): ! = 13.8, 23.6, 25.8, 26.1, 31.9, 33.7, 39.4, 42.8, 62.5, 64.9, 
68.9, 169.3. 
MS (EI, 70 eV): m/z = 197.3 (16.27), 214.2 (100), 231.2 (5.99), 374.1 (20.84) [MNH4+]. 
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Elemental Analysis: Anal. Calcd for C12H20Br2O2: C, 40.47; H, 5.66. Found: C, 40.69; H, 
5.73. 
(1R,2S)-1,2-dibromo-2-methyl-1-phenylpentan-3-one (150d) 
According to the general procedure, (E)-2-methyl-1-phenylpent-1-
en-3-one (0.61 g, 3.50 mmol) and 6.80 mL of bromine solution 
(0.56 M in chloroform) afforded 150d (0.79 g, 2.39 mmol, 70 %) as 
colorless oil after column purification on silica gel. Rf (EtOAc/hexane 1:9): 0.57.  
1H NMR (300 MHz, CDCl3): ! = 1.21 (t, J = 7.13 Hz, 3H), 2.01 (s, 3H), 2.75-3.10 (m, 
2H), 5.68 (s, 1H), 7.30-7.40 (m, 3H), 7.47-7.59 (m, 2H). 
13C NMR (75MHz, CDCl3): ! = 8.7, 21.6, 29.4, 56.5, 68.8, 127.9, 129.0, 130.9, 135.5, 
202.6. 
MS (EI, 70 eV): m/z = 175.1 (100), 192.2 (98.01), 349.9 (21.43) [MNH4+]. 
HRMS (EI, 70 eV): Calcd for C12H14Br2O, [M+]: 331.9412, found: 331.9410. 
 
(2S,3R)-ethyl 2,3-dibromo-2-methyl-3-phenylpropanoate (150e) 
According to the general procedure, ethyl 2-methyl-3-phenylacrylate 
(0.81 g, 4.26 mmol) and 8.30 mL of bromine solution (0.56 M in 
chloroform) afforded 150e (0.82 g, 2.43 mmol, 72 %) as colorless 
oil after column purification on silica gel. Rf (EtOAc/hexane 1:9): 
0.40. 
1H NMR (300 MHz, CDCl3): ! = 1.39 (t, J = 7.13 Hz, 3H), 2.06 (s, 3H), 4.30-4.40 (m, 
2H), 5.77 (s, 1H), 7.32-7.40 (m, 3H), 7.50-7.58 (m, 2H). 
13C NMR (75MHz, CDCl3): ! = 13.9, 22.1, 57.3, 61.8, 62.8, 127.7, 129.0, 130.9, 135.5, 
169.3. 
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MS (EI, 70 eV): m/z = 191.2 (21.78), 208.2 (100), 286.1 (3.19) [M-HBr], 366 (96.9) 
[MNH4+]. 
HRMS (EI, 70 eV): Calcd for C12H14Br2O2, [M+]: 347.9361, found: 347.9355. 
 
(E)-ethyl 2,3-dibromo-3-phenylacrylate (152)14 
According to the general procedure, ethyl 3-phenylpropiolate (1.22 
g, 7.01 mmol) and 13.70 mL of bromine solution (0.56 M in 
chloroform) afforded 152 (0.74 g, 2.24 mmol, 32 %) as gummy oil 
after column purification on silica gel. Rf (EtOAc/hexane 1:9): 0.58. 
1H NMR (300 MHz, CDCl3): ! = 1.41 (t, J = 7.13 Hz, 3H), 4.39 (q, J = 7.13 Hz, 2H), 
7.35-7.49 (m, 5H). 
13C NMR (75MHz, CDCl3): ! = 13.4, 62.8, 107.6, 121.5, 128.1, 128.3, 128.4, 128.7, 
129.7, 138.2, 164.0. 
MS (EI, 70 eV): m/z = 102.1 (100), 182.0 (47.31), 227 (67.10), 253.0 (68.31), 288.9 
(38.81), 331.9 (38.64) [ M+]. 
 
 General procedure for the Photoredox catalyzed reduction of halides: 
An oven dried 10 mL vial equipped with a plastic septum and magnetic stir bar was 
charged with tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), the 
corresponding halide (0.173 mmol, 1.0 equiv), 1,5-dimethoxynaphthalene (0.087 mmol, 
0.5 equiv) and ascorbic acid (0.348 mmol, 2 equiv). The flask was purged with a stream 
of nitrogen and 1.0 mL of solvent (MeOH: H2O = 10:1) was added. The resultant mixture 
was degassed for 10 min by nitrogen sparging and placed at a distance of ~ 0.5 -1.0 cm 
from a blue LED lamp.20 After the reaction was completed (as judged by TLC analysis), 
the mixture was diluted with 3.0 mL of methanol and directly concentrated in vacuo. The 
residue was purified by chromatography on silica gel, using PE/ EA as the solvent 
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system. 1,5-Dimethoxynaphthalene (DMN) was re-isolated during the column 
purification [Rf (EtOAc/hexane 1:9): 0.63].   
Determination of Quantum Yield: 
Quantum yield was determined by the laboratory apparatus reported by Riedle et 
al.21 In a typical experimental setup, light from a blue LED was passed through a 
reference cuvette containing 2.0 mL of solvent (MeOH:H2O = 10:1) and the transmitted 
radient power Pref was noted by a solar cell. Then the reference cuvette was exchanged 
with the sample cuvette containing 147a (0.271 mmol, 1 equiv), tris(2,2"-bipyridyl) 
ruthenium (II) chloride hexahydrate (0.004 g, 2 mol%), 1,5-dimethoxynaphthalene (0.025 
g, 0.135 mmol, 0.5 equiv) and ascorbic acid (0.093 g, 0.542 mmol, 2 eqiv) in 2.0 mL of 
solvent (MeOH:H2O = 10:1) and the timer was started. After 30 min, transmitted power, 
Psample was noted in the same solar cell and the sample was taken to the chemical analysis 
to measure the final product concentration. Conversion to the product 148a was 
determined by the crude NMR of the sample and the quantum yield was determined by 
the following equation: 
 
Here, Nprod and Cprod are the number of molecules and the according concentration 
of product species. Nph, abs is the number of photons absorbed. V is the sample volume, 
NA, h and c are natural constants, Pabs is the absorbed optical power, t is the illumination 
time and " is the wavelength of the blue LED. 
Therefore, 
Cprod = 18 mmol/l (13% conversion) 
V = 2.0 mL 
!"#$%&'$()*+,#*%),!
!"#$%&'(#)*+#,*-.'.#/01223! "**!
NA = 6.022 x 10 23 mol-1 
Pabs = ( Pref – Psample) = 371 mW 
h = 6.626 x 10-34 Js 
c = 2.998 x 108 m/s 
t = 30 min = 1800 s 
" = 460 nm 
Quantum yield = 0.014 
Reaction Apparatus 
 
1-(4-methoxyphenyl) ethanone (143a)22 
According to the general procedure, 142a (0.102 g, 0.44 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 143a (0.06 g, 0.41 mmol, 93 %) as white solid after column 
purification on silica gel. Rf (EtOAc/hexane 1:9): 0.25. 
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1H NMR (300 MHz, CDCl3), ! = 2.52 (s, 3H), 3.83 (s, 3H), 6.91 (d, J = 9.05 Hz, 2H), 
7.91 (d, J = 9.05 Hz, 2H). 
13C NMR (75 MHz, CDCl3), ! = 26.3, 55.4, 113.6, 130.3, 130.8, 163.4, 196.8. 
1-(4-bromophenyl) ethanone (143c)22 
According to the general procedure, 142c (0.101 g, 0.36 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 
143c (0.064 g, 0.32 mmol, 89 %) as white solid after column purification on silica gel. Rf 
(EtOAc/hexane 1:9): 0.38. 
1H NMR (300 MHz, CDCl3), ! = 2.59 (s, 3H), 7.61 (d, J = 8.78 Hz, 2H), 7.82 (d, J = 8.78 
Hz, 2H). 
13C NMR (75 MHz, CDCl3), ! = 26.5, 128.3, 129.8, 131.9, 135.8, 197.0. 
 
1-(4-nitrophenyl)ethanone (143d)22 
According to the general procedure, 142d (0.148 g, 0.61 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 143d (0.073 g, 0.44 mmol, 72 %) as white solid after column purification on 
silica gel. Rf (EtOAc/hexane 1:9): 0.31. 
1H NMR (300 MHz, CDCl3), ! = 2.69 (s, 3H), 8.08-8.15 (d, J = 8.78 Hz, 2H), 8.29-8.35 
(d, J = 9.05 Hz, 2H). 
13C NMR (75 MHz, CDCl3), ! = 27.0, 123.9, 129.3, 141.3, 196.3. 
 
 
!"#$%&'$()*+,#*%),!
!"#$%&'(#)*+#,*-.'.#/01223! "*$!
1-(naphthalen-2-yl)ethanone (143e)22 
According to the general procedure, 142e (0.152 g, 0.60 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 
143e (0.086 g, 0.51 mmol, 84 %) as white solid after column purification on silica gel. Rf 
(EtOAc/hexane 1:9): 0.35. 
1H NMR (300 MHz, CDCl3), ! = 2.79 (s, 3H), 7.51-7.70 (m, 2H), 7.83-8.12 (m, 4H), 
8.48 (s, 1H).  
13C NMR (75 MHz, CDCl3), ! = 26.7, 123.9, 126.8, 127.8, 128.4, 128.5, 129.5, 130.2, 
197.7. 
 
1-(4-methoxyphenyl)propan-1-one (143f)22 
According to the general procedure, 142f (0.098 g, 0.41 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
1,5-dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 143f (0.037 g, 0.22 mmol, 54 %) as white solid after column purification on 
silica gel. Rf (EtOAc/hexane 1:9): 0.32. 
1H NMR (300 MHz, CDCl3), ! = 1.21 (t, J = 7.40 Hz, 3H), 2.95 (q, J = 7.31 Hz, 2H), 
3.86 (s, 3H), 6.93 (d, J = 9.05 Hz, 2H), 7.95 (d, J = 9.05 Hz, 2H). 
13C NMR (75 MHz, CDCl3), ! = 8.4, 31.4, 55.4, 113.6, 130.0, 130.2, 163.3, 199.5. 
 
3,4-Dihydronaphthalen-1(2H)-one (143g)23 
According to the general procedure, 142g (0.079 g, 0.36 mmol), tris(2,2´-
bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
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dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 143g (0.037 g, 
0.25 mmol, 71 %) as gummy oil after column purification on silica gel. Rf  
(EtOAc/hexane 1:9): 0.33. 
1H NMR (300 MHz, CDCl3), ! = 2.07-2.21 (m, 2H), 2.66 (t, J = 6.99 Hz, 2H), 2.97 (t, J = 
6.17 Hz, 2H), 7.21-7.35 (m, 2H), 7.41-7.52 (m, 1H), 8.03 (dd, J = 1.09 Hz, 7.68 Hz, 1H). 
13C NMR (75 MHz, CDCl3), ! = 23.3, 29.7, 39.2, 126.2, 126.6, 127.5, 132.6, 133.4, 
144.5, 198.4. 
 
Cyclohexanone (143i) 24 
According to the general procedure, 142i (0.101 g, 0.56 mmol), tris(2,2´-
bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 143i 
(0.028 g, 0.28 mmol, 50 %) as yellowish oil after column purification on silica gel. Rf  
(EtOAc/hexane 1:9): 0.36. 
1H NMR (300 MHz, CDCl3), ! = 1.59-1.71 (m, 2H), 1.72-1.87 (m, 4H), 2.21-2.32 (m, 
4H). 
13C NMR (75 MHz, CDCl3), ! = 24.7, 26.9, 42.1, 212.0. 
 
4-Phenylcyclohexanone (143j)25 
According to the general procedure, 142j (0.075 g, 0.29 mmol), tris(2,2´-
bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 143j 
(0.039 g, 0.22 mmol, 75 %) as white solid after column purification on silica gel. 
Rf  (EtOAc/hexane 1:9): 0.28. 
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1H NMR (300 MHz, CDCl3), ! = 1.85-2.05 (m, 2H), 2.15-2.30 (m, 2H), 2.45-2.57 (m, 
4H), 2.95-3.10 (m, 1H), 7.15-7.40 (m, 5H). 
13C NMR (75 MHz, CDCl3), ! = 33.9, 41.4, 42.8, 126.6, 128.6, 144.8, 211.2. 
MS (EI, 70 eV): m/z =104.1 (89.14), 119.1 (63.97), 174.1 (100) [M+]. 
 
 
(E)-1,3-diphenylprop-2-en-1-one (148a)26 
According to the general procedure, 147a (0.064 g, 0.17 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
1,5-dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 148a (0.033 g, 0.16 mmol, 92 %) as pale yellow solid after column purification 
on silica gel. Rf  (EtOAc/hexane 1:9): 0.41. 
1H NMR (300 MHz; CDCl3), ! = 7.36-7.70 (m, 9H), 7.84 (d, J = 15.6 Hz, 1H), 7.98-8.10 
(m, 2H).  
13C NMR (75 MHz; CDCl3), ! = 122.1, 128.5, 128.5, 128.6, 128.9, 130.5, 132.8, 134.9, 
138.2, 144.8, 190.6. 
 
Ethyl (E)-cinnamate (148b)26 
According to the general procedure, 147b (0.11 g, 0.29 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 148b (0.046 g, 0.26 mmol, 88 %) as gummy oil after column purification on 
silica gel. Rf (EtOAc/hexane 1:9): 0.51. 
1H NMR (300 MHz, CDCl3), ! = 1.33 (t, J = 7.2 Hz, 3H), 4.26 (q, J = 7.2, 2H), 6.43 (d, J 
= 16 Hz, 1H), 7.34-7.39 (m, 3H), 7.46-7.53 (m, 2H), 7.68 (d, J = 16 Hz, 1H). 
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13C NMR (75 MHz, CDCl3), ! = 14.3, 60.5, 118.3, 128.0, 128.9, 130.2, 134.4, 144.6, 
167.0. 
 
2H-chromen-2-one (148d)27 
According to the general procedure, 147d (0.10 g, 0.33 mmol), tris(2,2´-
bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-dimethoxy                 
naphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 148d (0.044 
g, 0.30 mmol, 92 %) as yellow solid after column purification on silica gel. Rf 
(EtOAc/hexane 1:9): 0.16. 
1H NMR (300 MHz, CDCl3): ! = 6.42 (d, J = 9.87 Hz, 1H), 7.21-7.35 (m, 2H), 7.46- 7.56 
(m, 2H), 7.72 (d, J = 9.87, 1H) 
13C NMR (75 MHz, CDCl3): ! = 116.7, 116.9, 118.8, 124.4, 127.8, 131.8, 143.4, 154.0, 
160.8. 
  
(E)-2-benzylidene-3,4-dihydronaphthalen-1(2H)-one (148e)28 
According to the general procedure, 147e (0.20 g, 0.50 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
1,5-dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 
equiv) afforded 148e (0.089 g, 0.38 mmol, 75 %) as white solid after column purification 
on silica gel. Rf  (EtOAc/hexane 1:9): 0.41. 
1H NMR (300 MHz, CDCl3): ! = 2.95 (t, J = 6.27 Hz, 2H), 3.14 (t, J = 6.27 Hz, 2H), 
7.23-7.52 (m, 8H), 7.89(s, 1H), 8.14 (d, J = 7.68, 1H). 
13C NMR (75 MHz, CDCl3): ! = 120.0, 121.3, 129.1, 129.8, 130.7, 135.3, 135.4, 159.3, 
162.8. 
MS (EI, 70 eV): m/z = 233.1 (100), 234.1 (55.48) [M+]. 
!"#$%&'$()*+,#*%),!
!"#$%&'(#)*+#,*-.'.#/01223! "*(!
(E)-1-(furan-2-yl)-3-phenylprop-2-en-1-one (148f)29 
According to the general procedure, 147f (0.071 g, 0.20 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
1,5-dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 148f (0.01 g, 0.052 mmol, 26 %) as white solid after column purification on 
silica gel. Rf  (EtOAc/hexane 1:9): 0.22. 
1H NMR (300 MHz, CDCl3): ! = 6.59-6.61 (m, 1H), 7.32-7.49 (m, 5H), 7.62-7.70 (m, 
3H), 7.88 (d, J = 15.64 Hz, 1H). 
13C NMR (75 MHz, CDCl3): ! = 112.5, 117.5, 121.1, 128.5, 128.9, 130.6, 134.7, 144.0, 
146.5, 153.7, 178.0. 
MS (EI, 70 eV): m/z = 77.1 (27.63), 103.1 (27.39), 141.0 (35.24), 197.1 (100), 198.1 
(72.91) [M+]. 
 
(S)-3-cinnamoyl-4-isopropyloxazolidin-2-one (148g)30 
According to the general procedure, 147g (0.06 g, 0.14 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
1,5-dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 148g (0.033 g, 0.13 mmol, 89 %) as white solid after 
column purification on silica gel. Rf (EtOAc/hexane 1:9): 0.12. 
1H NMR (300 MHz, CDCl3): ! = 0.91 (d, J = 7.12 Hz, 3H), 0.96 (d, J = 7.12 Hz, 3H), 
2.38-2.52 (m, 1H), 4.11-4.37 (m, 2H), 4.51-4.60 (m, 1H), 7.32-7.50 (m, 3H), 7.53-7.70 
(m, 2H), 7.83 (d, J = 15.7 Hz, 1H), 7.96 (d, J = 15.7 Hz, 1H). 
13C NMR (75 MHz, CDCl3): ! = 14.7, 18.0, 28.5, 58.6, 63.4, 117.1, 128.6, 128.9, 130.6, 
134.6, 146.2, 154.2, 165.2. 
MS (EI, 70 eV): m/z = 147.1 (15.45), 260.2 (31.55) [MH+], 277.1 (100) [MNH4+]. 
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(E)-3-cyclohexyl-1-phenylprop-2-en-1-one (148h)29 
According to the general procedure, 147h (0.049 g, 0.13 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
1,5-dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 148h (0.008 g, 0.04 mmol, 28 %) as yellow oil after column purification on 
silica gel. Rf (EtOAc/hexane 1:9): 0.53. 
1H NMR (300 MHz, CDCl3): ! = 1.12-1.42 (m, 5H), 1.61-1.91 (m, 5H), 2.17-2.33 (m, 
1H), 6.82 (d, J = 15.6 Hz, 1H), 7.01 (dd, J = 15.6, 6.6 Hz, 1H), 7.40-7.58 (m, 3H), 7.92 
(d, J = 6.9 Hz, 2H).  
13C NMR (75MHz, CDCl3): ! = 25.7, 25.9, 31.8, 41.0, 123.4, 128.4, 128.5, 132.5, 138.2, 
154.9, 191.4. 
MS (EI, 70 eV): m/z = 77.0 (28.75), 105.0 (100), 157.1 (6.07), 214.1 (28.58) [M+]. 
 
(E)-ethyl dec-2-enoate (148i)31 
According to the general procedure, 147i (0.112 g, 0.31 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 148i (0.016 g, 0.08 mmol, 26 %) as gummy colorless oil after column 
purification on silica gel. Rf (EtOAc/hexane 1:9): 0.56. 
1H NMR (300 MHz, CDCl3): ! = 0.87 (t, J = 6.72 Hz, 3H), 1.13-1.65 (m, 13H), 2.11-2.25 
(m, 2H), 4.17 (q, J = 7.13 Hz, 2H), 5.80 (d, J = 15.64 Hz, 1H), 6.90-7.03 (m, 1H). 
13C NMR (75MHz, CDCl3): ! = 14.0, 14.2, 22.6, 28.0, 29.0, 29.1, 31.7, 32.2, 60.1, 121.2, 
149.5, 166.8. 
MS (EI, 70 eV): m/z = 55.1 (100), 101.1 (90.63), 153.2 (61.84), 198.2 (2.95) [M+]. 
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(E)-ethyl 3-phenylbut-2-enoate (151a)32 
According to the general procedure, 150a (0.094 g, 0.27 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxy naphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 151a (0.036 g, 
0.19 mmol, 70 %) as yellow oil after column purification on silica gel. Rf (EtOAc/hexane 
1:9): 0.48. 
1H NMR (300 MHz, CDCl3): ! = 1.32 (t, J = 7.13 Hz, 3H), 2.58 (s, 3H), 4.22 (q, J = 7.13 
Hz, 2H), 6.14 (s, 1H), 7.32-7.55 (m, 5H). 
13C NMR (75MHz, CDCl3): ! = 14.3, 17.9, 59.8, 117.2, 126.3, 128.4, 128.9, 142.2, 
155.6, 166.9.  
MS (EI, 70 eV): m/z = 191.2 (44.35) [MH+], 208.1 (100) [MNH4+]. 
 
Ethyl 3-methyl-5-phenylpent-2-enoate (E:Z = 84:16) (151b)33 
According to the general procedure, 150b (0.088 g, 0.23 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
1,5-dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 151b (0.033 
g, 0.15 mmol, 65 %) as yellow oil (E/Z mixture) after column purification on silica gel. 
Rf (EtOAc/hexane 1:9): 0.46. 
1H NMR (E-isomer) (300 MHz, CDCl3): ! = 1.32 (t, J = 7.13 Hz, 3H), 2.21 (s, 3H), 2.40-
2.48 (m, 2H), 2.74-2.84 (m, 2H), 4.15 (q, J = 7.13 Hz, 2H), 5.69 (s, 1H), 7.13-7.35 (m, 
5H).  
13C NMR (75MHz, CDCl3): ! = 14.3, 18.9, 33.9, 42.7, 59.5, 116.0, 126.1, 128.2, 128.4, 
141.1, 158.9, 166.8. 
1H NMR (Z-isomer) (300 MHz, CDCl3): ! = 1.32 (t, J = 7.13 Hz, 3H), 1.88 (s, 3H), 2.40-
2.48 (m, 2H), 2.74-2.84 (m, 2H), 4.15 (q, J = 7.13 Hz, 2H), 5.69 (s, 1H), 7.13-7.35 (m, 
5H).  
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13C NMR (75MHz, CDCl3): ! = 14.3, 18.9, 33.9, 42.7, 59.5, 116.0, 126.1, 128.2, 128.4, 
141.1, 158.9, 166.8. 
MS (EI, 70 eV): m/z = 91.1 (100), 144.2 (22.65), 173.1 (9.47), 218.2 (1.87) [M+]. 
 
(E)-ethyl 3-cyclohexyl-2-methylacrylate (151c)32 
According to the general procedure, 150c (0.13 g, 0.34 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 151c (0.019 g, 0.09 mmol, 27 %) as gummy oil after column purification on 
silica gel. Rf (EtOAc/hexane 1:9): 0.76. 
1H NMR (300 MHz, CDCl3): ! = 1.11-1.78 (m, 10H), 1.28 (t, J = 7.13 Hz, 3H), 1.84 (s, 
3H), 2.23-2.39 (m, 1H), 4.18 (q, J = 7.13 Hz, 2H), 6.58 (d, J = 8.23 Hz, 1H). 
13C NMR (75MHz, CDCl3): ! =12.4, 14.3, 25.6, 25.9, 31.9, 37.7, 60.4, 147.3, 168.2. 
MS (EI, 70 eV): m/z = 197.2 (25.78) [MH+], 214.3 (100) [MNH4+]. 
 
(E)-2-methyl-1-phenylpent-1-en-3-one (151d)28 
According to the general procedure, 150d (0.08 g, 0.24 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 151d (0.032 g, 0.18 mmol, 75 %) as colorless oil after column purification on 
silica gel. Rf (EtOAc/hexane 1:9): 0.42. 
1H NMR (300 MHz, CDCl3): ! = 1.18 (t, J = 7.27 Hz, 3H), 2.09 (s, 3H), 2.84 (q, J = 7.27 
Hz, 2H), 7.30-7.45 (m, 5H), 7.53 (s, 1H). 
13C NMR (75MHz, CDCl3): ! = 8.8, 13.2, 30.8, 128.5, 129.7, 136.0, 137.2, 138.2. 203.0. 
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MS (EI, 70 eV): m/z = 145.1 (5.11), 175.1 (100) [MH+], 192.2 (90.75) [MNH4+]. 
 
Ethyl 2-methyl-3-phenylacrylate (E:Z  = 75:25) ( (151e)32 
According to the general procedure, 150e (0.064 g, 0.19 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 1,5-
dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) 
afforded 151e (0.023 g, 0.12 mmol, 65 %) as colorless oil (E/Z mixture) after column 
purification on silica gel. Rf (EtOAc/hexane 1:9): 0.34. 
1H NMR (E-isomer) (300 MHz, CDCl3): ! = 1.35 (t, J = 7.13 Hz, 3H), 2.12 (s, 3H), 4.28 
(q, J = 7.13 Hz, 2H), 7.29-7.43 (m, 5H), 7.70 (s, 1H). 
13C NMR (75MHz, CDCl3): ! = 14.0, 14.3, 128.2, 128.3, 128.6, 129.6, 135.9, 138.6, 
168.7. 
1H NMR (Z-isomer) (300 MHz, CDCl3): ! = 1.15 (t, J = 7.13 Hz, 3H), 2.12 (s, 3H), 4.18 
(q, J = 7.13 Hz, 2H), 6.71 (s, 3H), 7.29-7.43 (m, 5H). 
13C NMR (75MHz, CDCl3): ! = 13.6, 21.3, 60.5, 127.4, 127.9, 128.0, 134.2, 168.7. 
MS (EI, 70 eV): m/z = 191.2 (43.49) [MH+], 208.1 (100) [MNH4+]. 
 
Ethyl 3-phenylpropiolate (153)34 
According to the general procedure, 152 (0.08 g, 0.24 mmol), 
tris(2,2´-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
1,5-dimethoxynaphthalene (0.5 equiv) and ascorbic acid (2 equiv) afforded 153 (0.03 g, 
0.17 mmol, 72 %) as gummy colorless oil after column purification on silica gel. Rf 
(EtOAc/hexane 1:9): 0.50. 
1H NMR (300 MHz, CDCl3): ! = 1.35 (t, J = 7.13 Hz, 3H), 4.30 (q, J = 7.13 Hz, 2H), 
7.30-7.50 (m, 3H), 7.55 - 7.65 (m, 2H). 
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13C NMR (75MHz, CDCl3): ! = 14.1, 62.1, 80.7, 86.0, 119.6, 128.5, 130.6, 133.0, 154.1. 
MS (EI, 70 eV): m/z = 102.1 (65.32), 129.0 (100), 174.0 (16.37) [M+]. 
 
1, 5-Dimethoxynaphthalene (Isolated after reaction) 
1H NMR (300 MHz; CDCl3), # = 3.98 (s, 6H); 6.85 (d, J = 7.47 Hz, 2H), 
7.36 (t, J = 8.09 Hz, 2H), 7.84 (d, J = 8.72 Hz, 2H).  
13C NMR (75 MHz; CDCl3), # = 55.5, 104.5, 114.1, 125.1, 126.6, 155.2. 
Rf  (EtOAc/hexane 1:9): 0.63 
 
 
11.3 Photo oxygenation of cyclic enamines and enol ethers 
 
tert-Butyl 4-methyl-2,3-dihydro-1H-pyrrole-1-carboxylate (172e)35 
Compound 172e was prepared in three steps starting from commercially available 3-
methyl-2-pyrrolidinone 172E, according to the following procedure. 
 
 
 
Scheme and conditions: (a) (Boc)2O (1.2 equiv.), DMAP (0.15 equiv.), CH3CN, rt, over night, 82 %. (b) 
DIBAL-H, THF, -78 °C, 3h, 92 % (crude). (c) (i) TFAA (1 equiv.), toluene, 0 °C; (ii) 2,6-lutidine, 0 °C to 
rt, over night; (iii) reflux, 20 min, 63 %. 
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In a 100 mL flask di-tert-butyl dicarbonate, (Boc)2O (5.28 g, 24.24 mmol) and 
4-(dimethylamino)pyridine, DMAP (0.37 g, 3.01 mmol) were added to 3-
methyl-2-pyrrolidinone, 172E (2.0 g, 20.20 mmol) in acetonitrile (30 mL) 
under nitrogen. The mixture was stirred at room temperature for over night. Evaporation 
of the solvent under reduced pressure and subsequent column chromatography on SiO2 
afforded 3.32 g (82 %) of 172Eʼ as colorless liquid. 1H NMR (300 MHz, CDCl3) # = 1.15 
(d, J = 6.86 Hz, 3H), 1.45 (s, 3H), 1.51-1.69 (m, 1H), 2.08-2.22 (m, 1H), 2.41-2.56 (m, 
1H), 3.45-3.56 (m, 1H), 3.65-3.75 (m, 1H). 13C NMR (75 MHz, CDCl3) # = 15.36, 26.38, 
27.99, 38.57, 44.29, 82.61, 150.40, 176.59. 
 
 To a solution of 172Eʼ (1.0 g, 5.03 mmol) in 7 mL of THF at -78 °C was 
slowly added DIBAL-H (1 M solution in hexane, 7.02 mL, 7.03 mmol) and 
stirred for 6 h. The reaction mixture was quenched with saturated NH4Cl 
(10.0 mL) and allowed to reach room temperature. Further the mixture was 
treated with 10 % Na2CO3 (10.0 mL) and 20 mL CH2Cl2, stirred for 10 min. The organic 
layer was separated and the aqueous layer extracted with CH2Cl2 (4 x 20 mL). The 
combined organic extract was dried over anhydrous Na2SO4 and concentrate in vacuo. 
The product 172Eʼʼ (0.92 g, 92 %) was directly used for next step without further 
purification. 
To a stirred solution of the crude product 172Eʼʼ (0.92g, 4.57 mmol), 2,6-
lutidine (10.66 mL, 91.54 mmol), and toluene (80 mL) at 0 °C under N2, was 
added 1 equiv of (CF3CO)2O, stirred for 6 h at 0 °C. The reaction mixture was 
slowly warmed to room temperature and stirred overnight. The mixture was 
refluxed for 30 min, cooled to room temperature. To the mixture was added saturated 
NaHCO3 (40.0 mL) and stirred for 1 h. The organic layer was separated and the aqueous 
layer extracted with hexane. The combined toluene/hexane extract was dried over 
anhydrous Na2SO4 and concentrated in vacuo. The residue was purified by column 
chromatography on SiO2 to afford 172e as colorless oil (0.57g, 63%). 
Rf (hexane/ ethylacetate 70: 30) = 0.76 
N
Boc
HO
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1H NMR (300 MHz, CDCl3) # = 1.41 (s, 9H), 1.70 (s, 3H), 2.36-2.55 (m, 2H), 3.57-3.75 
(m, 2H), 6.11 (6.23) (s, 1H). 13C NMR (75 MHz, CDCl3) # = 13.63, 28.47, 33.17, 45.27, 
79.64, 118.23, 124.15, 151.4. 
MS (EI, 70 eV): m/z (%) = 128.1 (20.11), 145.1 (100), 184.1 (76.63) [MH+], 201.2 
(7.35) [MNH4+]. 
 
(1S,5S,6S)-tert-Butyl 6-(hydroxymethyl)-2-azabicyclo[3.1.0]hex-3-ene-2-carboxylate 
(172c)  
An oven-dried, 50 mL flask was flushed with dry nitrogen and charged 
with lithium aluminum hydride (35 mg, 0.87 mmol) in 5 mL THF. A 
solution of 172a (0.30 g, 1.25 mmol) in 3 mL of THF was added 
dropwise at 0 °C and was stirred further for additional 2 h at room 
temperature. After completion of the reaction (monitored by TLC), 5 mL water was 
added slowly to destroy the excess hydride. The organic layer, combined with two ethyl 
acetate extracts of the aqueous layer, was dried over anhydrous Na2SO4 and concentrated 
in vacuo. The crude material was purified by column chromatography on silica gel to 
afford 172c (0.15 g, 57 %) as gummy oil. 
Rf (hexane/ ethylacetate 70: 30) = 0.15. 
1H NMR (300 MHz, CDCl3) # = 0.55-0.65 (m, 1H), 1.46 (s, 9H), 2.06-2.27 (m, 1H), 
3.30-3.87 (m, 3H), 5.05-5.35 (m, 1H), 6.29 (d, J = 3.56 Hz, 1H). 13C NMR (75 MHz, 
CDCl3) # = 23.99, 25.23, 28.33, 39.91, 63.09, 81.19, 111.14, 128.39, 151.84. 
IR (neat) = 3375, 1700, 1591, 1414, 1392, 1367, 1135, 761 ,-.". 
MS (EI, 70 eV): m/z (%) = 173.0 (100), 194.0 (8.56), 212.0 (12.95) [MH]+, 229.1 (61.31) 
[MNH4]+. 
HRMS (EI, 70 eV): Calcd for C11H17NO3 [M+]: 211.1208, found: 211.1209. 
 
2-(4-Methoxyphenyl)-3,4-dihydro-2H-pyran (182b)36 
According to the literature procedure,37 an oven-dried schlenk flask 
was evacuated and filled with nitrogen were added 4-iodoanisole 
(0.502 g, 2.14 mmol), 3,4-dihydro-2H-pyran (2.18 mL, 25.64 
mmol), K2CO3 (0.442 g, 3.20 mmol), DMF (6 mL) and palladium 
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(II) acetate (0.024 mg, 0.107 mmol). The mixture was stirred at 115 °C for 72 h, allowed 
to cool to room temperature. EtOAc (20 mL) was added to the reaction mixture, and then 
the reaction mixture was washed with H2O (3 # 10 mL). The organic layer was dried over 
Na2SO4. After filtration, solvent was evaporated and purified by column chromatography 
(hexanes–EtOAc, 19:1), to afford 2-(4-methoxy-phenyl)-3,4-dihydro-2H-pyran 182b 
(0.305 g, 75%) as colorless oil. 
Rf (hexane/ ethylacetate 70: 30) = 0.59 
1H NMR (300 MHz, CDCl3) # = 1.83-2.11 (m, 3H), 2.17-2.37 (m, 1H), 3.82 (s, 3H), 
4.72-4.82 (m, 2H), 6.54 (d, J = 5.48 Hz, 1H), 6.83-6.97 (m, 2H), 7.25-7.37 (m, 2H). 13C 
NMR (75 MHz, CDCl3) # = 20.48, 30.19, 55.30, 76.63, 100.58, 113.81, 127.28, 134.20, 
144.33, 159.14. 
MS (EI, 70 eV): m/z (%) = 119.0 (20.99), 134.1 (100), 190.1 (21.98)[M]+. 
 
General procedure for the Photo-oxidation of cyclic enamines and enol ethers:  
An oven dried 10 mL round bottom flask equipped with a plastic septum and magnetic 
stir bar was charged with tris(2,2 "-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
the corresponding cyclic enamine/enol ethers (0.209 mmol, 1.0 equiv) and 1 mL of 
CH3CN. The resultant mixture was bubbled for 3 min by oxygen sparging and placed at a 
distance of ~ 0.5 -1.0 cm from a blue LED lamp20 with an oxygen balloon. After the 
reaction was completed (judged by TLC analysis), the mixture was directly concentrated 
in vacuo. The residue was purified by chromatography on silica gel, using PE/ EA or 
PE/acetone as the solvent system. 
 
(1R,2S)-Methyl 2-(N-(tert-butoxycarbonyl)formamido)-3-formylcyclopropanecarbo-
xylate (173a)38 
According to the general procedure, 172a (0.05 g, 0.209 
mmol), tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate 
(2 mol%) afforded 173a (0.041 g, 0.15 mmol, 72 %) in 30 
min as colorless oil after column purification on silica gel. 
 Rf (hexane/ EtOAc 5:1) = 0.19. 
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1H NMR (300 MHz, CDCl3) # = 1.52 (s, 9H), 2.75 (dd, J = 6.0, 4.8 Hz, 1H), 2.96 (ddd, J 
= 8.2, 6.0, 2.3 Hz, 1H), 3.21 (dd, J = 7.92, 4.8 Hz, 1H), 3.75 (s, 3H), 9.07 (s, 1H), 9.54 (d, 
J = 2.46 Hz, 1H). 13C NMR (75 MHz, CDCl3) # = 27.78, 27.88, 34.94, 36.66, 52.62, 
85.40, 151.90, 163.40, 170.01, 193.10. 
MS (EI, 70 eV): m/z (%) = 189.1 (7.61), 272.1 (1.12) [MH+], 289.1 (100) [MNH4+]. 
 
(1R,2S)-2-(N-(tert-butoxycarbonyl)formamido)-3-formylcyclopropanecarboxylic 
acid (173b) 
According to the general procedure, 172b (0.051 g, 0.226 
mmol), tris(2,2 "-bipyridyl)ruthenium(II)chloride hexahydrate (2 
mol%) afforded 173b (0.052 g, 0.202 mmol, 89 %) in 1 h as 
colorless oil after column purification on silica gel. 
 Rf (hexane/ EtOAc 30:70) = 0.15. 
1H NMR (300 MHz, CDCl3) # = 1.54 (s, 9H). 2.75 (dd, J = 4.66, 5.76 Hz, 1H), 3.05-2.96 
(m, 1H), 3.23 (dd, J = 4.66, 7.95 Hz, 1H), 9.09 (s, 1H), 9.56 (d, J = 2.46 Hz, 1H). 13C 
NMR (75 MHz, CDCl3) # = 27.90, 28.37, 35.11, 36.75, 85.64, 151.84, 163.49, 174.35, 
192.93. 
MS (CI, NH3): m/z (%) = 57.1 (100), 112.0 (25.58), 157 (23.69), 240.1 (0.58), 257 (0.90) 
[M+]. 
 
tert-Butyl formyl((1S,3S)-2-formyl-3-(hydroxymethyl)cyclopropyl)carbamate (173c) 
According to the general procedure, 172c (0.071 g, 0.331 
mmol), tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate 
(2 mol%) afforded 173c (0.068 g, 0.279 mmol, 85 %) in 1 h 
as colorless oil after column purification on silica gel. 
 Rf (hexane/ EtOAc 1:1) = 0.31. 
1H NMR (300 MHz, CDCl3) # = 1.52 (s, 9H), 2.20-2.30 (m, 1H), 2.41-2.49 (m, 1H), 2.60 
(bs, 1H), 2.82 (dd, J = 5.48, 7.68 Hz, 1H), 3.50 (dd, J = 7.68, 10.97 Hz, 1H), 3.85-4.00 (d 
J = 10.42 Hz, 1H), 9.12 (s, 1H), 9.45 (d, J = 3.01 Hz, 1H). 13C NMR (75 MHz, CDCl3) 
# = 27.96, 30.05, 32.40, 35.91, 62.07, 85.42, 152.20, 164.17, 195.61. 
IR (neat) = 3455, 1741, 1699, 1370, 1290, 1157, 849 ,-.". 
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HRMS (EI, 70 eV): Calcd for C11H18NO5 [MH+]: 244.1185, found: 244.1186. 
 
tert-Butyl formyl(3-oxopropyl)carbamate (173d) 
According to the general procedure, 172d (0.05 g, 0.295 mmol), 
tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%) 
afforded 173d (0.048 g, 0.238 mmol, 81 %) in 2.5 h as colorless oil 
after column purification on silica gel.  
Rf (hexane/ EtOAc 80:20): = 0.31. 
1H NMR (300 MHz, CDCl3) # = 1.54 (s, 9H), 2.67 (dt, J = 1.64, 6.86 Hz, 2H), 3.95 (t, J = 
6.99 Hz, 2H), 9.13 (s, 1H), 9.76(t, J = 1.78 Hz, 1H). 13C NMR (75 MHz, CDCl3) # = 
26.99, 33.49, 41.63, 83.67, 161.83, 198.75. 
IR (neat) = 1740, 1722, 1686, 1341, 1153, 776 ,-.". 
MS (EI, 70 eV): m/z (%) = 57.1 (100), 100.0(1.21), 133.0(0.99). 
 
tert-Butyl formyl(3-oxobutyl)carbamate (173e) 
According to the general procedure, 172e (0.093 g, 0.508 mmol), 
tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%) 
afforded 173e (0.102 g, 0.474 mmol, 93 %) in 4 h as colorless oil 
after column purification on silica gel.  
Rf (hexane/ EtOAc 70:30 ) = 0.53. 
1H NMR (300 MHz, CDCl3) # = 1.55 (s, 9H), 2.15 (s, 3H), 2.68 (t, J = 7.54 Hz, 2H), 3.85 
(t, J = 7.54 Hz, 2H), 9.12 (s, 1H). 13C NMR (75 MHz, CDCl3) # = 28.04, 29.99, 35.82, 
41.78, 84.39, 162.89, 206.17. 
MS (EI, 70 eV): m/z (%) = 116.0 (41.76), 133.0 (100), 216.1 (18.99) [MH+], 233.1 
(94.11) [MNH4+]. 
HRMS (EI, 70 eV): Calcd for C10H17NO4 [M+]: 215.1158, found: 215.1162. 
 
tert-Butyl formyl(4-oxobutyl)carbamate (173f) 
According to the general procedure, 172f (0.01 g, 0.546 mmol), 
tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%) 
afforded 173f (0.111 g, 0.516 mmol, 94 %) in 3.5 h as colorless 
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oil after column purification on silica gel.  
Rf (hexane/ EtOAc 70:30) = 0.63. 
1H NMR (300 MHz, CDCl3) # = 1.55 (s, 9H). 1.81-1.93 (m, 2H), 2.43-2.50 (m, 2H), 3.63 
(t, J = 6.99 Hz, 2H), 9.16 (s, 1H), 9.77 (t, J = 1.09 Hz, 1H). 13C NMR (75 MHz, CDCl3) 
# = 20.79, 28.04, 39.70, 41.02, 84.27, 152.36, 163.12, 201.05. 
IR (neat): 1736, 1687, 1344, 1153, 1072, cm-1.  
MS (EI, 70 eV): m/z (%) = 57.1 (100), 159.1 (2.86) [M+- C4H8]. 
HRMS (EI, 70 eV): Calcd for C10H17NO4 [MH+]: 216.1236, found: 216.1239. 
 
1,3,3-Trimethyl-5-nitroindolin-2-one (173g)39 
According to the general procedure, 172g (0.05 g, 0.229 mmol), 
tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%) 
afforded 173g (0.036 g, 0.164 mmol, 72 %) in 3 h as yellowish oil 
after column purification on silica gel.  
Rf (hexane/ EtOAc 70:30) = 0.42 
1H NMR (300 MHz, CDCl3) # = 1.43 (S, 6H), 3.29 (S, 3H), 6.92 (d, J = 8.78 Hz, 1H), 
8.10 (d, J = 2.46 Hz, 1H), 8.26 (dd, J = 2.19, 8.78 Hz, 1H). - 13C NMR (75 MHz, CDCl3) 
# = 24.18, 26.66, 44.23, 107.57, 118.33, 125.20, 136.48, 148.38, 181.27. 
MS (EI, 70 eV): m/z (%) = 130.0 (20.00), 159.0 (25.50), 190.0 (10.24), 205.0 (64.20), 
220.0 (100) [M]+ 
 
1,3,3-Trimethylindolin-2-one (173h)40 
According to the general procedure, 172h (0.102 g, 0.507 mmol), 
tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%) afforded 
173h (0.031 g, 0.177 mmol, 35 %) in 5 h as colorless oil after column 
purification on silica gel. 
 Rf (hexane/ EtOAc 70:30) = 0.64. 
1H NMR (300 MHz, CDCl3) # = 1.34 (s, 6H), 3.19 (s, 3H), 6.83 (d, J = 7.68 Hz, 1H), 
7.04 (t, J = 7.40 Hz, 1H), 7.16-7.25 (m, 2H). 13C NMR (75 MHz, CDCl3) # = 24.39, 
26.21, 44.18, 108.01, 122.26, 122.47, 127.66, 135.92, 142.47, 181.32. 
IR (neat) = 2968, 1707, 1613, 1493, 1472, 1382, 1348, 1124, 755 ,-.". 
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MS (EI, 70 eV): m/z (%) = 117.0 (12.03), 160.1 (100), 175.1 (73.92)[M+]. 
 
1,4,4-Trimethylquinoline-2,3-(1H,4H)-dione (173hʼ)41 
According to the general procedure, 172h (0.102 g, 0.507 mmol), 
tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%) afforded 
173hʼ (0.027 g, 0.133 mmol, 26 %) in 5 h as colorless oil after column 
purification on silica gel.  
Rf (hexane/ EtOAc 70:30) = 0.33. 
1H NMR (300 MHz, CDCl3) # = 1.53 (s, 6H), 3.52 (s, 3H), 7.10 (d, J = 8.23 Hz, 1H), 
7.16 (t, J = 7.54 Hz, 1H), 7.32-7.40 (m, 2H). 13C NMR (75 MHz, CDCl3) # = 23.9, 30.16, 
48.35, 115.63, 124.47, 124.68, 127.55, 128.57, 130.71, 156.95, 195.47. 
IR (neat) = 1739, 1677, 1607, 1459, 1369, 755 ,-.". 
MS (EI, 70 eV): m/z (%) = 160.1 (100), 175.1 (24.30), 203.1 (15.17) [M+]. 
 
4-Oxobutyl formate (183a)42 
According to the general procedure, 182a (0.12 g, 1.07 mmol), 
tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate (1 mol%) 
afforded 183a (0.084 g, 0.724 mmol, 68 %) in 3 h as colorless oil 
after column purification on silica gel.  
Rf (hexane/ EtOAc 70:30) = 0.37. 
1H NMR (300 MHz, CDCl3) # = 1.95-2.06 (m, 2H), 2.57 (t, J = 7.13 Hz, 2H), 4.20 (t, J = 
6.72 Hz, 2H), 8.04 (s, 1H), 9.80 (s, 1H). 13C NMR (75 MHz, CDCl3) # = 21.12, 40.26, 
62.85, 160.87, 200.89. 
 
1-(4-Methoxyphenyl)-4-oxobutyl formate (183b) 
According to the general procedure, 182b (0.05 g, 0.263 
mmol), tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate 
(1 mol%) afforded 183b (0.035 g, 0.157 mmol, 60 %) in 3.5 
h as colorless oil after column purification on silica gel.  
Rf (hexane/ EtOAc 1:1) = 0.70. 
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1H NMR (300 MHz, CDCl3) # = 1.98-2.34 (m, 3H), 2.43-2.49 (m, 1H), 3.80 (s, 3H), 5.84 
(t, J = 6.84 Hz, 1H), 6.86-6.91 (m, 2H), 7.25-7.30 (m, 2H), 8.07 (s, 1H), 9.74 (t, J = 1.09 
Hz, 1H). 13C NMR (75 MHz, CDCl3) # = 28.29, 39.91, 55.31, 74.61, 114.07, 127.97, 
130.98, 159.70, 160.28, 200.74. 
MS (EI, 70 eV): m/z (%) = 77.0 (17.25), 109.0 (21.39), 121.0 (22.49), 137.0 (59.07), 
178.0 (100), 222.0 (14.80)[M+]. 
HRMS (EI, 70 eV): Calcd for C12H14O4 [M+]: 222.0892, found: 222.0887. 
 
2,3-Dioxabicyclo[2.2.2]oct-5-ene (163)43 
According to the general procedure, 162 (0.16 g, 2.01 mmol), tris(2,2 "- 
bipyridyl)ruthenium(II)chloride hexahydrate (1 mol%) afforded 163 (0.141 g, 
0.125 mmol, 62 %) in 1 h as colorless oil after column purification on silica gel. 
Rf (hexane/ EtOAc 70:30) = 0.64. 
1H NMR (300 MHz, CDCl3) # = 1.43-1.51 (m, 2H), 2.20-2.33 (m, 2H), 4.60-4.70 (m, 
2H), 6.67 (dd, J = 3.29, 4.39 Hz, 2H). 13C NMR (75 MHz, CDCl3) # = 21.61, 70.87, 
132.20. 
 
1-Isopropyl-4-methyl-2,3-dioxabicyclo[2.2.2]oct-5-ene (166)44 
According to the general procedure, 165 (0.501 g, 3.67 mmol), tris(2,2 "- 
bipyridyl)ruthenium(II)chloride hexahydrate (1 mol%) afforded 166 (0.408 
g, 2.42 mmol, 65 %) in 1 h as colorless oil after column purification on silica 
gel.  
Rf (hexane/ EtOAc 70:30) = 0.54. 
1H NMR (300 MHz, CDCl3) # = 0.99 (d, J = 7.13 Hz, 6H), 1.37 (s, 3H), 1.51 (d, J = 9.60 
Hz), 1.85-2.06 (m, 3H), 6.40 (d, J = 8.78 Hz, 1H), 6.49 (d, J = 8.78 Hz, 1H). - 13C NMR 
(75 MHz, CDCl3) # = 17.17, 17.25, 21.41, 25.60, 29.50, 32.13, 74.38, 79.80, 133.04, 
136.39. 
 
General procedure for one pot hydrazone formation via Photo-oxidation of cyclic 
enamines:  
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An oven dried 10 mL round bottom flask equipped with a plastic septum and magnetic 
stir bar was charged with tris(2,2 "-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
the corresponding cyclic enamine (0.209 mmol, 1.0 equiv.), tosyl-hydrazine (0.251 
mmol, 1.2 equiv.) and 1 mL of CH3CN. The resultant mixture was bubbled for 3 min by 
oxygen sparging and placed at a distance of ~ 0.5 -1.0 cm from a blue LED lamp20 with 
an oxygen balloon. After the full conversion of cyclic enamine to corresponding aldehyde 
(judged by TLC analysis), the light was switched off and stirring was continued until the 
full consumption of aldehyde (monitored by TLC). The crude mixture was directly 
concentrated in vacuo. The residue was purified by chromatography on silica gel, using 
PE/ EA as the solvent system. 
 
(1S,2R)-Methyl-2-(N-(tert-butoxycarbonyl)formamido)-3-((2-tosylhydrazono) 
methyl)cyclopropanecarboxylate (177) 
According to the general procedure, 172a (0.05 g, 0.209 
mmol), tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate 
(2 mol%) and tosyl-hydrazine (0.046 g, 0.251 mmol) were 
irradiated 30 min with blue LED followed by 2.5 h stirring at 
room temperature in absence of light afforded 177 (0.079 g, 0.179 mmol, 86 %, dr = 
78:22) as colorless oil after column purification on silica gel.  
Rf (hexane/ EtOAc 70:30) = 0.19. 
Major isomer, 1H NMR (300 MHz, CDCl3) # = 1.47 (s, 9H), 2.43 (s, 3H), 2.48 (dd, J = 
4.39, 6.03 Hz, 1H), 2.51-2.60 (m, 1H), 3.08 (dd, J = 4.39, 7.68 Hz, 1H), 3.73 (s, 3H), 
6.99 (d, J = 5.48 Hz, 1H), 7.31 (d, J = 7.95 Hz, 2H), 7.73 (d, J = 8.23 Hz, 2H), 8.03 (s, 
1H), 8.81 (s, 1H). 13C NMR (75 MHz, CDCl3) # = 21.63, 26.58, 27.81, 28.63, 36.39, 
52.45, 85.03, 127.84, 129.47, 135.10, 143.99, 144.34, 152.16, 163.59, 170.83. 
Minor isomer, 1H NMR (300 MHz, CDCl3) # = 1.42 (s, 9H), 2.41(s, 3H), 2.35 (dd, J = 
4.66, 6.03 Hz, 1H), 2.62-2.72 (m, 1H), 3.17 (dd, J = 4.11, 7.68 Hz, 1H), 3.75 (s, 3H), 
6.32 (d, J = 6.86 Hz, 1H), 7.31 (d, J = 7.95 Hz, 2H), 7.87 (d, J = 8.23 Hz, 2H), 8.51 (s, 
1H), 8.93 (s, 1H). 13C NMR (75 MHz, CDCl3) # = 21.63, 26.58, 27.81, 28.63, 36.39, 
52.45, 85.03, 128.86, 129.76, 135.10, 143.99, 144.34, 152.16, 163.59, 170.83. 
IR (neat) = 1732, 1707, 1284, 1159, 731 ,-.". 
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MS (EI, 70 eV): m/z (%) = 439.9 (51.69) [MH+], 456.9 (77.97), [MNH4+]. 
 
tert-Butyl formyl(4-(2-tosylhydrazono)butyl)carbamate (178) 
According to the general procedure, 172f (0.05 g, 0.273 
mmol), tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate 
(2 mol%) and tosyl-hydrazine (0.061 g, 0.327 mmol) were 
irradiated 3.5 h with blue LED followed by 2.5 h stirring at 
room temperature in absence of light afforded 178 (0.094 g, 0.245 mmol, 90 %, dr = 
93:7) as colorless oil after column purification on silica gel.  
Rf (hexane/ EtOAc 1:1) = 0.51. 
Major isomer, 1H NMR (300 MHz, CDCl3) # = 1.52 (s, 9H), 1.61-1.75 (m, 2H), 2.15-2.25 
(m, 2H), 2.41 (s, 3H), 3.51 (t, J = 7.27 Hz, 2H), 7.17 (t, J = 5.07 Hz, 1H), 7.27-7.34 (m, 
2H), 7.76-7.84 (m, 2H), 7.86 (s, 1H), 9.12 (s, 1H). 13C NMR (75 MHz, CDCl3) # = 21.60, 
24.68, 28.04, 29.64, 39.67, 84.22, 127.96, 129.63, 135.26, 144.13, 151.04, 163.02. 
Minor isomer, 1H NMR (300 MHz, CDCl3) # = 1.54 (s, 9H), 1.80-1.91 (m, 2H), 2.05-
2.13 (m, 2H), 2.42 (s, 3H), 3.62 (t, J = 6.99 Hz, 2H), 6.69 (t, J = 5.35 Hz, 1H), 7.27-7.34 
(m, 2H), 7.76-7.84 (m, 2H), 8.04 (s, 1H), 9.17 (s, 1H). 13C NMR (75 MHz, CDCl3) # = 
21.60, 24.68, 28.04, 29.64, 39.67, 84.22, 127.96, 129.63, 135.26, 144.13, 151.04, 163.02.!
IR (neat) = 1737, 1686, 1342, 1147, 569 ,-.". 
MS (EI, 70 eV): m/z (%) = 383.9 [MH+], 400.9 [MNH4+].!
 
Preparation of Wittig Salt 
Methyl 2-(triphenylphosphoranylidene)acetate (179)45 
A solution of methyl bromoacetate (4.0 g, 26.14 mmol) in 10 mL of 
ethyl acetate was added to a solution of 8.21 g (31.37 mmol) of 
triphenylphosphane in 50 mL of ethyl acetate. After stirring overnight, 
the white precipitate was filtered off, washed with diethyl ether and dried in vacuo at 40 
°C for 4 h. The crude precipitate was dissolved in 150 mL of dichloromethane and 2 
equiv. (2.05 g, 51.25 mmol) of NaOH in 100 mL water was added to it and vigorously 
shaken in a separatory funnel. The water layer was washed with dichloromethane (2 x 20 
mL). The combined dichloromethane layers were dried with Na2SO4 and the solvent was 
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evaporated to yield 8.65 g (25.74 mmol, 98%) of the two rotameric forms of 179 as a 
white solid. 
1H NMR (300 MHz, CDCl3) # = 2.90 (25 %) + 3.56 (75 %) (s, 3H), 7.42-7.84 (m, 15H). 
13C NMR (75 MHz, CDCl3) # = 30.60, 49.81, 127.18, 128.43, 131.96, 132.16, 133.25, 
171.31. 
 
General procedure for one pot alkene formation via Photo-oxidation of cyclic 
enamines: 
An oven dried 10 mL round bottom flask equipped with a plastic septum and magnetic 
stir bar was charged with tris(2,2 "-bipyridyl)ruthenium(II)chloride hexahydrate (2 mol%), 
the corresponding cyclic enamine (0.209 mmol, 1.0 equiv) and 1 mL of CH3CN. The 
resultant mixture was bubbled for 3 min by oxygen sparging and placed at a distance of ~ 
0.5 -1.0 cm from a blue LED lamp20 with an oxygen balloon. After the reaction was 
completed (as judged by TLC analysis), the light was stitched off and the flask was 
flushed with nitrogen. Then Wittig salt 179 (0.250 mmol, 1.2 equiv) was added to it and 
stirring was continued at room temperature until the full consumption of aldehyde 
(monitored by TLC). After completion of the reaction, 5 mL hexane and 2 mL water 
were added to it. Organic layer was separated and the aqueous layer was again extracted 
with hexane (3 x 8 mL) and the combined organic layer was dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by chromatography on silica gel, using 
PE/EA as the solvent system. 
 
(1S,2R)-Methyl-2-(N-(tert-butoxycarbonyl)formamido)-3-((E)-3-methoxy-3-oxoprop 
-1-en-1-yl)cyclopropanecarboxylate (180) 
According to the general procedure, 172a (0.05 g, 0.209 
mmol), tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate 
(2 mol%) and 1 mL of CH3CN were irradiated 30 min and 
followed by addition of Wittig salt 179 (0.084 g, 0.251 mmol) 
in absence of light afforded 180 (0.046g, 0.140 mmol, 67 %, trans:cis = 94:6) as white 
solid. 
Rf (hexane/ EtOAc 70:30) = 0.38. 
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1H NMR (300 MHz, CDCl3) # = 1.51(s, 9H), 2.26 (dd, J = 4.11, 5.48 Hz, 1H), 2.49-2.59 
(m, 1H), 3.23 (dd, J = 4.39, 7.68 Hz, 1H), 3.72 (s, 3H), 3.76 (s, 3H), 6.02 (d, J = 15.64 
Hz, 1H), 6.40 (dd, J = 9.87, 15.64 Hz, 1H), 9.17 (s, 1H). 13C NMR (75 MHz, CDCl3) # = 
27.83, 29.38, 29.61, 36.84, 51.67, 52.56, 85.17, 123.22, 142.36, 152.22, 163.47, 166.06, 
170.80. 
IR (neat) = 1715, 1655, 1449, 1370, 1284, 1254, 1156 ,-.". 
MS (EI, 70 eV): m/z (%) = 202.1 (3.30), 245.0 (18.55), 345.1 (100) [MNH4+]. 
 
(E)-Methyl 6-(N-(tert-butoxycarbonyl)formamido)hex-2-enoate (181) 
According to the general procedure, 172f (0.05 g, 0.273 
mmol), tris(2,2 "- bipyridyl)ruthenium(II)chloride hexahydrate 
(2 mol%) and 1 mL of CH3CN were irradiated 3.5 h and 
followed by addition of Wittig salt 179 (0.109 g, 0.327 
mmol) in absence of light afforded 181 (0.054 g, 73 %, trans:cis = 90:10) as gummy oil. 
Rf (hexane/ EtOAc 80:20) = 0.63. 
1H NMR (300 MHz, CDCl3) # = 1.54 (s, 9H), 1.63-1.76 (m, 2H), 2.14-2.26 (m, 2H), 3.60 
(t, J = 7.27 Hz, 2H), 3.71 (s, 3H), 5.84 (dt, J = 15.64, 1.64 Hz, 1H), 6.86-6.99 (m, 1H), 
9.15 (s, 1H). 13C NMR (75 MHz, CDCl3) # = 26.61, 28.03, 29.40, 39.93, 51.43, 84.14, 
121.55, 147.86, 152.36, 162.99, 166.87. 
IR (neat) = 1724, 1686, 1437, 1343, 1146, 852 ,-.". 
MS (EI, 70 eV): m/z (%) = 172.1 (8.93), 189.1 (32.86), 289.2 (100) [MNH4+]. 
 
 11.4 Studies towards the synthesis of Sandresolide A 
!
(R,R)-N,N'-Bis(1-hydroxymethyl-2-methylpropyl)-2,2-dimethyl-malonamide (211) 
An oven dried 250 mL, 3-necked round-bottom flask equipped 
with a stirring bar and two 50 mL pressure-equalizing addition 
funnels connected to a mineral oil bubbler was purged with 
nitrogen and charged with (D)-valinol (5.13 g, 0.050 mol, 2.0 
NH
O O
NH OHOH
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eq.). The flask was immersed in an ice bath at 0 °C and NEt3 (17.4 mL, 0.124 mol) was 
added drop wise via the first addition funnel. 2,2-Dimethylpropanedioyl dichloride (3.3 
mL, 0.25 mol, 1.0 eq.) in dry CH2Cl2 (25 mL) was then added drop wise over 25 min. via 
the second addition funnel. The internal temperature increases from 0 °C to 10 °C during 
the addition. Subsequently, the ice bath was removed and the reaction mixture was 
allowed to warm to rt. Stirring was continued for 45 min, resulting in a colorless 
precipitate that was dissolved by addition of dry CH2Cl2 (120 mL). After addition of 
aqueous HCl (1N, 30 mL), the aqueous layer was separated and extracted with CH2Cl2 
(3x15 mL). The combined organic layers were washed with sat. NaHCO3 (30 mL) and 
brine (30 mL), dried over MgSO4, filtered and concentrated in vacuo to afford crude 
product as a pale yellow solid. Recrystallization of the crude product from ethyl acetate 
(40 mL) yielded 211 (4.30 g, 14.2 mmol, 57%) as white crystals. The mother liquor was 
concentrated and the residue recrystallized from ethyl acetate (10 mL) to yield a second 
crop of 211 (1.60 g, 5.27 mmol, 21%); the process was repeated to yield a third crop of 
211 (0.440 g, 1.45 mmol, 6%, total yield: 6.40 g, 21.1 mmol, 84%). 
Rf (ethylacetate:methanol 95:5) = 0.25. mp. 98-99 °C;  
1H NMR (300 MHz, CDCl3): ! = 0.92 (d, J = 6.8 Hz, 6 H), 0.96 (d, J = 6.8 Hz, 6 H), 
1.50 (s, 6 H), 1.82 (oct, J = 6.8 Hz, 2 H), 2.66 (bs, 2 H), 3.52 (m, 2 H), 3.69–3.86 (m, 4 
H), 6.41 (d, J = 8.6 Hz, 2 H). 13C NMR (75 MHz, CDCl3): ! = 18.8, 19.6, 23.7, 29.1, 
50.2, 57.1, 63.5, 174.5. 
 
(R,R)-bis(4-iso-propyloxazoline) ((+)208) 
 
An oven dried 500 mL, 2-necked round-bottom flask equipped 
with a stirring bar and a 50 mL, pressure-equalizing addition funnel 
connected to a mineral oil bubbler was purged with nitrogen and 
charged with (R,R)-N,N'-bis-(1-hydroxymethyl-2-methylpropyl)-
2,2-dimethylmalon- amide (211) (5.5 g, 18.4 mmol), DMAP (0.204 g, 1.67 mmol) and 
dry CH2Cl2 (130 mL). The flask was immersed in a water bath at rt and NEt3 (10.25 mL, 
73.4 mmol) was added slowly via syringe. Subsequently, tosyl-chloride (7.10 g, 37 
mmol, 2.0 eq.), dissolved in dry CH2Cl2 (15 mL), was added dropwise over 30 min. After 
completion of the addition the funnel was rinsed with dry CH2Cl2 (2.5 mL) and the 
N N
OO
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reaction mixture was stirred for an additional 27 h at rt. The reaction mixture was treated 
with sat. NH4Cl (70 mL) followed by water (40 mL). The aqueous layer was separated 
and extracted with CH2Cl2 (3x55 mL), and the combined organic layers were dried over 
MgSO4. The organic solution was filtered and concentrated under vacuum. The oily 
residue was treated with hot pentane (40 mL), stirred for 5 min and the supernatant liquid 
was decanted. This procedure was repeated three times and the collected pentane layers 
were combined and concentrated under vacuum to yield (+)-211 (4.05 g, 15.2 mmol, 
83%) as a colorless oil, which rendered solid while stored at -35 °C under a N2-
atmosphere. 
An analytically pure sample for characterization purposes was obtained by Kugelrohr- 
distillation (95-100 °C, 0.5 mm Hg) of the crude material. 
Rf (dichloromethane/methanol 9:1) = 0.25 
1H NMR (300 MHz, CDCl3) ! = 0.85 (d, J = 6.8 Hz, 6 H), 0.91 (d, J = 6.8 Hz, 6 H), 1.51 
(s, 6 H), 1.88-1.73 (m, 2 H), 4.06-3.93 (m, 4 H), 4.26-4.15 (m, 2 H). 13C NMR (75 MHz, 
CDCl3) ! = 17.3, 18.5, 24.4, 32.2, 38.5, 69.9, 71.5, 168.7. 
 
(1R,2R,3R)-(+)-2- Oxalic acid 2-ethoxycarbonyl-3-formylcyclopropylester methyl 
((+)-206) 
A 500 mL flask equipped with a stirring bar and a 500 mL, 
pressure-equalizing, addition funnel with incorporated Mariotte 
tube connected to a mineral oil bubbler, was purged with 
nitrogen and cooled to 0 °C. It was charged with Cu(OTf)2 (0.227 g, 0.628 mmol, 
0.66%mol), (R,R)-iso-propyl-bis(oxazoline) (+)-211 (0.211 g, 0.799 mmol, 0.84 mol%) 
and dry CH2Cl2 (10 mL) resulting in a deep blue solution. After stirring for 10 min furan-
2-carboxylic acid methyl ester 200 (12 g, 95 mmol, 1.0 eq.) was poured in and phenyl 
hydrazine (3 drops) was added via a syringe leading to a color change to red-brown 
which indicates the reduction of copper(II) to copper(I). This solution was stirred for 30 
min and subsequently ethyldiazoacetate (215 mL solution of 10.14% mass, 0.25 mol, 
2.67 eq.) in CH2Cl2 was added via the addition funnel during 5 days. On completion of 
addition the solution was stirred for 1 h until no gas evolution was observed any longer. 
The reaction mixture was passed through a pad of basic alumina, followed by CH2Cl2 
(500 mL). The organic layers were combined and concentrated under reduced pressure to 
O CO2Me
H
H
EtO2C
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afford yellow-brown oil. The residue was purified by fractioned distillation under 
reduced pressure (p = 3x10-2 mbar, b.p. = 38-44 °C) and starting material (4.78 g, 37.9 
mmol, 40%) was recovered. The brown residue was purified by column chromatography 
(silica, 4x36 cm, hexanes: ethylacetate 9:1) to yield the desired product (+)-206 (10.8 g, 
50.90 mol, 85% ee, 54% yield, 89% yield based on recovered starting material) as a 
yellowish oil. To obtain enantiomeric pure product the oil was treated with n-pentane 
(200 mL) followed by CH2Cl2 (8 mL) with stirring until the solution changed from 
cloudy to clear. The solution was kept for 16 h at -27 °C and a small enantiomerically 
pure crystal was added which gave rise to colorless crystals after 6 d. The supernatant 
liquid was removed by filtration and the remaining crystals were dried in vacuo to afford 
(+)-206 (6.90 g, 33.0 mmol, 34%, >99% ee) as colorless crystals. After concentration of 
the mother liquor in vacuo the residue was again treated with n-pentane (120 mL) and 
CH2Cl2 (2 mL) and set for crystallization at -27 °C for 5 d. Removal of the supernatant 
liquid and drying in vacuo afforded (+)-206 (0.609 g, 2.87 mmol, 3%, >99% ee, total 
yield: 7.51 g, 35.39 mol, 38% yield, 62% yield based on recovered starting material) as 
colorless crystals. 
Rf (hexanes: ethylacetate 5:1, Vanilline) = 0.16. mp. = 42 °C. – [! ]20D = +272 (c = 1.0, 
CH2Cl2). – 1H NMR (300 MHz, CDCl3): ! = 1.16 (dd, J = 2.7, 1.1 Hz, 1 H, 6-H), 1.27 (t, 
J = 7.1 Hz, 3 H, CH3), 2.87 (ddd, J = 5.3, 2.9, 2.7 Hz, 1 H, 5-H), 3.81 (s, 3 H, OCH3), 
4.16 (q, J = 7.1 Hz, 2 H, CH2CH3), 4.97 (dd, J = 5.3, 1.1 Hz, 1 H, 1-H), 6.40 (d, J = 2.9 
Hz, 1 H, 4-H). – 13C NMR (75 MHz, CDCl3): ! = 14.20 (+, CH3), 21.43 (+, C-6), 31.97 
(+, C-5), 52.26 (+, OCH3), 61.08 (-, CH2), 67.54 (+, C-1), 116.19 (+, C-4), 149.15 
(Cquart, C-3), 159.54 (Cquart, CO), 171.78 (Cquart, CO). – IR (KBr): $ = 3118, 2956, 
1720, 1617, 1428, 1380, 1297, 1166, 1124, 1041, 954, 831, 725 cm–1.  
 
(1R,2R,3R)-(-)-oxalic acid 2-ethoxycarbonyl-3-formyl-cyclopropyl ester methyl ester  
((+)-207)) 
A 100 mL flask was charged with a solution of (+)-206 (3.022 g, 
14.24 mmol, 1.0 eq.) in dry CH2Cl2 (50 mL). The flask was 
equipped with a gas passing tube connected with one side to an 
ozone generator and with the other side to a drying tube 
containing KOH coated clay ending up in the hood. The solution was cooled to -78 °C 
OC(O)CO2Me
CO2Et
OHC
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and a constant stream of oxygen containing ozone (O2 = 150 l/h, O3 = 7 g/h) was 
immersed into the solution until a deep blue color appeared (approx. 15 min). Excess of 
ozone was expelled by passing a constant flow of oxygen for another 10 min into the 
solution. The gas inlet tube was replaced by a drying tube. DMS (2.28 mL, 57 mol, 4.0 
eq.) was added at -78 °C, and the reaction mixture was allowed to warm up slowly to rt 
and stirred for 22 h. The solution was washed with sat. NaHCO3 (10 mL) and the aqueous 
layer was extracted with CH2Cl2 (10 mL). The combined organic layers were washed 
with H2O (5 mL) and the aqueous layer was extracted again with CH2Cl2 (5 mL). The 
combined organic layers were dried (Na2SO4) and concentrated under reduced pressure to 
yield the aldehyde (3.199 g, 13.10 mmol, 92%) as a pale yellow oil which can be used 
without any further purification. To obtain a colorless microcrystalline solid the crude 
product was crystallized from Et2O (3 mL) and stored at -35 °C for 2 weeks. The solvent 
was removed by a pipette and the solid was dried in vacuo to give (+)-207 (3.124 g, 
12.78 mmol) in 94% yield. 
mp. = 52 °C. - [! ]20D = + 37.5 (c = 1.0, CH2Cl2);  
1H NMR (300 MHz, CDCl3): ! = 1.30 (t, J = 7.2 Hz, 3 H), 2.81 (ddd, J = 7.2, 6.0, 4.0 
Hz, 1 H), 2.93 (dd, J = 6.0, 3.6 Hz, 1 H), 3.92 (s, 3 H), 4.20 (q, J = 7.2 Hz, 1 H), 4.21 (q, 
J = 7.1 Hz, 1 H), 4.83 (dd, J = 7.2, 3.6 Hz, 1 H), 9.47 (d, J = 4.0 Hz, 1 H).- 13C NMR (75 
MHz, CDCl3): ! = 14.1 (+, CH3), 26.36 (+, C-3), 34.86 (+, C-2), 54.00 (+, CO2CH3), 
58.87 (+, C-1), 62.03 (-, CH2), 156.59 (Cquart, CO), 156.86 (Cquart, CO), 168.13 
(Cquart, CO2Et), 192.13 (+, CHO). – IR (KBr): $ = 2985, 1779, 1751, 1724, 1708, 1445, 
1312, 1290, 1208, 1005, 736 cm-1. 
 
(1R,2R,3S)-2-(ethoxycarbonyl)-3-((S)-1-hydroxybut-3-en-1-yl)cyclopropyl methyl 
oxalate (214) 
14g (57.33 mmol) of cyclopropane carbaldehyde (+)-207 
was taken in a 220 mL of anhydrous dichloromethane at -78 
°C, to this 8.64 mL (68.79 mmol) of BF3. EtO2 was added 
slowly. After five minutes, 13.7 mL (86 mmol) of allyltrimethylsilane was added drop 
wise and the reaction was stirred for 12 h at -78 °C.  Saturated NaHCO3 was added to the 
reaction mixture and allowed to rt. The organic layer was separated and the aqueous layer 
OC(O)CO2Me
CO2Et
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was extracted with CH2Cl2 (3x25 mL). The combined organic layers washed with brine 
and dried over anhydrous Na2SO4. Removal of the solvent under reduced pressure afford 
the cyclopropane allylalcohol 214 in quantitative yield. 
1H NMR (300 MHz, CDCl3): ! = 1.25 (t, J = 7.0 Hz, 3H), 1.81-1.92 (m, 1H), 2.15 (dd, J 
= 6.2, 2.7 Hz, 1H), 2.31-2.51 (m, 4H), 3.70 (ddd, J = 7.3, 7.3, 5.4 Hz, 1H), 3.88 (s, 3H), 
4.13 (q, J = 7.0 Hz, 2H), 4.72 (dd, J = 7.5, 2.8 Hz, 1H), 5.14-5.22 (m, 2H), 5.76-5.93 (m, 
1H). - 13C NMR (75 MHz, CDCl3): ! = 14.1, 24.7, 31.3, 41.7, 53.8, 58.8, 61.3, 67.8, 
118.8, 133.4, 157.2, 157.2, 170.6.  
 
(2R,3S)-2-allyl-5-oxotetrahydrofuran-3-carbaldehyde (201) 
16.4 g (61.19 mmol) of cyclopropane allylalcohol 214 was taken in 
260 mL of methanol and to this 9.65 g (30.6 mmol) of Ba(OH)2 in 310 
mL of methanol was added drop wise at 0 °C . The reaction was stirred 
for 6 h and the solvent was removed under reduced pressure. The crude 
mixture was diluted with CH2Cl2 and water. The layers were separated after long time. 
The organic layer was taken and dried over anhydrous Na2SO4 and the crude product was 
purified by column chromatography to afford 201 in 50 % yield. 
1H NMR (300 MHz, CDCl3): ! = 2.32-2.59 (m, 2H), 2.71 (dd, J = 18.2, 9.9 Hz, 1H), 2.89 
(dd, J = 18.2, 7.5 Hz, 1H), 3.19 (m, 1H), 4.74 (dd J = 11.9, 6.2 Hz, 1H), 5.10- 5.27 (m, 
2H), 5.75 (m, 1H), 9.69 (d, J = 1.2 Hz, 1H). - 13C NMR (75 MHz, CDCl3): ! = 28.8, 39.2, 
51.2, 78.0, 120.4, 130.9, 174.2, 197.4. 
 
(4R,5R)-5-allyl-4-(1-hydroxybut-3-en-1-yl)dihydrofuran-2(3H)-one (223) 
A solution of (+)-201 (0.10 g, 0.649 mmol, 1 eq.) in CH2Cl2 (2 mL) 
was cooled down to -78 °C under N2 atmosphere. BF3.Et2O (0.1 mL, 
0.77 mmol) was added via syringe and stirred for 20 min. 
Trimethylallylsilane (0.11 g, 0.97 mmol) in CH2Cl2 (2 mL) was 
added subsequently via syringe drop wise for 5 min. The resulting brown solution was 
stirred for overnight at -78 °C, and then it was quenched with sat. NaHCO3 (0.5 mL), 
allowed to warm up to room temperature. The layers were separated and the aqueous 
layer was again extracted with CH2Cl2 (5 x 2 mL). The combined organic layers were 
OO
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washed with H2O, brine, dried (Na2SO4), filtered and concentrated in vacuo to yield 223 
(0.104 g, 82%). The yellowish oil thus obtained (in 73 : 27 dr ratio) was used without 
further purification. 
1H NMR (300 MHz, CDCl3): ! = 2.01-2.91 (m, 7H), 3.71-3.82 (m, 1H), 4.71 (dd, J = 
11.9, 6.2 Hz, 1H), 5.12-5.41 (m, 4H), 5.72-6.02 (m, 2H). - 13C NMR (75 MHz, CDCl3): ! 
= 28.75, 38.80, 40.09, 44.68, 68.59, 81.15, 119.04, 119.64, 132.21, 133.45, 176.42. 
 
(4S,5R)-5-allyl-4-((S)-1-((triethylsilyl)oxy)but-3-en-1-yl)dihydrofuran-2(3H)-one 
(224) 
To a solution of 223 (100 mg, 0.510 mmol, 1 eq.) in CH2Cl2 (2 mL) 
was added DMAP (0.5 eq.), Et3N (0.141 mL, 1.02 mmol, 2 eq.), 
followed by the drop wise addition of TESCl (0.13 mL, 0.765 mmol, 
1.5 eq.) and stirred at room temperature for 36 h. The reaction 
mixture was quenched with H2O and the layers were separated. The organic phase was 
washed with NaHCO3 (1 mL), brine and dried over Na2SO4. The filtrate was concentrated 
in vacuo and purified by silica gel column chromatography (PE: EA= 9:1) to afford 224 
(81 mg, and the another diastereomer 37 mg, overall 75%) as colorless oil.  
1H NMR (300 MHz, CDCl3): ! = 0.66 (t, J = 7.71, 6H), 0.91 (q, J = 7.71, 9H), 2.01-2.19 
(m, 1H), 2.20-2.53 (m, 5H), 2.61-2.69 (m, 1H), 3.71-3.82 (m, 1H), 4.35 (dd, J = 11.9, 6.2 
Hz, 1H), 5.12-5.21 (m, 4H), 5.72-5.92 (m, 2H). - 13C NMR (75 MHz, CDCl3): ! = 5.11, 
6.59, 28.22, 38.77, 41.00, 44.22, 70.23, 81.36, 118.19, 118.93, 132.33, 133.41, 176.61. 
Rf (hexanes: ethylacetate 19:1, Vanillin) = 0.47.  
HRMS (EI, 70 eV): Calcd for C17H30O3Si [M+]: 310.5308, found: 310.5011. 
 
(4S,5R)-ethyl 5-allyl-2-oxo-4-(1-((triethylsilyl)oxy)but-3-en-1-yl)tetrahydrofuran-3-
carboxylate (230) 
A solution of 224 (60 mg, 0.193 mmol, 1 eq.) in THF (2 mL) was 
cooled down to -78 °C under N2 atmosphere. Freshly prepared 
LDA (1.7 eq.) was added via syringe and stirred for 30 min. 
Ethylchloroacetate (0.046 mL, 0.291 mmol) in THF (2 mL) was 
added subsequently via syringe drop wise for 5 min. The resulting solution was stirred for 
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another hour at -78 °C, and then warm to rt and then it was quenched (after disappearance 
of starting material judged by TLC) with sat. NH4Cl (0.5 mL). The layers were separated 
and the aqueous layer was again extracted with ethylacetate (5 x 2 mL). The combined 
organic layers were washed with H2O, brine, dried (Na2SO4), filtered and concentrated in 
vacuo to yield 230 (51 mg, 75%) as colorless oil.  
1H NMR (300 MHz, CDCl3): ! = 0.66 (t, J = 7.71, 6H), 0.91 (q, J = 7.71, 9H), 1.25 (t, J = 
7.13 Hz, 3H), 2.01-2.19 (m, 1H), 2.20-2.31 (m, 1H), 2.39-2.48 (m, 2H), 2.80-2.90 (m, 
1H), 3.71-3.82 (m, 1H), 3.84 (d, J = 2.4 Hz, 1H), 4.17 (q, J = 7.13 Hz, 2H), 4.35 (m, 1H), 
4.92-5.18 (m, 4H), 5.52-5.82 (m, 2H). - 13C NMR (75 MHz, CDCl3): ! = 5.12, 6.82, 
14.04, 38.83, 40.67, 47.02, 48.21, 62.11, 70.58, 80.66, 118.76, 119.20, 132.07, 132.86, 
168.56, 171.68. 
Rf (hexanes: ethylacetate 9:1, Vanillin) = 0.39. 
HRMS (EI, 70 eV): Calcd for C20H34O5Si [M+]: 382.2176, found: 382.2123. 
 
(1R,6aS)-ethyl 1-allyl-4-methylene-3-oxo-6-((triethylsilyl)oxy)hexahydro-1H-
cyclopenta[c]furan-3a-carboxylate (228a) 
To a suspension of Mn(OAc)3 (58 mg, 0.219 mmol, 2 eq.) and 
Cu(OAc)2 (22 mg, 0.109 mmol, 1eq.) in CH3COOH (1 mL), 
compound 230 (34 mg, 0.109 mmol) in 1 mL of CH3COOH was 
added and refluxed at 94 °C for 5h. After cooled to rt, 2 mL of 
water and sat. NaHSO3 solution (0.5 mL) were added to it. Then the solution was 
extracted with CH2Cl2 (10x3 mL). The combined organic layers were washed with 
NaHCO3, brine, dried (Na2SO4), filtered and concentrated in vacuo and then passed 
through silica gel to afford 228a (29 mg, 70%) as colorless oil.  
1H NMR (300 MHz, CDCl3): ! = 0.66 (t, J = 7.71, 6H), 0.91 (q, J = 7.71, 9H), 1.25 (t, J = 
7.13 Hz, 3H), 2.41-2.59 (m, 3H), 2.65-2.75 (m, 1H), 3.12-3.21 (m, 1H), 4.27 (q, J = 7.13 
Hz, 2H), 4.35-4.41 (m, 1H), 4.72-4.78 (m, 1H), 5.12-5.22 (m, 2H), 5.27 (bs, 1H), 5.61 
(bs, 1H), 5.81-5.91 (m, 1H). - 13C NMR (75 MHz, CDCl3): ! = 4.74, 6.74, 39.86, 41.79, 
54.97, 62.39, 71.81, 114.19, 118.91, 132.48, 142.77, 168.56, 171.68. 
Rf (hexanes: ethylacetate 9:1, Vanillin) = 0.34. 
HRMS (EI, 70 eV): Calcd for C20H32O5Si [M+]: 380.5506, found: 380.5496. 
OO H
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12. Appendix 
 
 
NMR-spectra 
 
 
 
1H-NMR spectra – upper image 
 
13C- NMR spectra – lower image 
 
 
Solvents, if not stated otherwise: CDCl3 
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2-Bromo-1-(4-methoxyphenyl)ethanone (142a) 
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1-(4-methoxyphenyl) ethanone (143a) 
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2-Bromo-1-(naphthalen-2-yl)ethanone (142e) 
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1-(naphthalen-2-yl)ethanone (143e) 
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2-Bromo-3,4-dihydronaphthalen-1(2H)-one (142g) 
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3,4-Dihydronaphthalen-1(2H)-one (143g) 
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2-Bromo, 4-phenylcyclohexanone (142j) 
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4-Phenylcyclohexanone (143j) 
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2,2-Dibromo-1-(4-methoxyphenyl)ethanone (144b) 
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2,2-Dibromo-3,4-dihydronaphthalen-1(2H)-one (144c) 
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(2S, 3R)-2, 3-dibromo-1,3-diphenylpropan-1-one (147a) 
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(E)-1,3-diphenylprop-2-en-1-one (148a) 
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(R)-2-bromo-2-((S)-bromo(phenyl)methyl)-3,4-dihydronaphthalen-1(2H)-one (147e) 
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(E)-2-benzylidene-3,4-dihydronaphthalen-1(2H)-one (148e) 
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(2S,3R)-2,3-dibromo-1-(furan-2-yl)-3-phenylpropan-1-one (147f) 
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(E)-1-(furan-2-yl)-3-phenylprop-2-en-1-one (148f) 
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(S)-3-((2S, 3R)-2,3-dibromo-3-phenylpropanoyl)-4-isopropyloxazolidin-2-one (147g) 
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(S)-3-cinnamoyl-4-isopropyloxazolidin-2-one (148g) 
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Ethyl 2,3-dibromodecanoate (147i) 
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(E)-ethyl dec-2-enoate (148i)$$$
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Ethyl 2,3-dibromo-3-phenylbutanoate (erythro:threo = 67:33) (150a) 
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(E)-ethyl 3-phenylbut-2-enoate (151a) 
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(2S,3R)-ethyl 2,3-dibromo-3-cyclohexyl-2-methylpropanoate (erythro:threo= 52:48) 
(150c) 
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(E)-ethyl 3-cyclohexyl-2-methylacrylate (151c) 
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(2S,3R)-ethyl 2,3-dibromo-2-methyl-3-phenylpropanoate (150e) 
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Ethyl 2-methyl-3-phenylacrylate (151e) 
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(E)-ethyl 2,3-dibromo-3-phenylacrylate (152) 
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Ethyl 3-phenylpropiolate (153) 
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(1S,5S,6S)-tert-Butyl 6-(hydroxymethyl)-2-azabicyclo[3.1.0]hex-3-ene-2-carboxylate 
(172c) 
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tert-Butyl 3-methyl-2-oxopyrrolidine-1-carboxylate (172Eʼ) !
!
NO
Boc
!"#$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$!""#$%&'!
%&$"'()*$+,-$.,/0)0$123445$! "#&!
tert-Butyl 4-methyl-2,3-dihydro-1H-pyrrole-1-carboxylate (172e) 
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2-(4-Methoxyphenyl)-3,4-dihydro-2H-pyran (182b) 
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(1R,2S)-Methyl 2-(N-(tert-butoxycarbonyl)formamido)-3-formylcyclopropanecarbo-
xylate (173a) 
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(1R,2S)-2-(N-(tert-butoxycarbonyl)formamido)-3-formylcyclopropanecarboxylic 
acid (173b) 
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tert-Butyl formyl((1S,3S)-2-formyl-3-(hydroxymethyl)cyclopropyl)carbamate (173c) 
 
!
OHC
Boc(OHC)N
CH2OH
!"#$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$!""#$%&'!
%&$"'()*$+,-$.,/0)0$123445$! "')!
tert-Butyl formyl(3-oxopropyl)carbamate (173d) 
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tert-Butyl formyl(3-oxobutyl)carbamate (173e) !
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tert-Butyl formyl(4-oxobutyl)carbamate (173f) !
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1,3,3-Trimethyl-5-nitroindolin-2-one (173g) 
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1,3,3-Trimethylindolin-2-one (173h) 
 
!
N
O
!"#$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$!""#$%&'!
%&$"'()*$+,-$.,/0)0$123445$! "'&!
1,4,4-Trimethylquinoline-2,3-(1H,4H)-dione (173h  ́) 
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4-Oxobutyl formate (183a) 
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1-(4-Methoxyphenyl)-4-oxobutyl formate (183b) 
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2,3-Dioxabicyclo[2.2.2]oct-5-ene (163) 
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1-Isopropyl-4-methyl-2,3-dioxabicyclo[2.2.2]oct-5-ene (166) 
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(1S,2R)-Methyl-2-(N-(tert-butoxycarbonyl)formamido)-3-((2-tosylhydrazono) 
methyl)cyclopropanecarboxylate (dr = 78:22) (177)!
!
Boc(OHC)N
CO2Me
N
TsHN
!"#$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$!""#$%&'!
%&$"'()*$+,-$.,/0)0$123445$! )(*!
tert-Butyl formyl(4-(2-tosylhydrazono)butyl)carbamate (dr = 93:7) (178) !!
!
N
N(CHO)Boc
TsHN
!"#$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$!""#$%&'!
%&$"'()*$+,-$.,/0)0$123445$! )(+!
Methyl 2-(triphenylphosphoranylidene)acetate (179) 
 
!
O
OMePh3P
!"#$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$!""#$%&'!
%&$"'()*$+,-$.,/0)0$123445$! )($!
(1S,2R)-Methyl 2-(N-(tert-butoxycarbonyl)formamido)-3-((E)-3-methoxy-3-oxoprop-
1-en-1-yl)cyclopropanecarboxylate (trans:cis = 94:6) (180) 
!
Boc(OHC)N
CO2Me
MeO2C
!"#$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$!""#$%&'!
%&$"'()*$+,-$.,/0)0$123445$! )(%!
(E)-Methyl 6-(N-(tert-butoxycarbonyl)formamido)hex-2-enoate (trans:cis = 90:10) 
(181) 
!
N(CHO)Boc
MeO2C
!"#$%&'()*(+($,-.
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